SAGE - Hindawi Access to Research International Journal of Alzheimer’s Disease Volume 2011 , Article ID 501862 , 34 pages doi : 10 . 4061 / 2011 / 501862 Research Article Alzheimer’s Disease : APP , Gamma Secretase , APOE , CLU , CR1 , PICALM , ABCA7 , BIN1 , CD2AP , CD33 , EPHA1 , and MS4A2 , and Their Relationships with Herpes Simplex , C . Pneumoniae , Other Suspect Pathogens , and the Immune System Chris Carter PolygenicPathways , Flat 2 , 40 Baldslow Road , Hastings , East Sussex TN34 2EY , UK Correspondence should be addressed to Chris Carter , chris car @ yahoo . com Received 3 August 2011 ; Accepted 2 September 2011 Academic Editor : Francesco Panza Copyright © 2011 Chris Carter . This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited . Alzheimer’s disease susceptibility genes , APP and gamma - secretase , are involved in the herpes simplex life cycle , and that of other suspect pathogens ( C . pneumoniae , H . pylori , C . neoformans , B . burgdorferri , P . gingivalis ) or immune defence . Such pathogens promote beta - amyloid deposition and tau phosphorylation and may thus be causative agents , whose e ﬀ ects are conditioned by genes . The antimicrobial e ﬀ ects of beta - amyloid , the localisation of APP / gamma - secretase in immunocompetent dendritic cells , and gamma secretase cleavage of numerous pathogen receptors suggest that this network is concerned with pathogen disposal , e ﬀ ects which may be abrogated by the presence of beta - amyloid autoantibodies in the elderly . These autoantibodies , as well as those to nerve growth factor and tau , also observed in Alzheimer’s disease , may well be antibodies to pathogens , due to homology between human autoantigens and pathogen proteins . NGF or tau antibodies promote beta - amyloid deposition , neuroﬁbrillary tangles , or cholinergic neuronal loss , and , with other autoantibodies , such as anti - ATPase , are potential agents of destruction , whose formation is dictated by sequence homology between pathogen and human proteins , and thus by pathogen strain and human genes . Pathogen elimination in the ageing population and removal of culpable autoantibodies might reduce the incidence and o ﬀ er hope for a cure in this a ﬄ iction . 1 . Introduction Hundreds of genes have been implicated in Alzheimer’s disease , many of which can be grouped into discrete sig - nalling networks and pathways relevant to the various sub - pathologies , risk factors , and biochemistry of Alzheimer’s disease . Many of the environmental risk factors associated with Alzheimer’s disease , including infectious agents ( herpes simplex , chlamydia pneumonia , and Borrelia burgdorferi ) as well as Vitamin A deﬁciency , hypercholesterolaemia , hyper - homocysteinaemia or folate deﬁciency , oestrogen depletion , cerebral nerve growth factor ( NGF ) deprivation , diabetes , cerebral hypoperfusion ( leading to hypoxia and hypogly - caemia ) or are able to promote cerebral beta - amyloid deposi - tion ( in the absence of any particular gene variant ) in animal models [ 1 ] . KEGG pathway and other analyses of the multi - ple genes implicated in Alzheimer’s disease have shown that subsets of susceptibility genes can be grouped into networks that are relevant to each of these amyloidogenic pathways ( e . g . , bacterial and viral entry pathways [ 1 , 2 ] , choles - terol / lipoprotein function [ 3 , 4 ] , growth factor signalling [ 5 ] , folate and homocysteine pathways [ 6 ] , insulin signalling [ 7 ] , and steroid or Vitamin A metabolism [ 8 , 9 ] ) . A large number of genes are also related to the immune network [ 10 ] ( see http : / / www . polygenicpathways . co . uk / alzkegg . htm and a recent review for further details [ 1 ] ) . These gene subsets are thus related to multiple external factors that are each able to promote beta - amyloid deposition , suggesting that certain genes are related to the causes of Alzheimer’s disease , ( agents able to provoke beta - amyloid deposition ) rather than ( and as well as ) to the underlying pathology of the disease itself . Several studies have implicated the herpes simplex virus in the aetiology of Alzheimer’s disease [ 11 – 13 ] . Viral DNA is found in amyloid plaques [ 14 ] , which are also heavily 2 International Journal of Alzheimer’s Disease enriched in proteins used by the virus during its life cycle , as well as in proteins related to the immune network [ 15 ] , and Immunoglobulin IgM , but not IgG seropositivity for herpes simplex is predictive of the subsequent development of Alzheimer’s disease [ 16 ] . IgM seropositivity is indicative of viral reactivation which again can be induced by several of the risk factors relevant to Alzheimer’s disease and its underlying genetic pathways ( e . g . , NGF deprivation , 17 - beta oestradiol , hypoxia , or fever and interleukin 6 activation , with the latter being common and general consequences of infection [ 1 ] ) . Along with herpes simplex , a number of other pathogens have been implicated in Alzheimer’s disease and its associated pathologies . The viral , bacterial , spirochete , and fungal pathogens implicated in dementia or Alzheimer’s disease are referenced at ( http : / / www . polygenicpathways . co . uk / alzen - vrisk . htm ) and include HHV - 6 , Chlamydia pneumoniae , Hel - icobacter pylori , periodontal pathogens involved in gum dis - ease [ 17 ] , Borrelia burgdorferi , and Cryptococcus neoformans . HIV - 1 is also able to provoke dementia with Alzheimer’s disease pathology [ 18 ] . Of these , H . pylori eradication has been reported to improve performance and increase lifespan in Alzheimer’s disease patients [ 19 ] , while two case reports indicated virtually complete recovery from long - term ( 3 years ) misdiagnosed dementia / Alzheimer’s disease following antifungal treatment for C . neoformans infection [ 20 , 21 ] . Many of these pathogens including herpes simplex , HHV - 6 , C . Pneumoniae , H . pylori and the periodontal pathogen , P . Gingivalis , have also been implicated in atherosclerosis [ 22 – 25 ] , while C . neoformans infection in rabbits induces an increase in neutrophil superoxide production , plasma lipid peroxidation , and an increase in inﬂammatory cells , fore - runners of atherosclerosis [ 26 ] . Atherosclerosis of the carotid arteries , or of the circle of Willis and leptomeningeal arteries , is a signiﬁcant predictor of risk in dementia or Alzheimer’s disease and correlates with Alzheimer’s disease pathology [ 27 , 28 ] . Cerebral hypoperfusion ( hypoglycaemia , hypoxia , ischaemia , or carotid occlusion ) or other factors linked to atherosclerosis ( e . g . , high cholesterol or homocysteine levels ) are also able , per se , to induce cerebral beta - amyloid deposi - tion in animal models ( see above ) . Genomewide association studies ( GWAS ) have now identiﬁed a subset of genes which , along with APOE4 [ 29 ] , contribute a high proportion of genetic risk . These in - clude clusterin ( CLU ) , phosphatidylinositol - binding clathrin assembly protein ( PICALM ) and complement receptor 1 ( CR1 ) as well as the ATP cassette transporter ABCA7 , Bridg - ing integrator BIN1 , a CD2 - associated protein ( CD2AP ) , CD33 , ephrin A1 ( EPHA1 ) , and a membrane - spanning 4 - domains , subfamily A ( MS4A ) cluster recently honed down to MS4A2 , although other genes within this cluster may also be relevant [ 30 , 31 ] . As discussed below , the major Alzheimer’s disease genes implicated by the recent GWAS data , as well as APP and gam - ma secretase , and previous GWAS results are majoritarily involved in pathogen entry and defence , particularly in rela - tion to herpes simplex , but also to other relevant pathogens , and in the immune network . This suggests that genes , pathogens , and the immune system act together to cause Alzheimer’s disease , and that a focus on pathogen detection and elimination should be a priority in the ageing at risk population . 2 . Methods The genes identiﬁed in a number of recent genomewide association studies are available at the GWAS repository at the National Human Genome Research Institute http : / / www . genome . gov / gwastudies / [ 32 ] and , along with pre - GWAS genes and environmental risk factors , at http : / / www . polygen - icpathways . co . uk / alzenvrisk . htm . The genes returned from very large sample sets ( N > 10 , 000 ) include ABCA7 , APOE , BIN1 , CD2AP , CD33 , CLU , CR1 , EPHA1 , MS4A2 , MS4A4A , MS4A4E , MS4A6A , and PICALM whose pro perties in re - lation to diverse pathogens were identiﬁed by literature su - rvey . While it is recognised that such genes , particularly APOE , ABCA7 , CR1 , and clusterin , which are involved in lipoprotein function and / or amyloid processing ( see below ) , may exert e ﬀ ects on other relevant branches of Alzheimer’s disease pathophysiology , the focus of this paper is on path - ogens and the immune system , which appear to be the com - mon factors integrating this network . Throughout the text , these and other genes implicated in Alzheimer’s disease from the GWAS and pre - GWAS era are highlighted in bold and appended to the various processes in which they are involved ( derived from a KEGG pathway analysis of these genes http : / / www . polygenicpathways . co . uk / alzkegg . htm ) Herpes simplex binding proteins , and key interactors , currently numbering over 450 , are stocked and referenced at http : / / www . polygenicpathways . co . uk / herpeshost . html . KEGG pa - thway analysis of this interactome is provided at http : www . polygenicpathways . co . uk / / HERPESKEGG . htm . Expression data are provided in Figure 1 and are also hyperlinked to the BioGPS webserver http : / / www . biogps . gnf . org / , which provides general gene information and mRNA expression proﬁles for most human genes , based on custom arrays from 79 human issues [ 33 , 34 ] . Predicted B - cell epitopes from human beta - amyloid ( 1 – 42 ) , nerve growth factor ( NP 002497 . 2 ) , or the microtubule protein , tau ( NP 001116538 . 2 ) were identiﬁed using the BepiPred server http : / / www . cbs . dtu . dk / services / BepiPred / [ 35 ] and their seq - uences compared with pathogen proteomes ( Borrelia burg - dorferi , C . neoformans , Helicobacter pylori , herpes viruses HSV - 1 , HSV - 2 , HHV - 6 , and the cytomegalovirus ( HHV - 5 ) ) using the NCBI BLAST server ( Protein versus protein : BlastP ) [ 36 ] . 3 . Results 3 . 1 . The Complement System ( ABCA7 , CR1 , CLU , CD2AP , and Beta - Amyloid ) Figure 2 . Complement receptor 1 ( highly expressed in myeloid CD33 + cells ( bone marrow ) http : / / www . biogps . org / # goto = genereport & id = 1378 / ) is a re - ceptor for herpes simplex , adenovirus 5 , the inﬂuenza virus and HIV - 1 , as well as for a number of other pathogens , including P . gingivalis , C . neoformans , Streptococcus pneu - moniae , Staphylococcus aureus , and the malaria parasite , International Journal of Alzheimer’s Disease 3 219577 K i d n e y T o n s i l L y m p h n o d e T h y m u s B o n e m a rr o w A d r e n a l g l a n d A d r e n a l c o r t e x O l f a c t o r y b u l b T r a c h e a S a l i v a r y g l a n d P i t u i t a r y F e t a ll i v e r F e t a ll u n g F e t a l t h y r o i d U t e r u s A d i p o c y t e P a n c r e a s T e s t i ss e m i n i f e r o u s t u b u l e T e s t i s l e y d i g c e ll T e s t i s g e r m c e ll T e s t i s C o l o r e c t a l a d e n o c a r c i n o m a B r o n c h i a l e p i t h e l i a l c e ll s S m oo t h m u s c l e C a r d i a c m y o c y t e s L e u k e m i a l y m p h o b l a s t i c ( M O L T - 4 ) L e u k e m i a c h r o n i c M y e l o g e n o u s K - 562 L e u k e m i a p r o m y e l o c y t i c - H L - 60 T h y r o i d P r o s t a t e L u n g P l a c e n t a S m a ll i n t e s t i n e C o l o n L i v e r H e a r t U t e r u s c o r p u s A pp e n d i x O v a r y D o r s a l r oo t g a n g l i o n C i l i a r y g a n g l i o n A t r i o v e n t r i c u l a r n o d e S k i n T r i g e m i n a l g a n g l i o n S u p e r i o r c e r v i c a l g a n g l i o n T o n g u e S k e l e t a l m u s c l e R e t i n a P i n e a l n i g h t P i n e a l d a y W h o l e b r a i n A m y g d a l a P r e f r o n t a l c o r t e x S p i n a l c o r d H y p o t h a l a m u s F e t a l b r a i n T h a l a m u s C a u d a t e n u c l e u s P a r i e t a ll o b e M e d u ll a o b l o n g a t a C i n g u l a t e c o r t e x O cc i p i t a ll o b e T e m p o r a ll o b e S u b t h a l a m i c n u c l e u s P o n s G l o b u s p a ll i d u s C e r e b e ll u m C e r e b e ll u m p e d u n c l e s C D 34 + C D 105 + e n d o t h e l i a l 721 B l y m p h o b l a s t s W h o l e b l oo d 0 100 200 300 400 L y m p h o m a b u r k i tt s ( d a u d i ) L y m p h o m a b u r k i tt s ( r a j i ) C D 33 + m y e l o i d C D 14 + m o n o c y t e s s at 3 × M 10 × M 30 × M M e d i a n ( 8 . 6 ) P a n c r e a t i c l s l e t C D 8 + T c e ll s C D 4 + T c e ll s C D 56 + N K c e ll s B D C A 4 + d e n t r i t i c c e ll s C D 71 + e a r l y e r y t h r o i d C D 19 + B c e ll s ( n e g . s e l . ) T e s t i s i n t e r s t i t i a l ABCA7 212883 0 200 at M e d i a n ( 6 . 9 ) 3 × M 10 × M K i d n e y T o n s i l L y m p h n o d e T h y m u s B o n e m a rr o w A d r e n a l g l a n d A d r e n a l c o r t e x O l f a c t o r y b u l b T r a c h e a S a l i v a r y g l a n d P i t u i t a r y F e t a ll i v e r F e t a ll u n g F e t a l t h y r o i d U t e r u s A d i p o c y t e P a n c r e a s T e s t i ss e m i n i f e r o u s t u b u l e T e s t i s l e y d i g c e ll T e s t i s g e r m c e ll T e s t i s C o l o r e c t a l a d e n o c a r c i n o m a B r o n c h i a l e p i t h e l i a l c e ll s S m oo t h m u s c l e C a r d i a c m y o c y t e s L e u k e m i a l y m p h o b l a s t i c ( M O L T - 4 ) L e u k e m i a c h r o n i c M y e l o g e n o u s K - 562 L e u k e m i a p r o m y e l o c y t i c - H L - 60 T h y r o i d P r o s t a t e L u n g P l a c e n t a S m a ll i n t e s t i n e C o l o n L i v e r H e a r t U t e r u s c o r p u s A pp e n d i x O v a r y D o r s a l r oo t g a n g l i o n C i l i a r y g a n g l i o n A t r i o v e n t r i c u l a r n o d e S k i n T r i g e m i n a l g a n g l i o n S u p e r i o r c e r v i c a l g a n g l i o n T o n g u e S k e l e t a l m u s c l e R e t i n a P i n e a l n i g h t P i n e a l d a y W h o l e b r a i n A m y g d a l a P r e f r o n t a l c o r t e x S p i n a l c o r d H y p o t h a l a m u s F e t a l b r a i n T h a l a m u s C a u d a t e n u c l e u s P a r i e t a ll o b e M e d u ll a o b l o n g a t a C i n g u l a t e c o r t e x O cc i p i t a ll o b e T e m p o r a ll o b e S u b t h a l a m i c n u c l e u s P o n s G l o b u s p a ll i d u s C e r e b e ll u m C e r e b e ll u m p e d u n c l e s C D 34 + C D 105 + e n d o t h e l i a l 721 B l y m p h o b l a s t s W h o l e b l oo d L y m p h o m a b u r k i tt s ( d a u d i ) L y m p h o m a b u r k i tt s ( r a j i ) C D 33 + m y e l o i d C D 14 + m o n o c y t e s P a n c r e a t i c l s l e t C D 8 + T c e ll s C D 4 + T c e ll s C D 56 + N K c e ll s B D C A 4 + d e n t r i t i c c e ll s C D 71 + e a r l y e r y t h r o i d C D 19 + B c e ll s ( n e g . s e l . ) T e s t i s i n t e r s t i t i a l APOE 120 160 40 80 500 0 3000 214439 x at K i d n e y T o n s i l L y m p h n o d e T h y m u s B o n e m a rr o w A d r e n a l g l a n d A d r e n a l c o r t e x O l f a c t o r y b u l b T r a c h e a S a l i v a r y g l a n d P i t u i t a r y F e t a ll i v e r F e t a ll u n g F e t a l t h y r o i d U t e r u s A d i p o c y t e P a n c r e a s T e s t i ss e m i n i f e r o u s t u b u l e T e s t i s l e y d i g c e ll T e s t i s g e r m c e ll T e s t i s C o l o r e c t a l a d e n o c a r c i n o m a B r o n c h i a l e p i t h e l i a l c e ll s S m oo t h m u s c l e C a r d i a c m y o c y t e s L e u k e m i a l y m p h o b l a s t i c ( M O L T - 4 ) L e u k e m i a c h r o n i c M y e l o g e n o u s K - 562 L e u k e m i a p r o m y e l o c y t i c - H L - 60 T h y r o i d P r o s t a t e L u n g P l a c e n t a S m a ll i n t e s t i n e C o l o n L i v e r H e a r t U t e r u s c o r p u s A pp e n d i x O v a r y D o r s a l r oo t g a n g l i o n C i l i a r y g a n g l i o n A t r i o v e n t r i c u l a r n o d e S k i n T r i g e m i n a l g a n g l i o n S u p e r i o r c e r v i c a l g a n g l i o n T o n g u e S k e l e t a l m u s c l e R e t i n a P i n e a l n i g h t P i n e a l d a y W h o l e b r a i n A m y g d a l a P r e f r o n t a l c o r t e x S p i n a l c o r d H y p o t h a l a m u s F e t a l b r a i n T h a l a m u s C a u d a t e n u c l e u s P a r i e t a ll o b e M e d u ll a o b l o n g a t a C i n g u l a t e c o r t e x O cc i p i t a ll o b e T e m p o r a ll o b e S u b t h a l a m i c n u c l e u s P o n s G l o b u s p a ll i d u s C e r e b e ll u m C e r e b e ll u m p e d u n c l e s C D 34 + C D 1 05 + e n d o t h e l i a l 72 1 B l y m p h o b l a s t s W h o l e b l oo d L y m p h o m a b u r k i tt s ( d a u d i ) L y m p h o m a b u r k i tt s ( r a j i ) C D 33 + m y e l o i d C D 14 + m o n o c y t e s P a n c r e a t i c l s l e t C D 8 + T c e ll s C D 4 + T c e ll s C D 56 + N K c e ll s B D C A 4 + d e n t r i t i c c e ll s C D 71 + e a r l y e r y t h r o i d C D 19 + B c e ll s ( n e g . s e l . ) T e s t i s i n t e r s t i t i a l BIN1 30 × M 3 × M 10 × M M e d i a n ( 53 . 7 ) 1 e + 3 1 . 5 e + 3 2 e + 3 2 . 5 e + 3 Figure 1 : Continued . 4 International Journal of Alzheimer’s Disease 203593 at 0 100 200 300 400 500 30 × M M e d i a n ( 8 . 2 ) 3 × M 10 × M K i d n e y T o n s i l L y m p h n o d e T h y m u s B o n e m a rr o w A d r e n a l g l a n d A d r e n a l c o r t e x O l f a c t o r y b u l b T r a c h e a S a l i v a r y g l a n d P i t u i t a r y F e t a ll i v e r F e t a ll u n g F e t a l t h y r o i d U t e r u s A d i p o c y t e P a n c r e a s T e s t i ss e m i n i f e r o u s t u b u l e T e s t i s l e y d i g c e ll T e s t i s g e r m c e ll T e s t i s C o l o r e c t a l a d e n o c a r c i n o m a B r o n c h i a l e p i t h e l i a l c e ll s S m oo t h m u s c l e C a r d i a c m y o c y t e s L e u k e m i a l y m p h o b l a s t i c ( M O L T - 4 ) L e u k e m i a c h r o n i c M y e l o g e n o u s K - 562 L e u k e m i a p r o m y e l o c y t i c - H L - 60 T h y r o i d P r o s t a t e L u n g P l a c e n t a S m a ll i n t e s t i n e C o l o n L i v e r H e a r t U t e r u s c o r p u s A pp e n d i x O v a r y D o r s a l r oo t g a n g l i o n C i l i a r y g a n g l i o n A t r i o v e n t r i c u l a r n o d e S k i n T r i g e m i n a l g a n g l i o n S u p e r i o r c e r v i c a l g a n g l i o n T o n g u e S k e l e t a l m u s c l e R e t i n a P i n e a l n i g h t P i n e a l d a y W h o l e b r a i n A m y g d a l a P r e f r o n t a l c o r t e x S p i n a l c o r d H y p o t h a l a m u s F e t a l b r a i n T h a l a m u s C a u d a t e n u c l e u s P a r i e t a ll o b e M e d u ll a o b l o n g a t a C i n g u l a t e c o r t e x O cc i p i t a ll o b e T e m p o r a ll o b e S u b t h a l a m i c n u c l e u s P o n s G l o b u s p a ll i d u s C e r e b e ll u m C e r e b e ll u m p e d u n c l e s C D 34 + C D 105 + e n d o t h e l i a l 721 B l y m p h o b l a s t s W h o l e b l oo d L y m p h o m a b u r k i tt s ( d a u d i ) L y m p h o m a b u r k i tt s ( r a j i ) C D 33 + m y e l o i d C D 14 + m o n o c y t e s P a n c r e a t i c l s l e t C D 8 + T c e ll s C D 4 + T c e ll s C D 56 + N K c e ll s B D C A 4 + d e n t r i t i c c e ll s C D 71 + e a r l y e r y t h r o i d C D 19 + B c e ll s ( n e g . s e l . ) T e s t i s i n t e r s t i t i a l CD2AP 0 100 200 300 400 500 206120 at 3 × M 10 × M 30 × M M e d i a n ( 12 . 2 ) K i d n e y T o n s i l L y m p h n o d e T h y m u s B o n e m a rr o w A d r e n a l g l a n d A d r e n a l c o r t e x O l f a c t o r y b u l b T r a c h e a S a l i v a r y g l a n d P i t u i t a r y F e t a ll i v e r F e t a ll u n g F e t a l t h y r o i d U t e r u s A d i p o c y t e P a n c r e a s T e s t i ss e m i n i f e r o u s t u b u l e T e s t i s l e y d i g c e ll T e s t i s g e r m c e ll T e s t i s C o l o r e c t a l a d e n o c a r c i n o m a B r o n c h i a l e p i t h e l i a l c e ll s S m oo t h m u s c l e C a r d i a c m y o c y t e s L e u k e m i a l y m p h o b l a s t i c ( M O L T - 4 ) L e u k e m i a c h r o n i c M y e l o g e n o u s K - 562 L e u k e m i a p r o m y e l o c y t i c - H L - 60 T h y r o i d P r o s t a t e L u n g P l a c e n t a S m a ll i n t e s t i n e C o l o n L i v e r H e a r t U t e r u s c o r p u s A pp e n d i x O v a r y D o r s a l r oo t g a n g l i o n C i l i a r y g a n g l i o n A t r i o v e n t r i c u l a r n o d e S k i n T r i g e m i n a l g a n g l i o n S u p e r i o r c e r v i c a l g a n g l i o n T o n g u e S k e l e t a l m u s c l e R e t i n a P i n e a l n i g h t P i n e a l d a y W h o l e b r a i n A m y g d a l a P r e f r o n t a l c o r t e x S p i n a l c o r d H y p o t h a l a m u s F e t a l b r a i n T h a l a m u s C a u d a t e n u c l e u s P a r i e t a ll o b e M e d u ll a o b l o n g a t a C i n g u l a t e c o r t e x O cc i p i t a ll o b e T e m p o r a ll o b e S u b t h a l a m i c n u c l e u s P o n s G l o b u s p a ll i d u s C e r e b e ll u m C e r e b e ll u m p e d u n c l e s C D 34 + C D 105 + e n d o t h e l i a l 721 B l y m p h o b l a s t s W h o l e b l oo d L y m p h o m a b u r k i tt s ( d a u d i ) L y m p h o m a b u r k i tt s ( r a j i ) C D 33 + m y e l o i d C D 14 + m o n o c y t e s P a n c r e a t i c l s l e t C D 8 + T c e ll s C D 4 + T c e ll s C D 56 + N K c e ll s B D C A 4 + d e n t r i t i c c e ll s C D 71 + e a r l y e r y t h r o i d C D 19 + B c e ll s ( n e g . s e l . ) T e s t i s i n t e r s t i t i a l CD33 208791 at 0 30000 3 × M 10 × M M e d i a n ( 1339 . 7 ) 5 e + 3 1 e + 4 1 . 5 e + 4 2 e + 4 2 . 4 e + 4 K i d n e y T o n s i l L y m p h n o d e T h y m u s B o n e m a rr o w A d r e n a l g l a n d A d r e n a l c o r t e x O l f a c t o r y b u l b T r a c h e a S a l i v a r y g l a n d P i t u i t a r y F e t a ll i v e r F e t a ll u n g F e t a l t h y r o i d U t e r u s A d i p o c y t e P a n c r e a s T e s t i ss e m i n i f e r o u s t u b u l e T e s t i s l e y d i g c e ll T e s t i s g e r m c e ll T e s t i s C o l o r e c t a l a d e n o c a r c i n o m a B r o n c h i a l e p i t h e l i a l c e ll s S m oo t h m u s c l e C a r d i a c m y o c y t e s L e u k e m i a l y m p h o b l a s t i c ( M O L T - 4 ) L e u k e m i a c h r o n i c M y e l o g e n o u s K - 562 L e u k e m i a p r o m y e l o c y t i c - H L - 60 T h y r o i d P r o s t a t e L u n g P l a c e n t a S m a ll i n t e s t i n e C o l o n L i v e r H e a r t U t e r u s c o r p u s A p p e n d i x O v a r y D o r s a l r oo t g a n g l i o n C i l i a r y g a n g l i o n A t r i o v e n t r i c u l a r n o d e S k i n T r i g e m i n a l g a n g l i o n S u p e r i o r c e r v i c a l g a n g l i o n T o n g u e S k e l e t a l m u s c l e R e t i n a P i n e a l n i g h t P i n e a l d a y W h o l e b r a i n A m y g d a l a P r e f r o n t a l c o r t e x S p i n a l c o r d H y p o t h a l a m u s F e t a l b r a i n T h a l a m u s C a u d a t e n u c l e u s P a r i e t a ll o b e M e d u ll a o b l o n g a t a C i n g u l a t e c o r t e x O cc i p i t a ll o b e T e m p o r a ll o b e S u b t h a l a m i c n u c l e u s P o n s G l o b u s p a ll i d u s C e r e b e ll u m C e r e b e ll u m p e d u n c l e s C D 34 + C D 105 + e n d o t h e l i a l 721 B l y m p h o b l a s t s W h o l e b l oo d L y m p h o m a b u r k i tt s ( d a u d i ) L y m p h o m a b u r k i t t s ( r a j i ) C D 33 + m y e l o i d C D 14 + m o n o c y t e s P a n c r e a t i c l s l e t C D 8 + T c e ll s C D 4 + T c e ll s C D 56 + N K c e ll s B D C A 4 + d e n t r i t i c c e ll s C D 71 + e a r l y e r y t h r o i d C D 19 + B c e ll s ( n e g . s e l . ) T e s t i s i n t e r s t i t i a l CLU Figure 1 : Continued . International Journal of Alzheimer’s Disease 5 217484 at 4 8 12 0 40 3 × M M e d i a n ( 6 . 1 ) K i d n e y T o n s i l L y m p h n o d e T h y m u s B o n e m a rr o w A d r e n a l g l a n d A d r e n a l c o r t e x O l f a c t o r y b u l b T r a c h e a S a l i v a r y g l a n d P i t u i t a r y F e t a ll i v e r F e t a ll u n g F e t a l t h y r o i d U t e r u s A d i p o c y t e P a n c r e a s T e s t i ss e m i n i f e r o u s t u b u l e T e s t i s l e y d i g c e ll T e s t i s g e r m c e ll T e s t i s C o l o r e c t a l a d e n o c a r c i n o m a B r o n c h i a l e p i t h e l i a l c e ll s S m oo t h m u s c l e C a r d i a c m y o c y t e s L e u k e m i a l y m p h o b l a s t i c ( M O L T - 4 ) L e u k e m i a c h r o n i c M y e l o g e n o u s K - 562 L e u k e m i a p r o m y e l o c y t i c - H L - 60 T h y r o i d P r o s t a t e L u n g P l a c e n t a S m a ll i n t e s t i n e C o l o n L i v e r H e a r t U t e r u s c o r p u s A pp e n d i x O v a r y D o r s a l r oo t g a n g l i o n C i l i a r y g a n g l i o n A t r i o v e n t r i c u l a r n o d e S k i n T r i g e m i n a l g a n g l i o n S u p e r i o r c e r v i c a l g a n g l i o n T o n g u e S k e l e t a l m u s c l e R e t i n a P i n e a l n i g h t P i n e a l d a y W h o l e b r a i n A m y g d a l a P r e f r o n t a l c o r t e x S p i n a l c o r d H y p o t h a l a m u s F e t a l b r a i n T h a l a m u s C a u d a t e n u c l e u s P a r i e t a ll o b e M e d u ll a o b l o n g a t a C i n g u l a t e c o r t e x O cc i p i t a ll o b e T e m p o r a ll o b e S u b t h a l a m i c n u c l e u s P o n s G l o b u s p a ll i d u s C e r e b e ll u m C e r e b e ll u m p e d u n c l e s C D 34 + C D 105 + e n d o t h e l i a l 721 B l y m p h o b l a s t s W h o l e b l oo d L y m p h o m a b u r k i tt s ( d a u d i ) L y m p h o m a b u r k i tt s ( r a j i ) C D 33 + m y e l o i d C D 14 + m o n o c y t e s P a n c r e a t i c l s l e t C D 8 + T c e ll s C D 4 + T c e ll s C D 56 + N K c e ll s B D C A 4 + d e n t r i t i c c e ll s C D 71 + e a r l y e r y t h r o i d C D 19 + B c e ll s ( n e g . s e l . ) T e s t i s i n t e r s t i t i a l CR1 16 6 . 1 5 10 15 20 25 0 30 205977 s at 3 × M M e d i a n ( 4 . 2 ) K i d n e y T o n s i l L y m p h n o d e T h y m u s B o n e m a rr o w A d r e n a l g l a n d A d r e n a l c o r t e x O l f a c t o r y b u l b T r a c h e a S a l i v a r y g l a n d P i t u i t a r y F e t a ll i v e r F e t a ll u n g F e t a l t h y r o i d U t e r u s A d i p o c y t e P a n c r e a s T e s t i ss e m i n i f e r o u s t u b u l e T e s t i s l e y d i g c e ll T e s t i s g e r m c e ll T e s t i s C o l o r e c t a l a d e n o c a r c i n o m a B r o n c h i a l e p i t h e l i a l c e ll s S m oo t h m u s c l e C a r d i a c m y o c y t e s L e u k e m i a l y m p h o b l a s t i c ( M O L T - 4 ) L e u k e m i a c h r o n i c M y e l o g e n o u s K - 562 L e u k e m i a p r o m y e l o c y t i c - H L - 60 T h y r o i d P r o s t a t e L u n g P l a c e n t a S m a ll i n t e s t i n e C o l o n L i v e r H e a r t U t e r u s c o r p u s A pp e n d i x O v a r y D o r s a l r oo t g a n g l i o n C i l i a r y g a n g l i o n A t r i o v e n t r i c u l a r n o d e S k i n T r i g e m i n a l g a n g l i o n S u p e r i o r c e r v i c a l g a n g l i o n T o n g u e S k e l e t a l m u s c l e R e t i n a P i n e a l n i g h t P i n e a l d a y W h o l e b r a i n A m y g d a l a P r e f r o n t a l c o r t e x S p i n a l c o r d H y p o t h a l a m u s F e t a l b r a i n T h a l a m u s C a u d a t e n u c l e u s P a r i e t a ll o b e M e d u ll a o b l o n g a t a C i n g u l a t e c o r t e x O cc i p i t a ll o b e T e m p o r a ll o b e S u b t h a l a m i c n u c l e u s P o n s G l o b u s p a ll i d u s C e r e b e ll u m C e r e b e ll u m p e d u n c l e s C D 34 + C D 105 + e n d o t h e l i a l 721 B l y m p h o b l a s t s W h o l e b l oo d L y m p h o m a b u r k i tt s ( d a u d i ) L y m p h o m a b u r k i tt s ( r a j i ) C D 33 + m y e l o i d C D 14 + m o n o c y t e s P a n c r e a t i c l s l e t C D 8 + T c e ll s C D 4 + T c e ll s C D 56 + N K c e ll s B D C A 4 + d e n t r i t i c c e ll s C D 71 + e a r l y e r y t h r o i d C D 19 + B c e ll s ( n e g . s e l . ) T e s t i s i n t e r s t i t i a l EPHA1 0 207496 at 8 20 M e d i a n ( 6 ) K i d n e y T o n s i l L y m p h n o d e T h y m u s B o n e m a rr o w A d r e n a l g l a n d A d r e n a l c o r t e x O l f a c t o r y b u l b T r a c h e a S a l i v a r y g l a n d P i t u i t a r y F e t a ll i v e r F e t a ll u n g F e t a l t h y r o i d U t e r u s A d i p o c y t e P a n c r e a s T e s t i ss e m i n i f e r o u s t u b u l e T e s t i s l e y d i g c e ll T e s t i s g e r m c e ll T e s t i s C o l o r e c t a l a d e n o c a r c i n o m a B r o n c h i a l e p i t h e l i a l c e ll s S m oo t h m u s c l e C a r d i a c m y o c y t e s L e u k e m i a l y m p h o b l a s t i c ( M O L T - 4 ) L e u k e m i a c h r o n i c M y e l o g e n o u s K - 562 L e u k e m i a p r o m y e l o c y t i c - H L - 60 T h y r o i d P r o s t a t e L u n g P l a c e n t a S m a ll i n t e s t i n e C o l o n L i v e r H e a r t U t e r u s c o r p u s A p p e n d i x O v a r y D o r s a l r oo t g a n g l i o n C i l i a r y g a n g l i o n A t r i o v e n t r i c u l a r n o d e S k i n T r i g e m i n a l g a n g l i o n S u p e r i o r c e r v i c a l g a n g l i o n T o n g u e S k e l e t a l m u s c l e R e t i n a P i n e a l n i g h t P i n e a l d a y W h o l e b r a i n A m y g d a l a P r e f r o n t a l c o r t e x S p i n a l c o r d H y p o t h a l a m u s F e t a l b r a i n T h a l a m u s C a u d a t e n u c l e u s P a r i e t a ll o b e M e d u ll a o b l o n g a t a C i n g u l a t e c o r t e x O cc i p i t a ll o b e T e m p o r a ll o b e S u b t h a l a m i c n u c l e u s P o n s G l o b u s p a ll i d u s C e r e b e ll u m C e r e b e ll u m p e d u n c l e s C D 34 + C D 105 + e n d o t h e l i a l 721 B l y m p h o b l a s t s W h o l e b l oo d L y m p h o m a b u r k i tt s ( d a u d i ) L y m p h o m a b u r k i t t s ( r a j i ) C D 33 + m y e l o i d C D 14 + m o n o c y t e s P a n c r e a t i c l s l e t C D 8 + T c e ll s C D 4 + T c e ll s C D 56 + N K c e ll s B D C A 4 + d e n t r i t i c c e ll s C D 71 + e a r l y e r y t h r o i d C D 19 + B c e ll s ( n e g . s e l . ) T e s t i s i n t e r s t i t i a l MS4A2 4 12 16 3 × M 7 . 06 + / − 0 . 269 Figure 1 : Continued . 6 International Journal of Alzheimer’s Disease x at 0 120 160 200 3 × M M e d i a n ( 11 . 5 ) K i d n e y T o n s i l L y m p h n o d e T h y m u s B o n e m a rr o w A d r e n a l g l a n d A d r e n a l c o r t e x O l f a c t o r y b u l b T r a c h e a S a l i v a r y g l a n d P i t u i t a r y F e t a ll i v e r F e t a ll u n g F e t a l t h y r o i d U t e r u s A d i p o c y t e P a n c r e a s T e s t i ss e m i n i f e r o u s t u b u l e T e s t i s l e y d i g c e ll T e s t i s g e r m c e ll T e s t i s C o l o r e c t a l a d e n o c a r c i n o m a B r o n c h i a l e p i t h e l i a l c e ll s S m oo t h m u s c l e C a r d i a c m y o c y t e s L e u k e m i a l y m p h o b l a s t i c ( M O L T - 4 ) L e u k e m i a c h r o n i c M y e l o g e n o u s K - 562 L e u k e m i a p r o m y e l o c y t i c - H L - 60 T h y r o i d P r o s t a t e L u n g P l a c e n t a S m a ll i n t e s t i n e C o l o n L i v e r H e a r t U t e r u s c o r p u s A pp e n d i x O v a r y D o r s a l r oo t g a n g l i o n C i l i a r y g a n g l i o n A t r i o v e n t r i c u l a r n o d e S k i n T r i g e m i n a l g a n g l i o n S u p e r i o r c e r v i c a l g a n g l i o n T o n g u e S k e l e t a l m u s c l e R e t i n a P i n e a l n i g h t P i n e a l d a y W h o l e b r a i n A m y g d a l a P r e f r o n t a l c o r t e x S p i n a l c o r d H y p o t h a l a m u s F e t a l b r a i n T h a l a m u s C a u d a t e n u c l e u s P a r i e t a ll o b e M e d u ll a o b l o n g a t a C i n g u l a t e c o r t e x O cc i p i t a ll o b e T e m p o r a ll o b e S u b t h a l a m i c n u c l e u s P o n s G l o b u s p a ll i d u s C e r e b e ll u m C e r e b e ll u m p e d u n c l e s C D 34 + C D 105 + e n d o t h e l i a l 721 B l y m p h o b l a s t s W h o l e b l oo d L y m p h o m a b u r k i tt s ( d a u d i ) L y m p h o m a b u r k i tt s ( r a j i ) C D 33 + m y e l o i d C D 14 + m o n o c y t e s P a n c r e a t i c l s l e t C D 8 + T c e ll s C D 4 + T c e ll s C D 56 + N K c e ll s B D C A 4 + d e n t r i t i c c e ll s C D 71 + e a r l y e r y t h r o i d C D 19 + B c e ll s ( n e g . s e l . ) T e s t i s i n t e r s t i t i a l PICALM 80 40 10 . 95 10 × M 215832 203460 s at 0 200 300 400 M e d i a n ( 10 . 5 ) 3 × M 10 × M K i d n e y T o n s i l L y m p h n o d e T h y m u s B o n e m a rr o w A d r e n a l g l a n d A d r e n a l c o r t e x O l f a c t o r y b u l b T r a c h e a S a l i v a r y g l a n d P i t u i t a r y F e t a ll i v e r F e t a ll u n g F e t a l t h y r o i d U t e r u s A d i p o c y t e P a n c r e a s T e s t i ss e m i n i f e r o u s t u b u l e T e s t i s l e y d i g c e ll T e s t i s g e r m c e ll T e s t i s C o l o r e c t a l a d e n o c a r c i n o m a B r o n c h i a l e p i t h e l i a l c e ll s S m oo t h m u s c l e C a r d i a c m y o c y t e s L e u k e m i a l y m p h o b l a s t i c ( M O L T - 4 ) L e u k e m i a c h r o n i c M y e l o g e n o u s K - 562 L e u k e m i a p r o m y e l o c y t i c - H L - 60 T h y r o i d P r o s t a t e L u n g P l a c e n t a S m a ll i n t e s t i n e C o l o n L i v e r H e a r t U t e r u s c o r p u s A pp e n d i x O v a r y D o r s a l r oo t g a n g l i o n C i l i a r y g a n g l i o n A t r i o v e n t r i c u l a r n o d e S k i n T r i g e m i n a l g a n g l i o n S u p e r i o r c e r v i c a l g a n g l i o n T o n g u e S k e l e t a l m u s c l e R e t i n a P i n e a l n i g h t P i n e a l d a y W h o l e b r a i n A m y g d a l a P r e f r o n t a l c o r t e x S p i n a l c o r d H y p o t h a l a m u s F e t a l b r a i n T h a l a m u s C a u d a t e n u c l e u s P a r i e t a ll o b e M e d u ll a o b l o n g a t a C i n g u l a t e c o r t e x O cc i p i t a ll o b e T e m p o r a ll o b e S u b t h a l a m i c n u c l e u s P o n s G l o b u s p a ll i d u s C e r e b e ll u m C e r e b e ll u m p e d u n c l e s C D 34 + C D 105 + e n d o t h e l i a l 721 B l y m p h o b l a s t s W h o l e b l oo d L y m p h o m a b u r k i tt s ( d a u d i ) L y m p h o m a b u r k i tt s ( r a j i ) C D 33 + m y e l o i d C D 14 + m o n o c y t e s P a n c r e a t i c l s l e t C D 8 + T c e ll s C D 4 + T c e ll s C D 56 + N K c e ll s B D C A 4 + d e n t r i t i c c e ll s C D 71 + e a r l y e r y t h r o i d C D 19 + B c e ll s ( n e g . s e l . ) T e s t i s i n t e r s t i t i a l PSEN1 100 30 × M 0 400 800 1 . 2 e + 3 1 . 6 e + 3 2000 218389 s at 3 × M 10 × M M e d i a n ( 127 . 3 ) K i d n e y T o n s i l L y m p h n o d e T h y m u s B o n e m a rr o w A d r e n a l g l a n d A d r e n a l c o r t e x O l f a c t o r y b u l b T r a c h e a S a l i v a r y g l a n d P i t u i t a r y F e t a ll i v e r F e t a ll u n g F e t a l t h y r o i d U t e r u s A d i p o c y t e P a n c r e a s T e s t i ss e m i n i f e r o u s t u b u l e T e s t i s l e y d i g c e ll T e s t i s g e r m c e ll T e s t i s C o l o r e c t a l a d e n o c a r c i n o m a B r o n c h i a l e p i t h e l i a l c e ll s S m oo t h m u s c l e C a r d i a c m y o c y t e s L e u k e m i a l y m p h o b l a s t i c ( M O L T - 4 ) L e u k e m i a c h r o n i c M y e l o g e n o u s K - 562 L e u k e m i a p r o m y e l o c y t i c - H L - 60 T h y r o i d P r o s t a t e L u n g P l a c e n t a S m a ll i n t e s t i n e C o l o n L i v e r H e a r t U t e r u s c o r p u s A pp e n d i x O v a r y D o r s a l r oo t g a n g l i o n C i l i a r y g a n g l i o n A t r i o v e n t r i c u l a r n o d e S k i n T r i g e m i n a l g a n g l i o n S u p e r i o r c e r v i c a l g a n g l i o n T o n g u e S k e l e t a l m u s c l e R e t i n a P i n e a l n i g h t P i n e a l d a y W h o l e b r a i n A m y g d a l a P r e f r o n t a l c o r t e x S p i n a l c o r d H y p o t h a l a m u s F e t a l b r a i n T h a l a m u s C a u d a t e n u c l e u s P a r i e t a ll o b e M e d u ll a o b l o n g a t a C i n g u l a t e c o r t e x O cc i p i t a ll o b e T e m p o r a ll o b e S u b t h a l a m i c n u c l e u s P o n s G l o b u s p a ll i d u s C e r e b e ll u m C e r e b e ll u m p e d u n c l e s C D 34 + C D 105 + e n d o t h e l i a l 721 B l y m p h o b l a s t s W h o l e b l oo d L y m p h o m a b u r k i tt s ( d a u d i ) L y m p h o m a b u r k i tt s ( r a j i ) C D 33 + m y e l o i d C D 14 + m o n o c y t e s P a n c r e a t i c l s l e t C D 8 + T c e ll s C D 4 + T c e ll s C D 56 + N K c e ll s B D C A 4 + d e n t r i t i c c e ll s C D 71 + e a r l y e r y t h r o i d C D 19 + B c e ll s ( n e g . s e l . ) T e s t i s i n t e r s t i t i a l APH1A Figure 1 : Continued . International Journal of Alzheimer’s Disease 7 0 100 200 300 400 218302 at 500 30 × M 3 × M 10 × M M e d i a n ( 9 . 5 ) K i d n e y T o n s i l L y m p h n o d e T h y m u s B o n e m a rr o w A d r e n a l g l a n d A d r e n a l c o r t e x O l f a c t o r y b u l b T r a c h e a S a l i v a r y g l a n d P i t u i t a r y F e t a ll i v e r F e t a ll u n g F e t a l t h y r o i d U t e r u s A d i p o c y t e P a n c r e a s T e s t i ss e m i n i f e r o u s t u b u l e T e s t i s l e y d i g c e ll T e s t i s g e r m c e ll T e s t i s C o l o r e c t a l a d e n o c a r c i n o m a B r o n c h i a l e p i t h e l i a l c e ll s S m oo t h m u s c l e C a r d i a c m y o c y t e s L e u k e m i a l y m p h o b l a s t i c ( M O L T - 4 ) L e u k e m i a c h r o n i c M y e l o g e n o u s K - 562 L e u k e m i a p r o m y e l o c y t i c - H L - 60 T h y r o i d P r o s t a t e L u n g P l a c e n t a S m a ll i n t e s t i n e C o l o n L i v e r H e a r t U t e r u s c o r p u s A pp e n d i x O v a r y D o r s a l r oo t g a n g l i o n C i l i a r y g a n g l i o n A t r i o v e n t r i c u l a r n o d e S k i n T r i g e m i n a l g a n g l i o n S u p e r i o r c e r v i c a l g a n g l i o n T o n g u e S k e l e t a l m u s c l e R e t i n a P i n e a l n i g h t P i n e a l d a y W h o l e b r a i n A m y g d a l a P r e f r o n t a l c o r t e x S p i n a l c o r d H y p o t h a l a m u s F e t a l b r a i n T h a l a m u s C a u d a t e n u c l e u s P a r i e t a ll o b e M e d u ll a o b l o n g a t a C i n g u l a t e c o r t e x O cc i p i t a ll o b e T e m p o r a ll o b e S u b t h a l a m i c n u c l e u s P o n s G l o b u s p a ll i d u s C e r e b e ll u m C e r e b e ll u m p e d u n c l e s C D 34 + C D 105 + e n d o t h e l i a l 721 B l y m p h o b l a s t s W h o l e b l oo d L y m p h o m a b u r k i tt s ( d a u d i ) L y m p h o m a b u r k i tt s ( r a j i ) C D 33 + m y e l o i d C D 14 + m o n o c y t e s P a n c r e a t i c l s l e t C D 8 + T c e ll s C D 4 + T c e ll s C D 56 + N K c e ll s B D C A 4 + d e n t r i t i c c e ll s C D 71 + e a r l y e r y t h r o i d C D 19 + B c e ll s ( n e g . s e l . ) T e s t i s i n t e r s t i t i a l PSENEN 0 200 400 600 700 208759 at 3 × M M e d i a n ( 88 . 4 ) K i d n e y T o n s i l L y m p h n o d e T h y m u s B o n e m a rr o w A d r e n a l g l a n d A d r e n a l c o r t e x O l f a c t o r y b u l b T r a c h e a S a l i v a r y g l a n d P i t u i t a r y F e t a ll i v e r F e t a ll u n g F e t a l t h y r o i d U t e r u s A d i p o c y t e P a n c r e a s T e s t i ss e m i n i f e r o u s t u b u l e T e s t i s l e y d i g c e ll T e s t i s g e r m c e ll T e s t i s C o l o r e c t a l a d e n o c a r c i n o m a B r o n c h i a l e p i t h e l i a l c e ll s S m oo t h m u s c l e C a r d i a c m y o c y t e s L e u k e m i a l y m p h o b l a s t i c ( M O L T - 4 ) L e u k e m i a c h r o n i c M y e l o g e n o u s K - 562 L e u k e m i a p r o m y e l o c y t i c - H L - 60 T h y r o i d P r o s t a t e L u n g P l a c e n t a S m a ll i n t e s t i n e C o l o n L i v e r H e a r t U t e r u s c o r p u s A pp e n d i x O v a r y D o r s a l r oo t g a n g l i o n C i l i a r y g a n g l i o n A t r i o v e n t r i c u l a r n o d e S k i n T r i g e m i n a l g a n g l i o n S u p e r i o r c e r v i c a l g a n g l i o n T o n g u e S k e l e t a l m u s c l e R e t i n a P i n e a l n i g h t P i n e a l d a y W h o l e b r a i n A m y g d a l a P r e f r o n t a l c o r t e x S p i n a l c o r d H y p o t h a l a m u s F e t a l b r a i n T h a l a m u s C a u d a t e n u c l e u s P a r i e t a ll o b e M e d u ll a o b l o n g a t a C i n g u l a t e c o r t e x O cc i p i t a ll o b e T e m p o r a ll o b e S u b t h a l a m i c n u c l e u s P o n s G l o b u s p a ll i d u s C e r e b e ll u m C e r e b e ll u m p e d u n c l e s C D 34 + C D 105 + e n d o t h e l i a l 721 B l y m p h o b l a s t s W h o l e b l oo d L y m p h o m a b u r k i tt s ( d a u d i ) L y m p h o m a b u r k i tt s ( r a j i ) C D 33 + m y e l o i d C D 14 + m o n o c y t e s P a n c r e a t i c l s l e t C D 8 + T c e ll s C D 4 + T c e ll s C D 56 + N K c e ll s B D C A 4 + d e n t r i t i c c e ll s C D 71 + e a r l y e r y t h r o i d C D 19 + B c e ll s ( n e g . s e l . ) T e s t i s i n t e r s t i t i a l NCSTN 214953 0 3000 500 739 . 8 s at 3 × M 10 × M M e d i a n ( 240 . 8 ) 1 e + 3 1 . 5 e + 3 2 e + 3 2 . 5 e + 3 K i d n e y T o n s i l L y m p h n o d e T h y m u s B o n e m a rr o w A d r e n a l g l a n d A d r e n a l c o r t e x O l f a c t o r y b u l b T r a c h e a S a l i v a r y g l a n d P i t u i t a r y F e t a ll i v e r F e t a ll u n g F e t a l t h y r o i d U t e r u s A d i p o c y t e P a n c r e a s T e s t i ss e m i n i f e r o u s t u b u l e T e s t i s l e y d i g c e ll T e s t i s g e r m c e ll T e s t i s C o l o r e c t a l a d e n o c a r c i n o m a B r o n c h i a l e p i t h e l i a l c e ll s S m oo t h m u s c l e C a r d i a c m y o c y t e s L e u k e m i a l y m p h o b l a s t i c ( M O L T - 4 ) L e u k e m i a c h r o n i c M y e l o g e n o u s K - 562 L e u k e m i a p r o m y e l o c y t i c - H L - 60 T h y r o i d P r o s t a t e L u n g P l a c e n t a S m a ll i n t e s t i n e C o l o n L i v e r H e a r t U t e r u s c o r p u s A pp e n d i x O v a r y D o r s a l r oo t g a n g l i o n C i l i a r y g a n g l i o n A t r i o v e n t r i c u l a r n o d e S k i n T r i g e m i n a l g a n g l i o n S u p e r i o r c e r v i c a l g a n g l i o n T o n g u e S k e l e t a l m u s c l e R e t i n a P i n e a l n i g h t P i n e a l d a y W h o l e b r a i n A m y g d a l a P r e f r o n t a l c o r t e x S p i n a l c o r d H y p o t h a l a m u s F e t a l b r a i n T h a l a m u s C a u d a t e n u c l e u s P a r i e t a ll o b e M e d u ll a o b l o n g a t a C i n g u l a t e c o r t e x O cc i p i t a ll o b e T e m p o r a ll o b e S u b t h a l a m i c n u c l e u s P o n s G l o b u s p a ll i d u s C e r e b e ll u m C e r e b e ll u m p e d u n c l e s C D 34 + C D 105 + e n d o t h e l i a l 721 B l y m p h o b l a s t s W h o l e b l oo d L y m p h o m a b u r k i tt s ( d a u d i ) L y m p h o m a b u r k i tt s ( r a j i ) C D 33 + m y e l o i d C D 14 + m o n o c y t e s P a n c r e a t i c l s l e t C D 8 + T c e ll s C D 4 + T c e ll s C D 56 + N K c e ll s B D C A 4 + d e n t r i t i c c e ll s C D 71 + e a r l y e r y t h r o i d C D 19 + B c e ll s ( n e g . s e l . ) T e s t i s i n t e r s t i t i a l APP Figure 1 : The mRNA distribution of the major genes derived from GWAS in Alzheimer’s disease , as well as that of APP and gamma - secretase components . Data are from the BioGps website . 8 International Journal of Alzheimer’s Disease C3 LRP1 LRP8 A2M CLU LRP2 CR1 APOA1 ABCA1 β Amy IDE Complement cascade CASP3 ABCA7 C . Neo H . Pylori P . Ging C3 CR1 C5 C5b C6 C7 C8 C9 CD59 C4 M A C CLU CD2 T cell activation Many pathogens Properdin C . Pneu C . Pneum C . Neo IgG IgM Ceramide P . Ging ITGAM ITGB2 C . Pneu C . Pneu H . Pyl Sphingomyelin P - choline C . Neo IL1AIL6 APOE CD2AP C1q phagocytosis β - amyloid processing Figure 2 : Portions of the complement cascade in relation to beta - amyloid processing : Alzheimer’s disease susceptibility genes returned from very large genomewide association studies are in black , and those from the pre - GWAS era in grey . Binding interactions are indicated by linked diamonds and other e ﬀ ects by arrows . C . Neo : Cryptococcus neoformans ; C . Pneu : chlamydia pneumoniae ; H . Pyl : Helicobacter pylori ; P . Ging : Porphyromonas gingivalis ; C1 – C9 : complement components . MAC : membrane attack complex . P - choline : phosphatidylcholine ; black star : Herpes simplex : see text for details . Plasmodium falciparum [ 37 – 43 ] and is a general clearance receptor for complement opsonised pathogens [ 44 ] . Clu - sterin , predominantly expressed in brain , liver , and testis , ( http : / / www . biogps . org / # goto = genereport & id = 1191 / ) is a ligand for the lipoprotein receptor , megalin ( LRP2 ) that is involved in beta - amyloid clearance , and also a complement inhibitor that prevents the formation of the membrane attack complex , a channel that is inserted into pathogen membranes , killing them by lysis [ 45 ] . This complex is also seen in Alzheimer’s disease neurones [ 46 , 47 ] . The herpes simplex virus interacts with other members of the complement cascade , by binding to the complement com - ponent and CR1 ligand , C3 and its derivatives and to CD59 , a further inhibitor of the formation of the complement membrane attack complex ( see review ) [ 48 ] . C . pneumoniae interacts with this pathway by binding to properdin ( CFP ) , a protein that stabilises the complement C3 and C5 convertase and contributes to the formation of the membrane attack complex [ 49 ] . CD59 is also incorporated into chlamydial inclusion bodies [ 50 ] . Complement component C3 binds to melanins derived from C . neoformans [ 51 ] and cryptococcal capsules bind to C3 and activate the alternative complement pathway [ 52 ] . Complement component C3 also binds to the bacterial surface of H . pylori , and the complement pathway is involved in bactericidal e ﬀ ects against this pathogen [ 53 ] . P . gingivalis also uses complement receptor 3 ( an int - egrin complex of integrin , alpha M / integrin , beta 2 ( ITGAM / ITGB2 ) ) for entry [ 54 ] , and herpes simplex glycoprotein C also binds to this complex [ 55 ] as does C . neoformans [ 56 ] , while ITGB2 is involved in C . pneumoniae entry in human coronary artery endothelial cells [ 57 ] . This macrophage com - plement receptor , also known as MAC - 1 , generally mediates the phagocytosis of pathogens coated with complement C3 derivatives [ 58 ] . T . C3 also binds to P . gingivalis although the pathogen has devised an elegant escape strategy involving digestion of complement components C3 , C4 , and C5 by bacterial secreted proteases , known as gingipains [ 59 ] . The complement inhibitor CD59 is also a ligand for CD2 , and CD59 activation of this receptor , presumably involving CD2AP , activates T cell receptor signalling resulting in the secretion of interleukins ( IL1A , IL2 and IL6 ) and granulocyte macrophage colony stimulating factor ( CSF2 ) [ 60 , 61 ] . ABCA7 plays a role in the complement - mediated activa - tion of phagocytosis in macrophages . Complement compo - nent C1q , which binds to IgM or IgG complexed antigens ( relevant to most pathogens ) , binds to macrophage calreti - culin and LRP1 and C1q binding to macrophages markedly increased the expression of both LRP1 and ABCA7 , e ﬀ ects International Journal of Alzheimer’s Disease 9 IGF2R CLU IGF2R endosomes PICALM Nucleus XPO1 V i r a l t r a ﬃ c DNM2 BIN1 C . Pneu H . Pyl CD2AP CD2 AP2 adaptins Gamma - adaptins Clathrins PICALM ActinsMyosins P . Ging CDH1 Microtubules Integrins BACE1BACE2SORL1PIN1 DISC1 , GSK3B , MAPT , TTLL7 ( − ) Clathrin endocytosis Many pathogens H . Pylori and other pathogens PICALM MYH8 MYH13 CTTN Dyneins . kinesins : DNM2 DNMBP KIF18B KNS2 Figure 3 : A schematic representation of clathrin - mediated endocytosis and intracellular transport pathways . Alzheimer’s disease susceptibility genes returned from very large genomewide association studies are in black , and those from the pre - GWAS era in grey . Binding interactions are indicated by linked diamonds and other e ﬀ ects by arrows . C . Pneu : chlamydia pneumoniae ; H . Pyl : Helicobacter pylori ; P . Ging : Porphyromonas gingivalis ; black star : Herpes simplex : see text for details . which enhance the phagocytic abilities of macrophages [ 62 ] . C1q also binds to complement receptor CR1 , an e ﬀ ect involved in the immune clearance of opsonised pathogens [ 63 ] . C1q also binds to beta - amyloid and is involved in amyloid - related complement activation [ 64 ] . 3 . 2 . Clathrin - Mediated Endocytosis ( BIN1 , CLU , CD2AP , PICALM ) Figure 3 . Mammalian surface receptors are endo - cytosed , via clathrin - dependent or independent processes ( KEGG : ADRB1 , ADRB2 , BIN1 , CAV1 , CD2AP , CLU , DNM2 , HLA - A , HSPA1B , LDLR , NTRK1 , PICALM ) and either recycled or tagged for destruction by the ubiq - uitin / proteasome system ( KEGG : UBD , UBE2I UBQLN1 , UCHL1 ) or by lysosomes ( KEGG : ABCA2 , ARSA , ARSB , CTSD , CTSS , NPC1 , NPC2 , LIPA ) . Early endosomes receive tra ﬃ c from the cell surface , which is transferred to late endosomes for tra ﬃ c to lysosomes . Late endosomes also receive tra ﬃ c from the trans - Golgi network used to syn - thesise proteins and from phagocytic pathways ( KEGG : CTSS , DLD , DLST , DNM2 , GAB2 , HLA - A , HLA - DRB1 , MPO , NOS1 , OLR1 , PIK3R1 , PSK1 , TAP2 , TLR2 , TLR4 ) . Endosomal tra ﬃ c moves along the microtubule ( GSK3B , MAPT , TTLL7 ) or actin / myosin ( MYH8 , MYH13 ) networks via dynein / dynactin ( DM2 , DNMBP ) or kinesin ( KIF18B , KIF20B , KNS2 ) , related motors and Rho GTPases , and vac - uolar sorting proteins ( SORCS1 , SORCS2 , SORCS3 , SORL1 ) inter alia [ 65 ] . These processes are usurped by many viruses and other pathogens to gain access to cells and to various intracellular compartments , while the lysosomal or proteaso - mal pathways may be used to destroy pathogen proteins [ 66 ] . Clathrin - mediated endocytosis is one of several processes used by Helicobacter pylori , herpes simplex , and many other viral , bacterial and fungal pathogens to gain entry to cells [ 67 – 69 ] . PICALM , expressed primarily in myeloid and den - dritic cells of the immune network http : / / www . biogps . org / # goto = genereport & id = 8301 / , plays a key role in clathrin - related endocytosis , binding to clathrin heavy chains ( CLTC and CLTCL1 ) , and recruiting the clathrin and adaptor protein 2 ( AP - 2 ) to the plasma membrane . The AP - 2 com - plex is a heterotetramer consisting of permutations of two large adaptins ( alpha ( AP2A1 , AP2A2 ) ) or beta ( AP2B1 ) , a medium adaptin ( AP1M1 , AP1M2 ) , and a small adaptin ( sigma AP2S1 ) . PICALM controls the endocytosis of the cation - independent mannose - 6 - phosphate IGF2 receptor ( IGF2R ) [ 70 ] , one used by Herpes simplex for entry and cell - to - cell transmission [ 71 ] and by C . pneumoniae for cellular entry [ 57 ] . IGF2R is also a component of late endosomes disrupted by the Helicobacter pylori VacA cytotoxin [ 72 ] . The mannose - 6 - phosphate receptor binds to clusterin . PICALM also binds to a nuclear exportin crm - 1 ( XPO1 ) used by the herpes simplex virus during its life cycle [ 48 ] . Gamma - adaptins ( GGA , GGA2 , GGA3 ) bind to clathrins and mannose - 6 - phosphate receptors and regulate protein 10 International Journal of Alzheimer’s Disease tra ﬃ c between the Golgi network and the lysosome and the sorting of mannose - 6 - phosphate receptors ( IGF2R and M6PR ) at the trans - Golgi network [ 73 ] . This network is also related to important Alzheimer’s disease susceptibility genes as the interactions culled from NCBI gene show that GGA1 binds to the sortilin - related receptor , SORL1 , and the APP cleaving beta - secretase BACE2 , while GGA2 binds to the beta - secretases BACE1 and BACE2 , SORL1 and the prolyl - isomerase PIN1 . CD2AP , primarily expressed in dendritic cells and B lymphoblasts http : / / www . biogps . org / # goto = genereport & id = 23607 / , is a sca ﬀ olding molecule that regulates the actin cy - toskeleton and is primarily associated with the T - lymphocyte marker protein CD2 . CD2 stimulates T cell activation and is involved in the creation of contacts between antigen presenting cells and T cells ( the immunological synapse ) , e ﬀ ects mediated via CD2AP and clathrin [ 74 ] . CD2AP is also involved in the entry of the helicobacter vacuolating toxin VacA and connects the actin cytoskeleton to early endosomes containing VacA [ 75 ] . CD2 is cleaved by gingipain proteases from P . gingivalis [ 76 ] . CD2AP also binds to the actin - bonding protein , cor - tactin ( CTTN ) , a protein that is exploited by several bacteria ( Escherichia coli , Shigella , Neisseria , Rickettsia , Chlamydia , Staphylococcus , Cryptosporidium , and Helicobacter pylori ) , fungi ( Candida Albicans ) , and viruses ( Vaccinia ) enabling them to modify the actin cytoskeleton , which they use for transport [ 77 – 79 ] . CD2AP has not been speciﬁcally associ - ated with herpes simplex , although the actin cytoskeleton is exploited by this and many other viruses [ 80 ] . CD2AP also associated with E - Cadherin , ( CDH1 ) [ 81 ] . The ectodomain of E - cadherin is involved in bacterial adherence to mammalian cells [ 82 ] . E - Cadherin binds to the H . pylori toxin CagA [ 83 ] and is also cleaved by the Helicobacter pylori protein HtRA allowing the pathogen to invade the intracellular compartment [ 84 ] . CDH1 and CDH5 expressions are increased by C . pneumoniae infection of human brain microvascular endothelial cells , contributing to vascular permeability changes and atherosclerosis [ 85 ] . Bridging integrator 1 ( BIN1 ) , also known as amphi - physin 2 , is primarily expressed in the pineal and skeletal muscle , or otherwise ubiquitously http : / / www . biogps . org / # goto = genereport & id = 274 / . It is also involved in the clath - rin - mediated endocytosis machinery [ 86 ] and binds to dy - namins that regulate the clathrin network [ 87 ] including DNM1 and the herpes simplex binding partner DNM2 [ 88 ] and to clathrins and the alpha adaptins , AP2A1 and AP2A2 [ 89 ] . BIN1 also participates in phagocytosis in macrophages and is associated , but only transiently , with early phagosomes ; however , it is retained on vacuoles con - taining Chlamydia pneumoniae , an e ﬀ ect that reduces the ability of the macrophage system to kill the bacteria via nitric oxide generation . Macrophages expressing a dominant negative BIN1 internalise C . pneumoniae , but do not allow their killing [ 90 ] . BIN1 also binds to a number of alpha integrins ( ITGA1 , ITGA3 , and ITGA6 ) [ 91 ] : integrins are used for attachment by many viruses , bacteria , and fungi and may serve as pattern recognition receptors regulating the immune response [ 92 ] . Individual integrins bind to many others , forming heteromeric complexes ; for example , ITGA1 binds to ITGA3 or ITGA6 , while ITGA3 binds to ITGB1 ( a receptor for the H . pylori protein CagA [ 93 ] ) , ITGB4 , or ITGB5 , and ITGA6 binds to ITGB1 and ITGB4 ( data from NCBI gene ) . 3 . 3 . The Immune Network ( APOE , BIN1 , CD2AP , CD33 , MS4A2 ) ( Figure 4 ) . CD33 , mainly expressed in myeloid cells , monocytes , and dendritic cells ( http : / / www . biogps . org / # goto = genereport & id = 945 / ) , is a member of the sialic acid binding Immunoglobulin g - like lectin ( SIGLEC ) family . CD33 - related SIGLECs regulate adaptive immune responses and are also important as macrophage pattern recogni - tion receptors for sialylated pathogens , including enveloped viruses [ 94 ] . CD33 binds to alpha2 - 3 - or alpha2 - 6 - linked sialic acids ( N - acetyl neuraminic acid ) [ 95 ] . These particular sialic acids are expressed on the surface envelope glyco - proteins ( B , D , and H ) of the herpes simplex virion , and these residues are required for viral entry into cells [ 96 ] . N - acetyl neuraminic acid is expressed by C . neoformans , is involved in fungal adhesion to macrophages [ 97 ] , and is also a component of the cell wall of B . burgdorferi [ 98 ] , while Helicobacter pylori adhesins also bind to this particular form of sialic acid [ 99 , 100 ] as does P . gingivalis [ 101 ] . BIN1 , as well as its relationship to the clathrin mediated endocytosis machinery , also regulates the expression of indoleamine 2 , 3 - dioxygenase ( IDO1 ) , an enzyme that cat - alyzes the ﬁrst rate - limiting step in tryptophan metabolism to N - formyl - kynurenine [ 102 ] . IDO1 upregulation is an important defence mechanism against pathogenic bacteria , many of which are unable to synthesise tryptophan . Their survival is compromised by the diversion of tryptophan metabolism to kynurenines [ 103 ] . This IDO1 response is also deleterious to other pathogens and parasites , including T . gondii , and to a number of viruses , including herpes simplex and other herpes viruses [ 104 ] . IDO1 protein expression is localised to plaques and tangles in the Alzheimer’s disease brain . IDO1 activation can lead to the production of toxic tryptophan derivatives such as 3 - hydroxyanthranilic acid or the N - methyl - D aspartate receptor agonist and excitatory neurotoxin , quinolinic acid [ 105 ] ( GRIN2B , GRIN3A ) . Plasma tryptophan levels are also lower in the ageing pop - ulation and in Alzheimer’s disease , a pattern accompanied by immune activation , and by increased concentrations of quinolinic acid [ 106 , 107 ] . MS4A2 , expressed mainly in the tonsils , lymph nodes , B cells , and dendritic cells http : / / www . biogps . org / # goto = genereport & id = 931 / , is a component of the immunoglobulin E ( IgE ) receptor , which is involved in allergic responses in which allergens bound to receptor bound IgE result in the activation of allergic mediators such as histamine [ 108 ] . Mice immunised with inactivated herpes simplex develop IgE - speciﬁc antibodies to the virus [ 109 ] . High levels of IgE are also observed in man following recurrent herpes simplex infection [ 110 ] and human IgE antibodies are also known to interact with herpes family viruses including HSV - 1 and 2 and the Epstein - Barr and cytomegalovirus [ 111 ] and also to C . pneumoniae , H . pylori , and B . burgdorferi International Journal of Alzheimer’s Disease 11 Sialic MS4A2 IgE CD33 BorrC . Neo P . Ging BIN1 IDO1 Inﬂammatory mediators BorrC . Neo C . Pneu Cytomeg H . Pyl EPHA1 EFNA1 SMURF2 ALK TGFBR CLU TGFB1 APOC1CELF2 PVRL2RFC3 Herpes simplex Chlamydia TOMM40 Microtubule Immune DISC1TTLL7 MTHD1L Homocysteine / folate BLMHCBSMTHFRMTRMTRRPON1PON2 FCER1G Antimicrobial Tryptophan ( reduced in AD ) Quinolinate ( increased in AD ) NMDA receptors GRIN2B GRIN3A FAM113BGAB2PAX2 CCL2 CCL3 CCR2 IL10 IL18 IL1A IL1B IL1RN IL33 IL6 IL8 TGFB1 TNF NOS1 NOS2 NOS3 PTGS2 Other immune : CD36 CD86 CRP EBF3 HLA - A2 HLA - DRB1 MICA TAP2 TLR2 TLR4 H . Pyl Figure 4 : Immune - related genes : Alzheimer’s disease susceptibility genes returned from very large genomewide association studies are in black , and those from the pre - GWAS era in grey . Binding interactions are indicated by linked diamonds and other e ﬀ ects by arrows . Borr : Borrelia burgdorferi ; C . Pneu : chlamydia pneumoniae ; Cytomeg : cytomegalovirus ; H . Pyl : Helicobacter pylori ; P . Ging : Porphyromonas gingivalis ; IgE : immunoglobulin E , Sialic : alpha2 - 3 - or alpha2 - 6 - linked sialic acids : the genes in the top right square were returned from GWAS prior to the very large studies . black star : Herpes simplex : see text for details . [ 112 – 115 ] . IgE - related allergic responses are also involved in C . neoformans infection [ 116 ] . Other members of this gene cluster ( including MS4A4A , MS4A4E , and MS4A6A ) are also structurally related to the immunoglobulin E receptor and to CD20 ( MS4A1 ) and also regulate B cell and T cell proliferation and / or di ﬀ erentiation [ 117 , 118 ] . EPHA1 is an ephrin receptor , primarily expressed in the liver and otherwise ubiquitously ( http : / / www . biogps . org / # goto = genereport & id = 2041 / ) . Only three protein / protein interactions for EPHA1 are reported in the NCBI gene inter - action section , including its ligand EFNA1 , the anaplastic lymphoma receptor tyrosine kinase ( ALK ) , and a SMAD - speciﬁc E3 ubiquitin protein ligase 2 ( SMURF2 ) . EFNA1 is one of several proteins identiﬁed as being important in the entry of C . pneumoniae into human coronary ar - tery endothelial cells [ 57 ] . SMURF2 is known to bind to the VP22 tegument protein of herpes simplex [ 119 ] and plays a role in clathrin - mediated endocytosis and the sub - sequent ubiquitin - related proteasomal degradation of TGF beta receptors , to which it binds [ 120 ] . Clusterin is a ligand for TGF beta receptors ( TGFBR1 / TGFBR2 ) [ 121 ] . TGF beta signalling exerts immunosuppressive e ﬀ ects and inhibits host immunosurveillance and the recruitment of immunocompetent cells by chemokines [ 122 ] . ALK is ubiquitously expressed ( http : / / www . biogps . org / # goto = gene - report & id = 238 / ) . It plays a role in neural development , and its expression decreases with age [ 123 ] . ALK is best characterised via its relationship with lymphomas , caused by ALK gene fusion with any of several other housekeeping genes [ 124 ] . Its key involvement in lymphoma suggests a role in the immune network although the function of the normal ALK protein is poorly understood . 3 . 4 . Lipoprotein Related ( APOE , ABCA7 , CLU ) ( Figures 2 and 5 ) . ABCA7 is an ATP - binding cassette transporter , predom - inantly localised in the pineal gland and cells of the immune network ( T cells , natural killer cells , and dendritic cells http : / / www . biogps . org / # goto = genereport & id = 10347 / ) . The lipoproteins APOA1 and APOE are substrates for ABCA7 , and in cultured HEK - 293 cells , plasma membrane - situated ABCA7 increases the e ﬄ ux of phosphatidylcholine and sphingomyelin e ﬄ ux to APOA1 and APOE , with no e ﬀ ect on cholesterol e ﬄ ux [ 125 ] . However , cholesterol e ﬄ ux to lipid - laden APOE , but not to lipid free APOE , is increased by ABCA7 expression in HEK - 293 cells [ 126 ] . Sphingomyelin is enriched in extracellular herpes simplex viral membranes : this sphingomyelin , together with phosphatidylserine , is collected by the viral envelope during viral passage from the nuclear membrane to the exocytosis pathway [ 127 ] . Herpes viral infection leads to an increased incorporation of phosphate into membrane sphingomyelin of the host [ 128 ] . Inhibition of sphingomyelinase has also been shown to markedly reduce herpes simplex viral reproduction [ 129 ] 12 International Journal of Alzheimer’s Disease and also inhibits the antifungal e ﬀ ects of neutrophils against C . neoformans infection . Sphingomyelin is a receptor for the Helicobacter toxin VacA [ 130 ] and is also incorporated into inclusion bodies in C . pneumoniae - infected cells [ 131 ] . Phosphatidylcholine plays an important role in the fusion of herpes simplex glycoproteins B and H with the host cell lipid membrane , a process used in viral entry [ 132 ] . Phos - phatidylcholine is also able to trigger capsular enlargement in C . neoformans infection [ 133 ] . ABCA7 expression increases the extracellular surface deposition of ceramide ( derived from sphingomyelin ) [ 134 ] . Ceramide , a potent activator of apoptosis , as well as its down - stream target , caspase 3 ( CASP3 ) are both able to reactivate the herpes simplex virus from latency [ 135 ] . Ceramide is also incorporated into C . pneumoniae inclusions , an e ﬀ ect that may play a role in the antiapoptotic e ﬀ ects of this bacterium [ 136 ] . APOA1 exerts antiviral e ﬀ ects against herpes simplex and inhibits viral entry into cells as well as viral - induced cell fusion and intercellular spread [ 137 ] . In macrophages , ABCA7 is expressed intracellularly and does not participate in cholesterol or phospholipid e ﬄ ux , instead playing a role in the phagocytosis of apoptotic cells , an important general defence mechanism against invading pathogens [ 62 , 138 ] . 3 . 4 . 1 . Apolipoprotein E . Possession of the APOE 4 allele facil - itates the entry and transmission of herpes simplex in mice models [ 139 ] . In man , APOE is also involved in hepatitis C , HIV - 1 , and herpes simplex infectivity [ 140 – 143 ] , and APOE4 facilitates the binding of C . pneumoniae elementary bodies to host cells [ 144 ] . APOE mRNA is primarily expressed in the liver , adipocytes ; kidney and brain , with very low expression in the peripheral immune network ( http : / / www . biogps . org / # goto = genereport & id = 348 / ) but nevertheless plays an important role in the immune system . For example , the presence of the APOE 4 allele is associated with an enhanced macrophage inﬂammatory response , and cytokine responses to the intracerebral injection of lipopolysaccharide are increased in APOE 4 transgenic mice , which also exhibit increased microglial activation . The anti - inﬂammatory e ﬀ ects of 17 - beta - oeastradiol on microglia are also reduced in such animals [ 145 , 146 ] . C - reactive protein ( CRP ) levels are also decreased in APOE 4 carriers [ 145 – 147 ] . CRP is an acute phase protein that binds to phosphocholine on dead or dying cells and on bacteria , subsequently activating the complement pathway [ 148 ] . Resistance to infection ( Klebsiel - la pneumoniae ) or endotoxaemia is also decreased in APOE knockout mice [ 149 ] . In addition , atherosclerosis is induced or worsened by infection with a number of relevant pathogens ( Cytome - galovirus , herpes simplex , Helicobacter pylori , inﬂuenza , C . pneumoniae or P . gingivalis ) in APOE knockout mice [ 150 – 156 ] . Helicobacter pylori is able to promote atherosclerosis in heterozygous APOE ( + / − ) LDLR ( + / − ) mice , which is associated with an immune response to the bacterial heat shock protein hsp60 [ 157 ] . 3 . 5 . Other GWAS Genes ( Figure 4 ) . Prior to the very large GWAS collaboration , several other genes had been identiﬁed DSG2 CDH1 SDC1 β - amy CD44 CD46 ERBB4 ADAM10 NGFR Pox Staph HHV - 6 Papill Adeno Meas C . Neo Strep Neiss P . Ging Rhino LRP1 VLDLR NOTCH1NOTCH4 EBV Rabies EFNB2 NipahHendra SPN HIV - 1 Flu DAG1 LassaLCMVLeprosy HepE SDC3 LDLR HepC Antimicrobial SDC2 Cyto CX3CL1 HSV - 1 PVRL1 MicrobialP - serine CXCL16 APP Figure 5 : Gamma - secretase - mediated cleavage of viral and path - ogen receptors . Gamma secretase substrates are indicated by the square boxes and their pathogen ligands in the oval boxes . Cyto : cytomegalovirus ; C . Neo : Cryptococcus neoformans ; Adeno : adeno - virus ; EBV : Epstein - Barr virus ; Flu - inﬂuenza A . ; HepC : hepatitis C ; HepE : hepatitis E ; HHV - 6 : human herpesvirus 6 ; HIV - 1 : human immunodeﬁciency virus ; HSV - 1 : herpes simplex ; Lassa : Lassa fever virus ; LCMV : Lymphocytic choriomeningitis virus ; Leprosy : mycobacterium leprae ; Meas : measles ; Neiss : Neisseria ; Papill : papillomavirus ; P . Ging : Porphyromonas gingivalis ; Pox : Vaccinia and other pox viruses , Rhino : rhinoviruses ; Staph : Staphy - lococcus aureus , Strep : streptococcus ; P serine : phosphatidylserine : Alzheimer’s disease susceptibility genes returned from very large genomewide association studies , and APP , are in black , as are the pathogens implicated in Alzheimer’s disease Genes from the pre - GWAS era are in grey . in smaller genomewide studies ( APOC1 , CELF2 , DISC1 , FAM113B , GAB2 , MTHFD1L , PAX2 , PCDH11X , PVRL2 RFC3 , SASH1 , TOMM40 , TTLL7 , and ZNF224 ) . PVRL2 is a receptor for herpes simplex ( HSV - 1 and HSV - 2 ) [ 158 ] , and the mitochondrial translocator , TOMM40 , a receptor for certain chlamydial species [ 159 ] . The replication factor RFC3 is part of a complex necessary for human DNA polymerase activity , a process exploited by many viruses including herpes simplex , whose virion component ICP34 . 5 binds to proliferating cell nuclear antigen ( PCNA ) , an RFC3 binding partner and also a cofactor for DNA polymerase [ 160 ] . ZNF224 is a transcriptional repressor binding to the protein arginine methyltransferase , PRMT5 [ 161 ] . Protein arginine methylation is important in viral infection and replication , as well as in cytokine signalling , and a related arginine methyltransferase , PRMT1 , regulates herpes sim - plex replication via methylation of the ICP27 viral gene [ 162 ] . DISC1 is a component of the microtubule - associated dynein motor complex used in viral tra ﬃ c [ 163 ] ; TTLL7 ( tubulin tyrosine ligase - like family , member 7 ) also regulates tubulin phosphorylation [ 164 ] and can again be related to viral tra ﬃ c along the microtubule network ( see below ) . CELF2 ( also known as CUGBP2 ) is a member of the APOBEC1 cytidine deaminase mRNA editing complex that also controls herpes simplex viral replication [ 165 ] . GAB2 International Journal of Alzheimer’s Disease 13 is a member of the GRB2 - associated binding protein family which act as adapter hubs transmitting signalling via cy - tokine and growth factor receptors , and T - and B - cell antigen receptors ( deﬁnition from NCBI gene ) , while PAX2 inhibits the expression of the antimicrobial peptide beta defensin ( DEFB1 ) [ 166 ] , a gene associated with HSV - 1 and cytomegalovirus seropositivity in children with acute lymphoblastic leukaemia [ 167 ] , as well as with H . pylori or chlamydial infections [ 168 , 169 ] , also endowed with anti - microbial activity against C . neoformans and other pathogens [ 170 ] . MTHD1L ( methylenetetrahydrofolate dehydrogenase ( NADP + dependent ) 1 - like ) is involved in the mitochondrial synthesis of tetrahydrofolate which in turn is important in the de novo synthesis of purines and thymidylate and in the regeneration of methionine from homocysteine ( deﬁni - tion from NCBI gene ) . Many pathogens , including herpes simplex , express thymidylate kinases , which are important for viral replication and a target for acyclovir [ 171 ] . Hyper - homocysteinaemia correlates with C . pneumoniae IgG im - munoreactivity in carotid artery atherosclerosis [ 172 ] and is also associated with H . pylori infection in the context of atherosclerosis [ 173 ] . The apolipoprotein APOC1 is a component of high - density lipoprotein : herpes simplex is present in all lipoprotein blood fractions in blood ( VLDL , LDL and HDL ) and the lipid component of these lipopro - teins binds to viral glycoprotein B [ 174 ] ( c . f . APOA1 , APOA4 , APOA5 , APOC1 , APOC2 , APOC3 , APOC4 , APOD , and APOE ) . No immediately apparent pathogen - relevant interactions were found for FAM113B ( expressed exclusively in T cells , dendritic cells , and natural killer cells http : / / www . biogps . org / # goto = genereport & id = 91523 / ) , PCDH11X ( which is ubiquitously expressed http : / / www . biogps . org / # goto = genereport & id = 27328 / ) , or SASH1 ( primarily exp - ressed in the brain and lung although also in other tissues , including the immune network http : / / www . biogps . org / # go - to = genereport & id = 23328 / ) although the pathogen / immune theme is clearly carried through , particularly in relation to herpes simplex , in this second rank of Alzheimer’s disease susceptibility genes . 3 . 6 . Beta Amyloid Processing ( Figure 2 ) . APOE , clusterin , and complement receptor 1 play key roles in beta amy - loid clearance as do two further herpes simplex binding proteins APOA1 , and alpha - 2 macroglobulin ( A2M ) . This is primarily mediated via lipoprotein receptors . A2M , or APOE - bound A β , is cleared by the lipoprotein receptor LRP1 , while LRP2 ( megalin ) clears clusterin - bound A β . LRP8 is a receptor for both APOE and clusterin . APOA1 is also involved in beta - amyloid clearance via its transporter ABCA1 . The role of ABCA7 has not been examined , although APOA1 is also a ligand for this transporter ( see above ) . The Varicella Zoster and herpes simplex glycoprotein E binding protein , insulin - degrading enzyme , are also involved in beta - amyloid degradation , as is caspase - 3 which is activated by the herpes simplex viral US3 kinase . The HSV - 1 binding protein , complement C3 is also a ligand for LRP1 and LRP8 , both of which play a role in C3 cellular uptake . Beta amyloid in the bloodstream is processed by its binding to complement C3 , which subsequently binds to complement receptor 1 on erythrocytes . The e ﬀ ects above are referenced in a recent review [ 48 ] . Clathrin - dependent endocytosis is also involved in the internalisation and recycling of neuronal APP , a procedure necessary for the subsequent cleavage of APP and the generation of beta - amyloid [ 175 , 176 ] , and in the neuronal [ 177 ] , but not the microglial uptake of both soluble and aggregated beta - amyloids , the latter representing an impor - tant rout of disposal [ 178 ] . However , while knockdown of the clathrin assembly protein AP180 in a neuronal cell line does reduce beta - amyloid generation , PICALM knockdown does not [ 179 ] . The accumulation of beta - amyloid in the brain interstitial space , related to the prior endocytosis of APP , is clathrin dependent [ 180 ] . Clathrin - mediated endocytosis is relevant to many receptors , including members of the lipoprotein family ( LRP1 , LRP2 , LRP8 , LDLR , VLDLR ) [ 181 ] , all of which are involved in beta - amyloid clearance , as well as in cholesterol and lipoprotein physiology [ 182 ] . ABCA7 plays a role in beta - amyloid secretion , which is increased in Chinese hamster ovary cells expressing APP and ABCA7 . This was related to an e ﬀ ect on APP intracellular retention , rather than on secretase - mediated proteolysis of APP [ 126 ] . Gamma - secretase cleaves APP , and other gamma - se - cretase substrates also play key roles in APP processing ( ADAM10 ) [ 183 ] , lipid and cholesterol function ( LRP1 , LDLR , VLDLR ) , and other processes relevant to Alzheimer’s disease , for example , NOTCH signalling [ 184 ] . No other immediately apparent relationships with beta - amyloid could be found by literature survey for CD2AP , CD33 , and EPHA1 or for MS4A - related proteins , although such are not precluded . 3 . 6 . 1 . The Microtubule Network and Tau Phosphorylation . Many pathogens , including herpes simplex , helicobacter , chlamydiae , P . gingivalis , and C . neoformans [ 185 – 188 ] , use the microtubule network that serves as a useful railway track between various cellular compartments , and may hijack dynein and kinesin motors for this purpose ( see http : / / www . polygenicpathways . co . uk / herpeshost . html for herpes sim - plex ) . Tau ( MAPT ) stabilises microtubules by interacting with tubulins and promoting microtubule assembly [ 189 ] . When tau is phosphorylated , by any of several kinases , microtubules become disorganised . Tau hyperphosphoryla - tion and neuroﬁbrillary tangles are among the core patholo - gies of Alzheimer’s disease [ 190 ] and can be promoted by herpes simplex infection [ 191 ] . In relation to viral / human protein homology , herpes simplex proteins are homologous to a number of kinases known to phosphorylate tau ( GSK3A , GSK3B , MAPK1 , and CAMK2B ) suggesting that tau phos - phorylation could be a direct result of a viral kinase [ 192 ] . 3 . 6 . 2 . APP and Gamma Secretase . APP plays a key role in the herpes simplex life cycle and is involved in its intracellular transport [ 193 ] , an e ﬀ ect likely related to the ability of both APP and the herpes simplex protein , US11 , to bind to the APP and kinesin binding protein APPBP2 ( also known as pat1 ) [ 194 , 195 ] . 14 International Journal of Alzheimer’s Disease The AntiMicrobial E ﬀ ects of Beta - Amyloid . Beta - amyloid is an antimicrobial peptide with broad spectrum activity against a variety of yeasts and bacteria , e ﬀ ects that were attenuated by anti - A β antibodies [ 196 ] , Beta - amyloid also has antiviral e ﬀ ects and , like acyclovir , attenuates the stim - ulatory e ﬀ ects of herpes simplex on miRNA - 146a levels in neuronal cells [ 197 ] . Beta - amyloid also activates innate immune responses via the activation of pattern recognition receptors , such as Toll receptors ( TLR2 , TLR4 ) , which are also involved in beta - amyloid clearance [ 198 , 199 ] . The antimicrobial , antiviral , and immunostimulant properties of beta amyloid are , however , likely to be abrogated by the presence of beta - amyloid autoantibodies in the sera of the ageing population and in Alzheimer’s disease [ 200 ] . As immunogenic regions of beta - amyloid are homologous to similar regions within proteins expressed by all of the principal pathogens discussed in this paper , such antibodies are likely to be derived from antibodies raised to numerous pathogens ( see below ) . Gamma Secretase : Localisation to Dendritic Cells and Cleavage of Pathogen Receptors . Gamma secretase is constituted of four components : the presenilins ( PSEN1 or PSEN2 ) , anteri - or pharynx - defective - 1 ( APH1A ) , the Presenilin enhancer - 2 ( PSENEN ) , and nicastrin ( NCSTN ) [ 201 ] . While all comp - onents are expressed in cerebral tissue , the major focus of distribution is within cells of the immune network ; dendritic cells , myeloid cells , and monocytes for PSEN1 http : / / www . biogps . org / # goto = genereport & id = 5663 / ; dendritic cells and natural killer cells for PSENEN http : / / www . biogps . org / # go - to = genereport & id = 55851 / , dendritic cells and myeloid cells for nicastrin http : / / www . biogps . org / # goto = genereport & id = 23385 / and B cells , dendritic cells , natural killer cells , and myeloid cells for APH1A . The substrate , APP , is the only gene in this set that appears to be preferentially distributed in brain compartments , but , as with gamma - secretase components , it is also highly expressed in dendritic cells of the immune system ( http : / / www . biogps . org / # goto = gene - report & id = 351 / ) . The primary function of such cells is to process antigens and present them to B cells and T cells . They scout for and recognise pathogens via the agency of numerous pattern recognition receptors , for example , Toll receptors ( TLR2 , TLR4 ) , or viral DNA sensors , expressed on their surface [ 202 , 203 ] . As well as cleaving APP , gamma secretase is involved in the proteolysis of at least three herpes simplex receptors , nectin 1 alpha ( PVRL1 ) [ 204 ] , and syndecans ( SDC1 , SDC2 ) [ 205 ] . SDC1 is also a receptor for HIV - 1 , Hepatitis E , and the human papillomavirus [ 206 – 209 ] , while SDC3 , also a gamma secretase substrate , is an HIV - 1 and papillomavirus receptor [ 210 , 211 ] . Several other gamma secretase substrates ( reviewed by Lle´o and Saura [ 201 ] ) also function as viral / pathogen receptors , including ADAM10 , a receptor for the cytotoxin Staphylococcus aureus alpha - haemolysin [ 212 ] , CD44 , an entry receptor for C . neoformans [ 213 ] , CD46 , a receptor for adenoviruses , measles virus , human herpes virus 6 ( HHV - 6 ) , Streptococci , and Neisseria [ 214 ] : CD46 is also cleaved by a protease secreted by P . gingivalis [ 215 ] . Desmoglein - 2 is an adenovirus receptor [ 216 ] , while rhinovirus receptors include the lipoprotein receptors LRP1 , LDLR , and VLDLR [ 217 , 218 ] . LDLR is also a hepatitis C receptor [ 219 ] . NOTCH1 and NOTCH4 are activated by the Epstein - Barr virus [ 220 , 221 ] , while ERBB4 is a receptor for vaccinia and other pox viruses [ 222 ] . The low a ﬃ nity nerve growth factor ( NGFR ) is a rabies virus receptor , [ 223 ] , Ephrin B2 , ( EFNB2 ) a Nipah virus and Hendra virus receptor [ 224 ] and sialophorin ( SPN ) , a receptor for the inﬂuenza A , and both human and simian immunodeﬁciency viruses [ 225 , 226 ] and for the C . neoformans virulence factor , galactoxylomannan [ 227 ] . Fractalkine ( CX3CL1 ) binds to the cytomegalovirus chemokine receptor , US28 [ 228 ] , while the chemokine CXCL16 is a scavenger receptor for phosphatidylserine and oxidized low density lipoprotein [ 229 ] : phosphatidylserine is the major lipid membrane component in most bacteria [ 230 ] . Dystroglycan is a receptor for the Lymphocytic cho - riomeningitis and Lassa fever viruses [ 231 , 232 ] and also for mycobacterium leprae ( the Leprosy pathogen ) [ 233 ] . The antimicrobial and immunostimulant e ﬀ ects of beta - amyloid , the cleavage of a number of pathogen receptors by gamma secretase , and the concentration of both APP and gamma - secretase components in dendritic cells suggest that a major function of this key group , implicated in both familial and late onset Alzheimer’s disease , is dedicated to pathogen defence , and that increased beta - amyloid genera - tion is primarily a defence mechanism to rid the body ( and brain ) of invading pathogens : This scenario is supported by the ability of herpes simplex , C . pneumoniae , and B . burgdor - feri to increase beta - amyloid deposition [ 234 – 236 ] . One might expect many other pathogens to increase beta - amyloid deposition , and that , as has been noted in atherosclerosis , ( a component of Alzheimer’s disease pathology ) , the ﬁnal extent of risk may depend upon the overall pathogen burden , rather than upon any speciﬁc pathogen [ 237 ] . 3 . 6 . 3 . Autoantibodies Derived from Pathogens as Contributory Causative Agents . . Viruses and bacteria express proteins con - taining short contiguous amino acid stretches ( pentapeptides or more , or longer gapped consensi ) that are identical to those in human proteins : these pathogen / human consensi number in millions and concern all human proteins [ 238 – 241 ] . Autoantibodies , which are observed in many , if not most human diseases , are often regarded as an epiphenomenon of little consequence . However , they can traverse the blood brain barrier [ 242 ] ( which is compromised in Alzheimer’s disease [ 243 ] ) and are also able to enter cells , essentially by hitching a ride on viruses , via high a ﬃ nity IgG receptors ( Fc gamma receptors ) ( FCER1G ) in the case of the rhinovirus , or the SARS coronavirus , or via the tripartite motif protein , TRIM21 , in the case of adenoviruses , where they are able to activate an intracellular immune attack . It would appear that the cellular entry of antibody laden viruses is diverted from their usually preferred receptors towards those used by antibodies [ 244 – 246 ] . This may be relevant to the MS4A family . Fc gamma receptors are localised in microglia and International Journal of Alzheimer’s Disease 15 astrocytes in the brain and their expression is upregulated by blood brain barrier disruption [ 247 ] , while TRIM21 appears to be exclusively localised in peripheral immunocompetent cells ( http : / / www . biogps . org / # goto = genereport & id = 6737 / ) . This ability places autoantibodies in a rather more sinister context , as their targeting of extracellular and intra - cellular human proteins would be expected to e ﬀ ect protein knockdown , a strictly immunopharmacological e ﬀ ect , as well as immune attack . In multiple sclerosis , schizophrenia , and cystic ﬁbrosis , as well as in Alzheimer’s disease , numerous autoantigens targeted by the autoantibodies reported in these conditions , contain peptide sequences identical to those in the pathogens also implicated in the disease . Such regions of homology are focalised within epitope regions of the human autoantigen [ 192 , 248 – 250 ] . In Parkinson’s disease , antibodies to the Epstein - Barr virus , which has been implicated in posten - cephalitic adult and juvenile Parkinsonism , are also known to cross - react with synuclein , a key protein involved in neu - rodegeneration in this disorder [ 251 – 253 ] . In addition , 22 autoantigens reported in HIV - 1 / AIDS contain HIV - 1 / human matching sequences [ 254 ] , supporting the contention that autoantibodies are in many cases antibodies initially raised to pathogens , which because of this homology , then target their human homologues . It has been argued that slightly dissimilar , rather than exact matches , are the more malignant in terms of autoimmunity , being less likely to be regarded as self , while the antibodies would retain low a ﬃ nity for human counterparts [ 254 , 255 ] . Autoantibody production would also be sustained , even after pathogen elimination , by continued encounter of the human homologue . The production of autoantibodies must be dependent upon the extent of pathogen / human matching , and thus by genes which determine human protein sequences . These pathogen / human matches are also highly and signiﬁcantly enriched in the products of sus - ceptibility genes implicated in Alzheimer’s disease , multiple sclerosis , and schizophrenia [ 192 , 248 , 250 ] . Many genes related to Alzheimer’s disease , including those described above , are involved in the immune network [ 10 , 256 ] , and the propensity for developing autoantibodies to particular proteins is also genetically determined and inherited [ 257 ] . Thus , despite the fact that all human proteins likely possess pathogen homologues , whether or not autoantibodies will be produced will depend on the extent of human / pathogen matching ( determined by human genes and the strain of pathogen encountered ) , on whether the pathogen protein is deemed as self or nonself ( a factor determined soon after birth ) and on other genetic factors related to the immune network , and autoimmunity . Somatic hypermutation , that drives the creation of multiple antibodies and which selects against those reacting to self , is disrupted in autoimmune disorders [ 258 ] . These links suggest an interplay , applicable to many diseases , where susceptibility gene products , risk promoting pathogens and autoimmunity can all be related via protein sequence homology . It has also been noted that autoantigens have a tendency to relate to proteins known to bind to dermatan sulphate , a component of dead cells [ 259 ] and a constituent of glycosaminoglycan receptors for many bacteria and viruses [ 260 ] . 3 . 6 . 4 . Sequence Comparisons : Beta - Amyloid , NGF , and Tau versus Pathogen Proteins . All three of these proteins are autoantigens in Alzheimer’s disease and were chosen for analysis because of the ability of their antibodies to promote features of Alzheimer’s disease , in vivo . In mice , immuni - sation with neuronal tau produces neuroﬁbrillary tangle - like structures , axonal damage , and gliosis , as in Alzheimer’s disease [ 261 ] . In addition , in transgenic mice , initially expressing NGF antibodies only in lymphocytes , NGF anti - bodies subsequently enter the brain provoking extensive cortical degeneration , cholinergic neuronal loss , tau hyper - phosphorylation , and beta - amyloid deposition [ 262 ] . Beta - amyloid autoantibodies are also able to promote meningoen - cephalitis , both in laboratory models and in clinical trials [ 263 , 264 ] . Beta - amyloid plaques contain numerous inﬂam - matory proteins , and even without meningoencephalitis , these are commonly found within the walls of meningeal and medium - sized cortical arteries in Alzheimer’s disease [ 265 ] . Almost the entire length of the tau protein ( 638 / 776 amino acids = 82 . 2 % ) was predicted as immunogenic ( B cell epitope ) , as deﬁned by the server set cuto ﬀ index of 0 . 35 . For the analysis in Table 1 , only regions of the tau protein with an immunogenicity index > 2 . 5 were examined for homology . For other proteins ( NGF and beta - amyloid ) , the analysis concerned immunogenic regions above the cuto ﬀ value of 0 . 35 . All pathogens express proteins with homology to each autoantigen , speciﬁcally within predicted B - cell epitope regions of the human autoantigen ( Table 1 ) , suggesting that antibodies raised to any could be responsible for targeting these human proteins , under the appropriate circumstances . Perversely , the successful elimination of the pathogen via antibody production could set in motion the very autoim - mune responses that may be crucial to the development of Alzheimer’s disease , a Pyrrhic victory , which would also be promulgated by any further encounter with these very common pathogens , or by structurally related proteins from other pathogens , as well as by continual encounter of the human autoantigen homologue ( see Section 3 . 6 . 5 ) . As well as autoantibodies to these three proteins , a num - ber of autoantibodies targeting highly relevant proteins have been reported in Alzheimer’s disease . These have functional e ﬀ ects on their target proteins and include antibodies that block the activity of ATP synthase , induce apoptosis , and increase the cellular uptake of high density lipoprotein [ 266 , 267 ] , antibodies to cholinergic neurones that cause immu - nalysis of brain synaptosomes [ 268 ] , antibrain antibodies that enhance intraneuronal beta - amyloid deposition [ 269 ] as well as antibodies to the nicotinic receptor CHRNA7 , that displace its ligand alpha - bungarotoxin [ 270 ] : autoantibodies to the receptor for advanced glycation products ( AGER ) [ 271 ] , to the antimicrobial peptide S100B , have also been reported [ 272 ] . 3 . 6 . 5 . Population Genetics : Susceptibility Genes Related to the Cause of the Disease , rather than to the Disease Itself . Using 16 International Journal of Alzheimer’s Disease Table 1 : Viral , bacterial , and fungal protein homology with beta - amyloid ( top ) , NGF ( middle ) , or tau ( bottom ) ; Predicted B cell epitope segments were compared with Borrelia burgdorferi , C . neoformans , C . pneumoniae , H . pylori , P . gingivalis and herpes viruses ( HSV1 , HHV6 , and cytomegalovirus ) proteomes by BLAST analysis . The B cell antigenicity indices are shown , and those above the server set threshold of 0 . 35 are in italics . The ﬁrst column shows the amino acid number within the peptide or protein sequence , and the second shows the amino acid pertaining to that position . The alignments with pathogen proteins are shown . Spaces represent nonidentical amino acids and + signs amino acids with similar physicochemical properties . Only highly antigenic regions of pentapeptides or more were processed . The VGGVV sequence , antibodies to which label beta - amyloid in brain tissue , despite relatively low antigenicity , has already been reported to be identical to proteins expressed by 69 viruses including HSV - 1 , HSV - 2 , and HHV6 . ( a ) Position B - Amy Amino acid B - cell index Alignments 1 D 0 . 41 C . neoformans + AE HDSG + Borrelia burgdorferi DAE F H + SG EV H . pylori DA FRH HSV - 1 + AE RH HHV - 6 D FR DS P . gingivalis + AEFR C . pneumoniae DA EFRHD and + AEFR + SG 2 A 0 . 35 C . neoformans AEFR D GY + V H . pylori AEF D S YE and AE + RH + Borrelia burgdorferi AEF H + Cytomagalovirus AEFR HD HSV - 1 AE R SG HHV - 6 AE + HD P . gingivalis A + F H + S and AEFR C . pneumoniae AEF DSG 3 E 0 . 62 H . pylori EFRHD HHV - 6 EF DSG Borrelia Burgdorferi EFR DS C . neoformans EF R DS YE P . gingivalis E R DSGY V C . pneumoniae EF SGYEV 4 F 0 . 73 C . neoformans FRHDS Borrelia burgdorferi + RH SGY + + and F H + SG H . pylori F HD EV Cytomegalovirus FR SGY P . gingivalis + RHDS C . Pneumonia F H + SGY 5 R 0 . 85 C . neoformans R D GYEV H . pylori RHDS Y V and R SGYE Borrelia burgdorferi RH + GY Cytomegalovirus RHD YE and RHDSG HSV - 1 RH SG HHV - 6 RHDS P . gingivalis R + DS Y + 6 H 0 . 57 C . neoformans HDSGY H . pylori H . pylori + DSGY and HD G EV and HD EV Borrelia burgdorferi H + SG Y + V HSV - 1 HDSG P . gingivalis HDSG C . pneumoniae + + SGY + V 7 D 0 . 69 C . neoformans DSGY + V H . pylori + SG + EV HSV - 1 DSGY P . gingivalis DSG + EV C . pneumoniae DSGY V 8 S 0 . 38 P . gingivalis SGYEV H . pylori SGYE C . neoformans SGY + + C . pneumoniae SG + EV 9 G 0 . 63 H . pylori GYEVH Borrelia burgdorferi GYE V KL + C . neoformans GYE LV and GY + + + LV P . gingivalis GYEV C . pneumoniae GYEV and GY HH 10 Y 0 . 56 H . pylori YE HH and YE + HQ and Y + + H Q and YE HHQ Cytomegalovirus YEVH Borrelia Burgdorferi YE + KL C . neoformans YE + QK FC P . gingivalis Y + + H H + K C . pneumoniae Y + V + Q LV 11 E 0 . 58 H . pylori EV + QK Cytomegalovirus EV HQ L Borrelia Burgdorferi EV + KL C . neoformans EV Q LV P . gingivalis EV KLV C . pneumoniae EV QKLV 12 V 0 . 35 H . pylori . + H QK Cytomegalovirus V HQ LV HHV - 6 VH QK + V Borrelia Burgdorferi VH KL C . neoformans + HH LV P . gingivalis VH + LV C . pneumoniae V HQKL 13 H − 0 . 17 H . pylori and C . pneumoniae HHQK Cytomegalovirus HH KL P . gingivalis HH KL 14 H − 0 . 66 Borreli Burgdorferi HQKL + C . pneumoniae and HSV - 1 HQKL P . gingivalis + QKLV 15 Q − 1 . 03 C . neoformans and P . gingivalis and C . pneumoniae QKLV 16 K − 1 . 47 H . pylori : Cryptococcus neoformans Borrelia burgdorferi Chlamydophila pneumoniae KLVFF Human herpesvirus 1 KLVF 17 L − 1 . 34 Human herpesvirus 5 : Human herpesvirus 6 LVFF 18 V − 1 . 20 19 F − 0 . 93 20 F − 0 . 98 21 A − 0 . 82 22 E − 0 . 31 23 D 0 . 23 24 V 0 . 81 Borrelia burgdorferi Cryptococcus neoformans Porphyromonas gingivalis VGSNK Cytomegalovirus + GSNK Helicobacter pylori Chlamydophila pneumoniae VGSN 25 G 1 . 24 H . pylori Chlamydophila pneumoniae GSNK 26 S 1 . 22 27 N 0 . 90 28 K 0 . 36 International Journal of Alzheimer’s Disease 17 ( a ) Continued . Position B - Amy Amino acid B - cell index Alignments 29 G 0 . 30 30 A − 0 . 24 31 I − 0 . 58 32 I − 1 . 00 33 G − 1 . 14 34 L − 1 . 19 35 M − 1 . 23 36 V − 1 . 16 69 viruses / phages VGGVV 37 G − 0 . 97 38 G − 1 . 02 39 V − 0 . 63 40 V − 0 . 45 41 I − 0 . 80 42 A − 1 . 06 ( b ) NGF position Amino acid B - cell index Alignment 18 A 0 . 59 C . neoformans AEPHS 19 E 1 . 16 P . gingivalis EPHSES—NVP Cytomegalovirus EPHS + S 20 P 1 . 32 C . neoformans P + S NVPAG and PHSES and P SESNV 21 H 1 . 78 Borrelia burgdorferi HSESN C . neoformans HSES VP and HSESN P H + P + 22 S 1 . 64 C . neoformans S + S VPAG T P Borrelia burgdorferi burgdorferi C . neoformans Chlamydophila pneumoniae P . gingivalis SESNV P . gingivalis S + SNVP C . pneumoniae SESNV A 23 E 1 . 68 C . neoformans ESNVP and ESNV AG 24 S 1 . 51 C . neoformans SNVPA 25 N 1 . 61 C . neoformans Cytomegalovirus P . gingivalis NVPAG C . neoformans NV TIPQA P . gingivalis + VPAG HT 26 V 1 . 45 C . neoformans P . gingivalis VPAGH C . neoformans VP AGHT C . neoformans VPAG TI and V AGHT + 27 P 1 . 36 C . neoformans HSV - 1 PAGHT C . neoformans PAGHT P C . neoformans PAG TIP 28 A 1 . 04 C . neoformans H . pylori AGHTI C . neoformans AG H IPQA and AGHT PQ and AGHT + P and AG TIP HSV - 1 HSV - 2 AGH PQ and AGHT QA 29 G 1 . 00 C . neoformans GHTI Q and GHT PQ and G TIPQ 30 H 0 . 93 C . pneumoniae HTI QA C . neoformans HT PQA and HTIP A 31 T 1 . 05 C . neoformans P . gingivalis TIPQA 32 I 0 . 95 33 P 0 . 64 34 Q 0 . 41 35 A 0 . 46 51 A 0 . 38 C . neoformans AR SAPA and AR APAA and A SAPAA and ARSA AA and ARSAP A and ARS PAA and AR—SAPAA 52 R 0 . 54 HSV - 1 RSAPAA Borrelia burgdorferi burgdorferri RSA AA 53 S 0 . 91 C . neoformans C . pneumoniae Cytomegalovirus HSV - 1 HSV - 2 P . gingivalis SAPAA 54 A 0 . 89 55 P 0 . 72 56 A 0 . 69 57 A 0 . 53 64 A 0 . 46 C . neoformans AG TRNI and AGQT RN and AGQTR P . gingivalis AGQTR 65 G 0 . 59 C . neoformans + RNITV and GQTRN 18 International Journal of Alzheimer’s Disease ( b ) Continued . NGF position Amino acid B - cell index Alignment 66 Q 0 . 42 P . gingivalis Borrelia burgdorferi QTRNI Cytomegalovirus QTRN—IT 67 T 0 . 43 C . neoformans P . gingivalis TRNIT 68 R 0 . 49 C . neoformans RNIT DP and RNITV 69 N 0 . 76 C . neoformans C . pneumoniae H . pylori NITVD 70 I 0 . 66 71 T 0 . 56 90 S 0 . 40 C . neoformans STQPPR and STQPP AA and STQPP EA C . pneumoniae STQ PRE C . pneumoniae Cytomegalovirus STQPP HSV - 1 STQ PR 91 T 0 . 63 C . neoformans TQP REA and TQPPR 92 Q 1 . 06 C . neoformans QPPRE 93 P 1 . 49 C . neoformans PP REAA C Neoformans P . gingivalis PPREA 94 P 1 . 91 C . neoformans HSV - 2 H . pylori PREAA 95 R 2 . 13 C . neoformans P . gingivalis REAAD and REAA TQ and RE ADT C . neoformans REAA DT and R AADT and R + AADT and READD HSV - 1 REAA T Borrelia burgdorferi burgdorferi Cytomagalovirus RE ADT Cytomagalovirus REAA TQ P . gingivalis REA + TQ 96 E 2 . 13 P . gingivalis EAADTQ and EA TQDLD C . neoformans EAADT + and EAAD QD and EAAD Q and EAA TQ 97 A 1 . 92 Borrelia burgdorferi burgdorferi C . neoformans AA TQD Borrelia burgdorferi burgdorferi P . gingivalis AAD QD HSV - 2 AADT D HHV - 6 AAD + DL C . neoformans AADT D and AA TQD and A DTQD and A TQDL and AADTQ and AADT + D + D P . gingivalis ADTQ L H . pylori AADTQ 98 A 1 . 9 Borrelia burgdorferi ADT DLD C . neoformans AD QDLD and AD QDL P . gingivalis ADT DL and AD QDL H . pylori + TQDLD 99 D 1 . 39 C . neoformans DT DLD and D QDLD C . pneumoniae DTQDL 100 T 1 . 25 C . neoformans H . pylori P . gingivalis TQDLD 101 Q 0 . 66 Borrelia burgdorferi burgdorferi C . neoformans H . pylori P . gingivalis QDLDF H . pylori QD DFEV 102 D 0 . 73 Borrelia burgdorferi burgdorferi C . neoformans H . pylori DLDFE C . neoformans DLD EVG and DLDF VG 103 L 0 . 54 C . neoformans LD EVGG and LDFE GG and LDFEV and LDF VGG H . pylori LDF EVGG HSV - 1 HSV - 2 L + EVGG 104 D 0 . 45 Borrelia burgdorferi burgdorferi DFEVG C . neoformans DF VGGA and D EVGGA 105 F 0 . 42 C . neoformans FEVGG Cytomegalovirus FE GGAA 106 E 0 . 49 C . neoformans EVGGAA and EVGGA P and EVGGA and EV GAAP and E + GGAAP H . pylori EVGGA Borrelia burgdorferi burgdorferi E + GG A PF + 107 V 0 . 39 P . gingivalis VGGAAP and VGGAA C . neoformans VGGAA PF and VGGAA NR and VGGAA and VG GAAP C . pneumoniae VGGA AP H . pylori VG GAAP and VGG APF and VGGAA P . gingivalis VGGAA 108 G 0 . 74 C . neoformans C . pneumoniae HSV - 2 GGAAP 109 G 0 . 44 C . neoformans GA APFN T and GAAPF 110 A 0 . 95 C . pneumoniae AAPFN Borrelia burgdorferi AAP + NR HSV - 1 AAP RT 111 A 0 . 83 C . neoformans APFN T RS C . neoformans H . pylori APFN TH C . pneumoniae AP N RT R RSSS 112 P 0 . 99 C . neoformans PFNRT and PF RTH Borrelia burgdorferi burgdorferi PF NRT 113 F 0 . 84 C . neoformans FNRT SKR 114 N 0 . 75 C . neoformans NR RSKRS S and NRT R RSSS Cytomegalovirus N T RSKRS 115 R 0 . 63 C . neoformans RT R SKRS and RTHRS Borrelia burgdorferi burgdorferi RTHRS 116 T 0 . 63 C . neoformans THRS RS and THRSK 117 H 0 . 64 C . neoformans HRS RSS and HRSKR C . Pneumonie HRSKR International Journal of Alzheimer’s Disease 19 ( b ) Continued . NGF position Amino acid B - cell index Alignment 118 R 0 . 94 C . neoformans RSKRSS and RS RSSS and RS KRSS and RS KRSS and RSK SSS and RSKRS S P . gingivalis RSKR S and RSKRS Borrelia burgdorferi burgdorferi RSKRS 119 S 0 . 88 C . neoformans SKRSSS and SKRSS C . pneumoniae H . pylori HSV - 1 HSV - 2 SKRSS 120 K 1 . 12 C . neoformans Cytomegalovirus HHV - 6 H . pylori KRSSS 121 R 1 . 13 122 S 1 . 12 123 S 0 . 83 124 S 0 . 50 144 G 0 . 52 C . neoformans GDKTTA and GDKTT 145 D 0 . 54 H . pylori DK TATDI Borrelia burgdorferi burgdorferi C . neoformans C . pneumoniae H . pylori DKTTA HSV - 1 + KTT TD 146 K 0 . 84 CF . Pneumoniae KTTAT + C . neoformans H . pylori KTTAT 147 T 1 . 27 C . neoformans HSV - 1 TTATDI C . neoformans P . gingivalis TTATD 148 T 1 . 22 C . neoformans TATDIK Borrelia burgdorferi burgdorferi C . neoformans C . pneumoniae H . pylori TATDI 149 A 1 . 21 C . neoformans HHV - 6 HHV - 6B P . gingivalis ATDIK 150 T 1 . 08 151 D 1 . 01 152 I 0 . 97 153 K 0 . 61 179 C 0 . 87 C . neoformans CR PNPV C . pneumoniae CRDPN P + S RGI 180 R 1 . 40 C . pneumoniae RDPNPV Borrelia burgdorferi burgdorferi RD NP VDS C . neoformans RDP PVDS and RDPNP + and RDPNP HHV - 6 HHV - 6B RDPNP HSV - 1 HSV - 2 RDPN V 181 D 1 . 36 Borrelia burgdorferi burgdorferi D NPVD and DPN VD C . neoformans DPNPV and DP PVD and DP PVDS and DPN VDS C . pneumoniae DPN VD HSV - 1 DPNP S HSV - 2 + P PVDS 182 P 1 . 69 C . neoformans PN VDSG and PNP DSG and PNPVD P . gingivalis PNPV + S and P PVDS 183 N 1 . 72 H . pylori NPVD G 184 P 1 . 85 C . neoformans PV DSGCR and P PVDS RG and PVDSG Cytomagalovirus P DSG RGI P . gingivalis PV DSGC 185 V 1 . 74 HSV - 2 VDSG RG HSV - 1 + DSG RG C . neoformans VDSG R 186 D 1 . 51 C . neoformans DSGC GI and DSG RG 187 S 1 . 28 Borrelia burgdorferi burgdorferi C . neoformans SGCRG and SG RGI and S CRGI 188 G 0 . 79 C . neoformans GC IDSKH W and GCRG D P . gingivalis GCRGI and GCRG + 189 C 0 . 79 P . gingivalis CRGID C . neoformans C GIDS 190 R 0 . 85 C . neoformans R IDSK and RGIDS and RGID K H . pylori RGIDS HSV - 1 HSV - 2 RG + DS H . pylori RG DSK Borrelia burgdorferi burgdorferi RGID K 191 G 0 . 65 C . neoformans GIDS HW and GIDSK and GIDS H Borrelia burgdorferi burgdorferi H . pylori P . gingivalis GIDSK P . gingivalis GID KH and G DSKH H . pylori GI SKH 192 I 0 . 60 Borrelia burgdorferi burgdorferi IDSKH C . neoformans P . gingivalis IDSK W 193 D 0 . 3 C . neoformans DSKH W Borrelia burgdorferi burgdorferi DSK WN 194 S 0 . 40 C . neoformans SKHW + 195 K 0 . 44 197 W 0 . 41 212 T 0 . 33 C . neoformans TMDGKQ and TMDGK 213 M 0 . 31 P . gingivalis MDGKQ 214 D 0 . 39 C . neoformans DGKQAA and DGKQA C . pneumoniae DGK AA 20 International Journal of Alzheimer’s Disease ( b ) Continued . NGF position Amino acid B - cell index Alignment 215 G 0 . 48 C . neoformans GKQAA 216 K 0 . 53 217 Q 0 . 45 ( c ) Tau position Amino acid B - cell index Alignment 53 E 2 . 516 C . neoformans ( GSK3 ) EDGSEEP S and E + G EEPG and + DGS + EP S and ED GSEE GS and EDGS + + GS and EDGSE and + D EEPG and EDG S PGS Cytomagalovirus EDG EEP and + DG EE and ED GSEE P . gingivalis EDGSEE and E + G SEEP and EDGS EE HHV - 6 HHV - 6B EDGS EE C . pneumoniae E GSEE Borrelia burgdorferi E GSEE HHV - 6 E GSEE 54 D 2 . 568 C . neoformans DGSEEP and DGS + EPG and DGSEE G P . gingivalis DGS EPGS and DGSEE and DGS EP and DGSE EP and DGSE P Cytomegalovirus DGS EP and DG EE G C . pneumoniae DGSE GS and + G EE GS Borrelia burgdorferi DGSE + P . gingivalis + GSEE 55 G 2 . 621 C . neoformans GSEEP and G EEPG and G + EPGS and GS EEPG and GSEE G Cytomegalovirus GS + EP S P . gingivalis GS EPG H . pylori GSEE G C . pneumoniae GSEE GS 56 S 2 . 732 C . neoformans SEEPG and SEE GS and S EPGS and SEEP S C . pneumoniae SEEPG and SEE GS and SE PGS P . gingivalis SEE GS and S EPGS 57 E 2 . 774 C . neoformans EEPGS and + EPGS and EEPG E and EE GSE C . pneumoniae EEPGS HSV - 1 HSV - 2 EEPG 58 E 2 . 678 HHV - 6 HHV - 6B EPGSE C . neoformans EPGSE and EPGS + P . gingivalis EPGS + 59 P 2 . 564 60 G 2 . 544 61 S 2 . 556 62 E 2 . 287 171 S 2 . 315 Borrelia burgdorferi SG GPED C . neoformans SG GPEDT and SGT PE and SGTGP and SG GPE and SGTG E and SG GP + P . gingivalis SGTG E C . pneumoniae SGTG PE Cytomegalovirus SGTGP + 172 G 2 . 54 C . neoformans GT PED and GTG ED and GTGPE and G GPED and GTGP D and G EDTE HSV - 1 GTGPE and GTGP D and GTGP + D HSV - 2 GTGP D and G GPED C . pneumoniae GTGPE H . pylori GTGP D 173 T 2 . 731 HHV - 6 TGPEDT and TG PEDT C . neoformans TG PEDT and TG EDT and T PEDT and TGPED C . pneumoniae TGPED H . pylori TG EDT Borrelia burgdorferi TGPE T + 174 G 2 . 709 C . neoformans GPEDT and GPED TE and GP DTE and GPED E HHV - 6 HHV - 6B TG PEDT 175 P 2 . 807 C . neoformans H . pylori P . gingivalis PEDTE 176 E 2 . 7 177 D 2 . 563 178 T 2 . 397 179 E 2 . 225 228 S 2 . 396 HSV - 1 SP DSPP and SPQ SP C . neoformans SPQDS and S QDSP and SP DSPP and SP DSPP and SPQD PP and PQ DSPPS and SPQ PPSK and SPQ SP and SP DSP and SPQ SP Cytomegalovirus SP DSPP P . gingivalis SP DSP Borrelia burgdorferi SP + + SPP and SP D PSK 229 P 2 . 744 C . neoformans PQ SPPS and P DSPPS and PQDSP and P + DSPP and PQ S PPSK and PQ SPP and PQD PP and P DSPP P . gingivalis PQDS P HSV - 2 P DSPP HHV - 6 PQ + PP and PQ PP K Borrelia burgdorferi PQ + P SK 230 Q 2 . 763 C . neoformans QDSPP and + + PPSK and QDS PS and Q SPPS P . gingivalis QD PPS C . pneumoniae QDS PS 231 D 2 . 929 C . neoformans DSP PSK and DSPPS and DSP SK and D PPSK and + SPPS P . gingivalis DSP SK 232 S 2 . 882 C . neoformans SPPSK International Journal of Alzheimer’s Disease 21 ( c ) Continued . Tau position Amino acid B - cell index Alignment 233 P 2 . 75 234 P 2 . 794 235 S 2 . 68 242 D 2 . 387 C . neoformans DGRPP C . pneumoniae DG PPQ HSV - 1 DG PPQ HSV - 2 DGRPP and DG PP + Cytomegalovirus DG R PQ and DG PP and + GRPP Borrelia burgdorferi DG PP 243 G 2 . 49 C . neoformans GRPPQ 244 R 2 . 56 245 P 2 . 42 246 P 2 . 164 247 Q 2 . 004 331 P 2 . 259 C . neoformans PGEG PE and P EGPEA and PGEGP and PGEG EA and P EGPEA and PGEG E Cytomegalovirus PGEGP EA and PG GPE C . pneumoniae PGE PEA and PGEGP H . pylori PG GPE HSV - 1 HHV - 6 PG GP A 332 G 2 . 681 C . neoformans GEGPE and GEG EA and GE PEA and G GPEA and GEGP A and GEG EA and G + GPEA C . pneumoniae GE PEA P . gingivalis GEGPE and GEG EA 333 E 2 . 715 C . neoformans P . gingivalis EGPEA HSV - 2 + GPEA 334 G 2 . 634 335 P 2 . 592 336 E 2 . 463 337 A 2 . 405 414 H 1 . 819 HSV - 1 HSV - 2 HPTPG C . neoformans HPT GSS and HP PGSS and HPTP SS and HP P SS C . pneumoniae HP PGS and + PT SS 415 P 2 . 274 Cytomegalovirus P PGSS and PTPG SS C . pneumoniae PT GSS and PTPG SS 416 T 2 . 503 417 P 2 . 717 418 G 2 . 469 419 S 2 . 054 420 S 1 . 76 493 P 2 . 43 HSV - 1 P APKTP and P APKTP and PPAP PP and PPA PP HSV - 2 PPAP TPP Cytomegalovirus P APKT and PPAP PP and PP P PPS and PP KTPP and PP A TPPS and PPA TPP C . neoformans PPAP TPPS and PPAP KTP S and PP PKTP and PP PKTP and PPAPKT and PPAP KT P . gingivalis PPAPK P C . pneumoniae PPAPK and PP PKT and PP AP PP and PP TPP Borrelia burgdorferi PAP T PS and PPA KTP and PP P TPP 494 P 2 . 77 HSV - 1 PAP KTP and PA KTPP HSV - 2 PAPK PP HHV - 6 PAP PPS C . neoformans PAPKTP S and PAPK PP P . gingivalis PAPKT C . pneumoniae PAP TP and PAPK P 495 A 2 . 94 C . neoformans AP PPS P . gingivalis A KTPPS HHV - 6 APKTP 496 P 2 . 89 C . neoformans PKTPPS and PKTP PS and PK TPPS P . gingivalis PKT PS 497 K 2 . 95 C . neoformans KTPPS 498 T 2 . 98 499 P 2 . 69 500 P 2 . 51 501 S 2 . 343 502 S 2 . 123 a classical example from the ﬁeld of population genetics and Darwinism , the light coloured genes of the peppered moth favour its selective predation by many di ﬀ erent birds when it alights on dark trees covered with soot pollution , while darker melanised forms are selectively targeted on lighter coloured trees [ 273 ] . The coloration susceptibility genes , or the variety of tree ( risk factors ) , do not kill the moth but allow several causes to do so . The causes can hide in plain sight , as epidemiological studies , as applied to human diseases , could conclude that the birds are not killing the moths , as they are always present , on both sets of trees , in both genetic conditions , whether the moths are alive or 22 International Journal of Alzheimer’s Disease dead ( c . f . the ubiquitous C . neoformans and many other common pathogens ) . Many of the pathogens implicated in Alzheimer’s disease ( herpes simplex , Borrelia burgdorferi and C . pneumoniae ) , and several other risk factors ( cholesterol , homocysteine , diabetes , or vitamin A or nerve growth factor deﬁciency ) are able to promote cerebral beta - amyloid deposition in animal models , without the aid of any gene variant . Subsets of susceptibility genes can be related to each of these amyloidogenic pathways [ 1 ] . In the case of genomewide association studies , the genes returned , as well as APP , beta amyloid , and gamma secretase , seem intimately concerned with pathogen life cycles and defence and the immune network . This suggests that the diverse microbial risk factors as well as other dietary and environmental factors implicated in Alzheimer’s disease are in fact causative agents , whose deleterious e ﬀ ects are conditioned by susceptibility genes . As the environmental risk factors are amenable to therapy , while the susceptibility gene products have so far proved largely resistant , this suggests numerous ways with which to tackle the problem of Alzheimer’s disease . Herpes Simplex Reactivation . Alzheimer’s disease plaques and tangles are highly enriched in human proteins used the herpes simplex during its life cycle , as well as in many immune - related proteins , suggesting that immune attack on a reactivated virus , diverted to neurones , which contain the complement membrane attack complex , may be ultimately responsible for the extensive neuronal destruction seen in Alzheimer’s disease [ 15 ] . The herpes simplex virus establishes latency in neurones , existing as a dormant form where only the latency transcript is expressed . A number of factors again related to susceptibility genes and environ - mental risk factors in Alzheimer’s disease can be related to herpes simplex latency and reactivation . The cerebral herpes simplex viral load is decreased in APOE knockout mice , while the viral load is much increased in APOE4 transgenic mice , compared to APOE3 mice , suggesting that APOE4 favours the establishment of a greater number of latent viruses in cerebral tissue [ 274 ] . In neuroblastoma cells , this latent form may even exert beneﬁcial e ﬀ ects , blocking apoptosis and promoting neurite extension via AKT1 upregulation [ 275 ] . However , this latent form can be reactivated by NGF deprivation [ 276 ] , and NGF promotes viral latency via the TrkA receptor NTRK1 [ 277 ] , the expression of which is reduced in the Alzheimer’s disease brain [ 278 ] . ( Relevant pathways and genes : neurotrophin signalling ( GSK3B , NTRK1 , NTRK2 , PIK3R1 , and SOS2 ) . Vitamin A supplementation in rats increases the cerebral levels of both NGF and BDNF [ 279 ] , while oestrogen deﬁciency lowers cerebral NGF levels , an e ﬀ ect reversed by 17 - beta oestradiol [ 280 ] , which is , however , also able to reactivate the virus , via oestrogen receptor alpha ( ESR1 ) [ 281 ] . High levels of total oestradiol have been reported as a risk factor for Alzheimer’s disease in both women and men [ 282 , 283 ] . Vitamin A related gens include APOE4 , the isoform least able to transport the vitamin A precursor retinyl palmitate , A2M ABCA1 ALB ALDH2 APOA1 CHD4 CLU CYP46A1 ESR1 GSTM1 GSTP1 HSPG2 KLF5 LIPA LPL LRAT LRP2 LRPAP1 MEF2A NPAS2 NR1H2 PARP1 PIN1 POU2F1 PPARA PPARG RXRA THRA TTR UBQLN1 VDR and many others controlled by retinoid receptor element ( reviewed in [ 126 ] ) . The virus can also be reactivated by heat [ 284 ] , IL6 [ 285 ] , or TNF [ 286 ] . IL6 plasma and CSF levels have been reported to be increased in Alzheimer’s disease and the secretion of IL6 from monocytes is increased [ 287 – 289 ] . IL6 plasma levels are raised by infection with C . pneumoniae [ 290 ] or Helicobacter pylori [ 291 ] , and IL6 production in monocytes is stimulated by C . neoformans [ 292 ] . Stress - activated corticosterone is also able to reactivate the virus [ 293 ] ( pathway = steroid hormone biosynthesis : COMT , CYP19A1 , HSD11B1 ) . Cortisol levels are increased in the ageing population and in Alzheimer’s disease [ 294 , 295 ] . A number of related stressors including adrenaline [ 296 ] , or downstream e ﬀ ectors such as cyclic AMP , protein kinase A , or C activation [ 297 ] are also able to reactivate the virus . Herpes simplex reactivation is blocked by beta - receptor antagonism ( ADRB1 ) [ 296 , 298 ] . Glucocorticoids and prostaglandins are also able to reactivate the virus [ 299 ] : cyclooxygenase inhibitors ( PTGS2 ) , celecoxib and indomethacin block viral reactivation and nonsteroidal anti - inﬂammatory use has been associated with a lower incidence of Alzheimer’s disease . Lysophosphatidic acid is also able to reactivate the virus [ 300 ] ( LPAR5 ) . Hypoxia also increases the replication of herpes simplex [ 301 ] : transient cerebral ischaemia also lowers NGF levels [ 302 ] , and these e ﬀ ects are relevant to the cerebral hypoperfusion seen in ageing and in Alzheimer’s disease [ 303 ] . Vitamin A and the retinoic acid isomers all - trans - , 9 - cis - , and 13 - cis - Retinoic Acid are all able to reduce viral replication [ 304 ] . Low Vitamin A levels are a problem in the ageing population and even in successfully ageing persons can be observed in 50 % of the population over the age of 80 – 85 [ 305 ] . Low vitamin A levels are also a risk factor for Alzheimer’s disease [ 306 ] . Mice deﬁcient in the nitric oxide synthase NOS2 are also more susceptible to herpes virus infection , and reactivation occurs is stimulated by caspase 3 activation ( CASP3 ) [ 135 ] . Thus , fever or cytokine release induced by diverse infections might be expected to reactivate herpes simplex as would several of the conditions associated with Alzheimer’s disease ( cerebral hypoperfusion , low cerebral NGF levels , vitamin A deﬁciency , or high oestradiol levels ) . 3 . 6 . 6 . The Microbiome in Alzheimer’s Disease . These path - ogens form a very small proportion of an extensive human microbiome comprising of trillions of bacteria , viruses , and other pathogens , whose inﬂuence on diseases is increasingly recognised [ 307 ] . Individual species may exert benevolent or malevolent e ﬀ ects which may well be dictated by the very extensive sequence homology between human and pathogen proteins which enables pathogens to intercalate with numerous important signalling networks , via compe - tition with their human counterparts [ 239 , 241 , 248 , 250 , 254 ] . These networks are implicated in diseases , and their e ﬃ ciency , as well as pathogen / host homology , is dictated by susceptibility genes . This host / pathogen matching covers International Journal of Alzheimer’s Disease 23 the entire human proteome and is represented by millions of short consensi of pentapeptides or more , not counting the longer gapped consensi . Clearly , powerful algorithms are needed to trawl human and pathogen proteomes and to link these homologies to susceptibility genes and to epitopes and autoantigens . The principles discussed here may apply to many other , if not most , human diseases . Protective Agents in Alzheimer’s Disease . Statins [ 308 ] , ﬁsh consumption [ 309 ] , omega - 3 polyunsaturated fatty acids [ 310 ] , the Mediterranean diet [ 311 ] , nonsteroidal anti - inﬂammatories [ 312 ] , or the generally healthy life - style of nuns living in convents [ 313 ] have all been associated with a reduced incidence or severity of Alzheimer’s disease , while homocysteine lowering B vitamins and folate have been shown to slow the rate of brain atrophy in cognitively impaired elderly patients [ 314 ] . A rather pessimistic study [ 315 ] recently stated that no ﬁrm conclusions could be drawn on the association of any modiﬁable factors with risk of Alzheimer’s disease . While this may be a justiﬁable statistical conclusion from meta - analysis , this is not to reckon with the diversity of the underlying genomic platform of each individual or with the profusion of diverse interacting risk and protective factors ( epistasis , gene / environment , and environment / environment interactions ) . As with the risk factors , protective agents can be linked to genetic and pathological pathways involved in cholesterol and lipid function ( statins , ﬁsh , and diet , e . g . , ABCA1 , ABCA2 , ABCA7 , ABCG1 , ACADS , ALDH2 , APP , APOA1 , APOA4 , APOA5 , APOC1 - 4 , APOE , CH25H , CYP46A1 , DHCR24 , FDPS , HMGCR , HMGCS2 , HSD11B1 , LIPC , LRP1 , LRP2 , LRP8 , LDLR , LIPA , LPL , OLR1 , PPARA , PPARG , PTPLA , VLDLR , NPC1 , NPC2 , SOAT1 , SREBF1 ) , homocysteine , methionine , and folate metabolism ( folate and vitamins , e . g . , BLMH , CBS , COMT , NAT2 , MTHFD1L , MTHFR , MTR , MTRR , PON1 , PON2 , PON3 , VDR ) and inﬂammatory pathways ( NSAID’S e . g . , C4A , C4B , CD2AP , CD33 , CFH , CCL2 , CCL3 , CCR2 , CSF1 , CLU , CR1 , FAS , GSK3B , IL1A , IL1B , IL6 , IL8 , IL10 , IL18 , PLAU , SERPINA1 , SERPINE1 , SERPINF2 , PTGS2 , TGFB1 , TNF ) . As with the risk factors , the success of such protective agents is likely to be determined by genes and other confounding factors . In this genomic era , a ﬀ ordable whole genome sequencing will soon be achieved , ushering in an age of more e ﬀ ective treatments tailored to individual genetic proﬁles . Alzheimer’s disease is clearly multifactorial with many related genetic and environmental risk factors , several underlying patholo - gies , and several available protective strategies . A recent study has also shown that many other seemingly benign factors ( eyesight , hearing , denture wearing , stomach , kidney , bladder or bowel problems , coughs , and colds ) as well as high blood pressure and diabetes , constituting a frailty index , combine to markedly increase both the incidence and severity of Alzheimer’s disease [ 316 ] . A further study , identifying physical inactivity , depression , smoking , mid - life hypertension or obesity , low education , and diabetes as key risk factors , has estimated that ∼ 50 % of Alzheimer’s disease cases may be preventable [ 317 ] . Elimination of the risk factors , including the regular detection and elimination of pathogens in the elderly , adherence to sensible dietary and vitamin supplement rec - ommendations , and the genetically tailored use of certain drug regimens are together likely to be able to markedly reduce the incidence of Alzheimer’s disease . Using phage display , it is now possible to express peptide fragments of the entire human proteome in a phage library , and to use this to trap autoantibodies in blood or other bodily ﬂuid samples . The antigen expressed by the labelled phage can be identiﬁed by high throughput sequencing [ 318 ] . Such technology is likely to be extremely useful in characterising biomarkers and pathological immune processes as well as potential pathogen / human cross - reactivity . Proteome - wide characterisation of the autoantibodies relevant to Alzheimer’s disease ( a move from GWAS to PWAS ) would also be very informative as selective autoan - tibody removal via a ﬃ nity dialysis might well be expected to inﬂuence the severity and progression of Alzheimer’s disease . Since the submission of this paper , Miklossy has reported a highly signiﬁcant association between spirochete infection and Alzheimer’s disease . As well as B . burgdorferi , several periodontal pathogen treponemas species were detected in brain samples and the pathological features of Alzheimer’s disease were reproduced by infection in vitro [ 319 ] . In addition , two groups have reported a very extensive reper - toire of autoantigens in Alzheimer’s disease , which can be characterised with a high degree of accuracy by a deﬁnitive immunosignature [ 320 , 321 ] . The principles outlined above could thus be tested by analysis of pathogen / autoantigen cross - reactivity . References [ 1 ] C . J . Carter , “The fox and the rabbits , environmental variables and population genetics . 1 : replication problems in association studies and the untapped power of GWAS . 2 : vitamin A deﬁciency , herpes simplex reactivation and other causes of Alzheimer’s disease , ” ISRN Neurology , vol . 2011 , Article ID 394678 , 29 pages , 2011 . [ 2 ] C . J . Carter , “Interactions between the products of the Herpes simplex genome and Alzheimer’s disease susceptibility genes : relevance to pathological - signalling cascades , ” Neurochem - istry International , vol . 52 , no . 6 , pp . 920 – 934 , 2008 . [ 3 ] C . J . Carter , “Convergence of genes implicated in Alzheimer’s disease on the cerebral cholesterol shuttle : APP , cholesterol , lipoproteins , and atherosclerosis , ” Neurochemistry Interna - tional , vol . 50 , no . 1 , pp . 12 – 38 , 2007 . [ 4 ] A . Papassotiropoulos , M . A . Wollmer , M . Tsolaki et al . , “A cluster of cholesterol - related genes confers susceptibility for Alzheimer’s disease , ” Journal of Clinical Psychiatry , vol . 66 , no . 7 , pp . 940 – 947 , 2005 . [ 5 ] R . Menon and C . Farina , “Shared molecular and functional frameworks among ﬁve complex human disorders : a com - parative study on interactomes linked to susceptibility genes , ” PLoS ONE , vol . 6 , no . 4 , Article ID e18660 , 2011 . [ 6 ] A . C . Naj , G . W . Beecham , E . R . Martin et al . , “Dementia revealed : novel chromosome 6 locus for Late - onset alzheimer disease provides genetic evidence for Folate - pathway abnor - malities , ” PLoS Genetics , vol . 6 , no . 9 , Article ID e1001130 , 2010 . 24 International Journal of Alzheimer’s Disease [ 7 ] D . Liolitsa , J . Powell , and S . Lovestone , “Genetic variability in the insulin signalling pathway may contribute to the risk of late onset Alzheimer’s disease , ” Journal of Neurology Neurosurgery and Psychiatry , vol . 73 , no . 3 , pp . 261 – 266 , 2002 . [ 8 ] A . B . Goodman and A . B . Pardee , “Evidence for defective retinoid transport and function in late onset Alzheimer’s disease , ” Proceedings of the National Academy of Sciences of the United States of America , vol . 100 , no . 5 , pp . 2901 – 2905 , 2003 . [ 9 ] V . Tseveleki , R . Rubio , S . S . Vamvakas et al . , “Comparative gene expression analysis in mouse models for multiple sclero - sis , Alzheimer’s disease and stroke for identifying commonly regulated and disease - speciﬁc gene changes , ” Genomics , vol . 96 , no . 2 , pp . 82 – 91 , 2010 . [ 10 ] J . C . Lambert , B . Grenier - Boley , V . Chouraki et al . , “Implica - tion of the immune system in Alzheimer’s disease : evidence from genome - wide pathway analysis , ” Journal of Alzheimer’s Disease , vol . 20 , no . 4 , pp . 1107 – 1118 , 2010 . [ 11 ] J . M . Hill , Y . Zhao , C . Clement , D . M . Neumann , and W . J . Lukiw , “HSV - 1 infection of human brain cells induces miRNA - 146a and Alzheimer - type inﬂammatory signaling , ” NeuroReport , vol . 20 , no . 16 , pp . 1500 – 1505 , 2009 . [ 12 ] R . F . Itzhaki and M . A . Wozniak , “Herpes simplex virus type 1 in Alzheimer’s disease : the enemy within , ” Journal of Alzheimer’s Disease , vol . 13 , no . 4 , pp . 393 – 405 , 2008 . [ 13 ] R . B . Pyles , “The association of herpes simplex virus and Alzheimer’s disease : a potential synthesis of genetic and environmental factors , ” Herpes , vol . 8 , no . 3 , pp . 64 – 68 , 2001 . [ 14 ] M . A . Wozniak , A . P . Mee , and R . F . Itzhaki , “Herpes simplex virus type 1 DNA is located within Alzheimer’s disease amyloid plaques , ” Journal of Pathology , vol . 217 , no . 1 , pp . 131 – 138 , 2009 . [ 15 ] C . J . Carter , “Alzheimer’s disease plaques and tangles : ceme - teries of a Pyrrhic victory of the immune defence network against herpes simplex infection at the expense of com - plement and inﬂammation - mediated neuronal destruction , ” Neurochemistry International , vol . 58 , no . 3 , pp . 301 – 320 , 2011 . [ 16 ] L . Letenneur , K . P´er ` es , H . Fleury et al . , “Seropositivity to Herpes Simplex Virus antibodies and risk of Alzheimer’s disease : a population - based cohort study , ” PLoS ONE , vol . 3 , no . 11 , Article ID e3637 , 2008 . [ 17 ] A . R . Kamer , R . G . Craig , A . P . Dasanayake , M . Brys , L . Glodzik - Sobanska , and M . J . de Leon , “Inﬂammation and Alzheimer’s disease : possible role of periodontal diseases , ” Alzheimer’s and Dementia , vol . 4 , no . 4 , pp . 242 – 250 , 2008 . [ 18 ] M . M . Esiri , S . C . Biddolph , and C . S . Morris , “Prevalence of Alzheimer plaques in AIDS , ” Journal of Neurology Neuro - surgery and Psychiatry , vol . 65 , no . 1 , pp . 29 – 33 , 1998 . [ 19 ] J . Kountouras , M . Boziki , E . Gavalas et al . , “Five - year survival after Helicobacter pylori eradication in Alzheimer disease patients , ” Cognitive and Behavioral Neurology , vol . 23 , no . 3 , pp . 199 – 204 , 2010 . [ 20 ] T . A . Ala , R . C . Doss , and C . J . Sullivan , “Reversible de - mentia : a case of cryptococcal meningitis masquerading as Alzheimer’s disease , ” Journal of Alzheimer’s Disease , vol . 6 , no . 5 , pp . 503 – 508 , 2004 . [ 21 ] M . Ho ﬀ mann , J . Muniz , E . Carroll , and J . de Villasante , “Cryptococcal meningitis misdiagnosed as alzheimer’s dis - ease : complete neurological and cognitive recovery with treatment , ” Journal of Alzheimer’s Disease , vol . 16 , no . 3 , pp . 517 – 520 , 2009 . [ 22 ] I . Kaklikkaya , N . Kaklikkaya , I . Birincioglu , K . Buruk , and N . Turan , “Detection of human herpesvirus 6 DNA but not human herpesvirus 7 or 8 DNA in atherosclerotic and nonatherosclerotic vascular tissues , ” Heart Surgery Forum , vol . 13 , no . 5 , pp . E345 – E349 , 2010 . [ 23 ] G . C . Makris , M . C . Makris , V . V . Wilmot , G . Geroulakos , and M . E . Falagas , “The role of infection in carotid plaque pathogenesis and stability : the clinical evidence , ” Current Vascular Pharmacology , vol . 8 , no . 6 , pp . 861 – 872 , 2010 . [ 24 ] A . Nazmi , A . V . Diez - Roux , N . S . Jenny , M . Y . Tsai , M . Szklo , and A . E . Aiello , “The inﬂuence of persistent pathogens on circulating levels of inﬂammatory markers : a cross - sectional analysis from the Multi - Ethnic Study of Atherosclerosis , ” BMC Public Health , vol . 10 , article 706 , 2010 . [ 25 ] A . Taniguchi , F . Nishimura , Y . Murayama et al . , “Por - phyromonas gingivalis infection is associated with carotid atherosclerosis in non - obese Japanese type 2 diabetic patients , ” Metabolism , vol . 52 , no . 2 , pp . 142 – 145 , 2003 . [ 26 ] C . J . Hall , L . Bouhafs , U . Dizcfalusy , and K . Sandstedt , “Cryp - tococcus neoformans causes lipid peroxidation ; therefore it is a potential inducer of atherogenesis , ” Mycologia , vol . 102 , no . 3 , pp . 546 – 551 , 2010 . [ 27 ] A . E . Roher , C . Esh , A . Rahman , T . A . Kokjohn , and T . G . Beach , “Atherosclerosis of cerebral arteries in Alzheimer disease , ” Stroke , vol . 35 , no . 11 , pp . 2623 – 2627 , 2004 . [ 28 ] M . van Oijen , F . J . de Jong , J . C . Witteman , A . Hofman , P . J . Koudstaal , and M . M . B . Breteler , “Atherosclerosis and risk for dementia , ” Annals of Neurology , vol . 61 , no . 5 , pp . 403 – 410 , 2007 . [ 29 ] E . H . Corder , A . M . Saunders , W . J . Strittmatter et al . , “Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families , ” Science , vol . 261 , no . 5123 , pp . 921 – 923 , 1993 . [ 30 ] C . Ant´unez , M . Boada , A . Gonz´alez - P´erez et al . , “The mem - brane - spanning 4 - domains , subfamily A ( MS4A ) gene clus - ter contains a common variant associated with Alzheimer’s disease , ” Genome Medicine , vol . 3 , no . 5 , article 33 , 2011 . [ 31 ] K . Morgan , “The three new pathways leading to Alzheimer’s disease , ” Neuropathology and Applied Neurobiology , vol . 37 , no . 4 , pp . 353 – 357 , 2011 . [ 32 ] L . A . Hindor ﬀ , P . Sethupathy , H . A . Junkins et al . , “A Catalog of Published Genome - Wide Association Studies , ” http : / / www . genome . gov / gwastudies / . Accessed [ June 2011 ] . [ 33 ] A . I . Su , T . Wiltshire , S . Batalov et al . , “A gene atlas of the mouse and human protein - encoding transcriptomes , ” Proceedings of the National Academy of Sciences of the United States of America , vol . 101 , no . 16 , pp . 6062 – 6067 , 2004 . [ 34 ] C . Wu , C . Orozco , J . Boyer et al . , “BioGPS : an extensible and customizable portal for querying and organizing gene annotation resources , ” Genome Biology , vol . 10 , no . 11 , article R130 , 2009 . [ 35 ] J . E . Larsen , O . Lund , and M . Nielsen , “Improved method for predicting linear B - cell epitopes , ” Immunome Research , vol . 2 , no . 2 , 2006 . [ 36 ] S . F . Altschul , T . L . Madden , A . A . Sch¨a ﬀ er et al . , “Gapped BLAST and PSI - BLAST : a new generation of protein database search programs , ” Nucleic Acids Research , vol . 25 , no . 17 , pp . 3389 – 3402 , 1997 . [ 37 ] Z . Beck , B . K . Brown , G . R . Matyas , V . R . Polonis , M . Rao , and C . R . Alving , “Infection of human peripheral blood mononuclear cells by erythrocyte - bound HIV - 1 : e ﬀ ects of antibodies and complement , ” Virology , vol . 412 , no . 2 , pp . 441 – 447 , 2011 . International Journal of Alzheimer’s Disease 25 [ 38 ] R . C . Carlisle , Y . Di , A . M . Cerny et al . , “Human erythrocytes bind and inactivate type 5 adenovirus by presenting Cox - sackie virus - adenovirus receptor and complement receptor 1 , ” Blood , vol . 113 , no . 9 , pp . 1909 – 1918 , 2009 . [ 39 ] E . Gyimesi , A . J . Bankovich , T . A . Schuman , J . B . Goldberg , M . A . Lindorfer , and R . P . Taylor , “Staphylococcus aureus bound to complement receptor 1 on human erythrocytes by bispeciﬁc monoclonal antibodies is phagocytosed by acceptor macrophages , ” Immunology Letters , vol . 95 , no . 2 , pp . 185 – 192 , 2004 . [ 40 ] Y . Hatano , S . Taniuchi , M . Masuda et al . , “Phagocytosis of heat - killed Staphylococcus aureus by eosinophils : compari - son with neutrophils , ” APMIS , vol . 117 , no . 2 , pp . 115 – 123 , 2009 . [ 41 ] J . Li , J . P . Wang , I . Ghiran et al . , “Complement receptor 1 expression on mouse erythrocytes mediates clearance of Streptococcus pneumoniae by immune adherence , ” Infection and Immunity , vol . 78 , no . 7 , pp . 3129 – 3135 , 2010 . [ 42 ] C . Spadafora , G . A . Awandare , K . M . Kopydlowski et al . , “Complement receptor 1 is a sialic acid - independent ery - throcyte receptor of Plasmodium falciparum , ” PLoS Path - ogens , vol . 6 , no . 6 , Article ID e1000968 , 2010 . [ 43 ] J . H . Powers , B . L . Buster , C . J . Reist et al . , “Complement - independent binding of microorganisms to primate erythro - cytes in vitro by cross - linked monoclonal antibodies via complement receptor 1 , ” Infection and Immunity , vol . 63 , no . 4 , pp . 1329 – 1335 , 1995 . [ 44 ] A . Repik , S . E . Pincus , I . Ghiran et al . , “A transgenic mouse model for studying the clearance of blood - borne pathogens via human complement receptor 1 ( CR1 ) , ” Clinical and Experimental Immunology , vol . 140 , no . 2 , pp . 230 – 240 , 2005 . [ 45 ] M . Calero , T . Tokuda , A . Rostagno et al . , “Functional and structural properties of lipid - associated apolipoprotein J ( clusterin ) , ” Biochemical Journal , vol . 344 , no . 2 , pp . 375 – 383 , 1999 . [ 46 ] S . Itagaki , H . Akiyama , H . Saito , and P . L . McGeer , “Ultra - structural localization of complement membrane attack complex ( MAC ) - like immunoreactivity in brains of patients with Alzheimer’s disease , ” Brain Research , vol . 645 , no . 1 - 2 , pp . 78 – 84 , 1994 . [ 47 ] P . L . McGeer , H . Akiyama , S . Itagaki , and E . G . McGeer , “Activation of the classical complement pathway in brain tissue of Alzheimer patients , ” Neuroscience Letters , vol . 107 , no . 1 – 3 , pp . 341 – 346 , 1989 . [ 48 ] C . J . Carter , “APP , APOE , complement receptor 1 , clusterin and PICALM and their involvement in the herpes simplex life cycle , ” Neuroscience Letters , vol . 483 , no . 2 , pp . 96 – 100 , 2010 . [ 49 ] C . Cortes , V . P . Ferreira , and M . K . Pangburn , “Native properdin binds to Chlamydia pneumoniae and promotes complement activation , ” Infection and Immunity , vol . 79 , no . 2 , pp . 724 – 731 , 2011 . [ 50 ] A . Hasegawa , L . F . Sogo , M . Tan , and C . S¨utterlin , “Host complement regulatory protein CD59 is transported to the chlamydial inclusion by a golgi apparatus - independent pathway , ” Infection and Immunity , vol . 77 , no . 4 , pp . 1285 – 1292 , 2009 . [ 51 ] ´A . L . Rosas , R . S . MacGill , J . D . Nosanchuk , T . R . Kozel , and A . Casadevall , “Activation of the alternative complement path - way by fungal melanins , ” Clinical and Diagnostic Laboratory Immunology , vol . 9 , no . 1 , pp . 144 – 148 , 2002 . [ 52 ] M . A . Gates - Hollingsworth and T . R . Kozel , “Phenotypic heterogeneity in expression of epitopes in the Cryptococcus neoformans capsule , ” Molecular Microbiology , vol . 74 , no . 1 , pp . 126 – 138 , 2009 . [ 53 ] G . Gonzalez - Valencia , G . I . Perez - Perez , R . G . Washburn , and M . J . Blaser , “Susceptibility of Helicobacter pylori to the bactericidal activity of human serum , ” Helicobacter , vol . 1 , no . 1 , pp . 28 – 33 , 1996 . [ 54 ] G . Hajishengallis , M . Wang , S . Liang et al . , “Subversion of innate immunity by periodontopathic bacteria via exploita - tion of complement receptor - 3 , ” Advances in Experimental Medicine and Biology , vol . 632 , pp . 203 – 219 , 2008 . [ 55 ] D . C . Altieri , O . R . Etingin , D . S . Fair et al . , “Structurally homologous ligand binding of integrin Mac - 1 and viral glycoprotein C receptors , ” Science , vol . 254 , no . 5035 , pp . 1200 – 1202 , 1991 . [ 56 ] G . J . Jones , J . C . Wiseman , K . J . Marr , S . Wei , J . Y . Djeu , and C . H . Mody , “In contrast to anti - tumor activity , YT cell and primary NK cell cytotoxicity for Cryptococcus neoformans bypasses LFA - 1 , ” International Immunology , vol . 21 , no . 4 , pp . 423 – 432 , 2009 . [ 57 ] A . Wang , S . C . Johnston , J . Chou , and D . Dean , “A systemic network for Chlamydia pneumoniae entry into human cells , ” Journal of Bacteriology , vol . 192 , no . 11 , pp . 2809 – 2815 , 2010 . [ 58 ] Z . Y . Huang , S . Hunter , P . Chien et al . , “Interaction of two phagocytic host defense systems : Fc γ receptors and complement receptor 3 , ” Journal of Biological Chemistry , vol . 286 , no . 1 , pp . 160 – 168 , 2011 . [ 59 ] K . Popadiak , J . Potempa , K . Riesbeck , and A . M . Blom , “Biphasic e ﬀ ect of gingipains from Porphyromonas gingivalis on the human complement system , ” Journal of Immunology , vol . 178 , no . 11 , pp . 7242 – 7250 , 2007 . [ 60 ] M . Deckert , M . Ticchioni , B . Mari , D . Mary , and A . Bernard , “The glycosylphosphatidylinositol - anchored CD59 protein stimulates both T cell receptor ζ / ZAP - 70 - dependent and - independent signaling pathways in T cells , ” European Journal of Immunology , vol . 25 , no . 7 , pp . 1815 – 1822 , 1995 . [ 61 ] S . Naderi , P . Hofmann , S . Seiter , W . Tilgen , H . Abken , and U . Reinhold , “CD2 - mediated CD59 stimulation in keratinocytes results in secretion of IL - 1 α , IL - 6 , and GM - CSF : implications for the interaction of keratinocytes with intraepidermal T lymphocytes , ” International Journal of Molecular Medicine , vol . 3 , no . 6 , pp . 609 – 614 , 1999 . [ 62 ] A . W . Jehle , S . J . Gardai , S . Li et al . , “ATP - binding cassette transporter A7 enhances phagocytosis of apoptotic cells and associated ERK signaling in macrophages , ” Journal of Cell Biology , vol . 174 , no . 4 , pp . 547 – 556 , 2006 . [ 63 ] S . W . Tas , L . B . Klickstein , S . F . Barbashov , and A . Nicholson - Weller , “C1q and C4b bind simultaneously to CR1 and addi - tively support erythrocyte adhesion , ” Journal of Immunology , vol . 163 , no . 9 , pp . 5056 – 5063 , 1999 . [ 64 ] M . Sarvari , I . Vago , C . S . Weber et al . , “Inhibition of C1q - beta - amyloid binding protects hippocampal cells against complement mediated toxicity , ” Journal of Neuroimmunol - ogy , vol . 137 , no . 1 - 2 , pp . 12 – 18 , 2003 . [ 65 ] B . Alberts , A . Johnson , J . Lewis , M . Ra ﬀ , K . Roberts , and P . Walker , Molecular Biology of the Cell , Garland Science , New York , NY , USA , 2007 . [ 66 ] S . J . Flint , L . W . Enquist , V . R . Racaniello , and A . M . Skalka , Principles of Virology , ASM Press , Herndon , Va , USA , 2008 . [ 67 ] T . Gianni , G . Campadelli - Fiume , and L . Menotti , “Entry of herpes simplex virus mediated by chimeric forms of nectin1 retargeted to endosomes or to lipid rafts occurs through acidic endosomes , ” Journal of Virology , vol . 78 , no . 22 , pp . 12268 – 12276 , 2004 . 26 International Journal of Alzheimer’s Disease [ 68 ] H . Parker , K . Chitcholtan , M . B . Hampton , and J . I . Keenan , “Uptake of Helicobacter pylori outer membrane vesicles by gastric epithelial cells , ” Infection and Immunity , vol . 78 , no . 12 , pp . 5054 – 5061 , 2010 . [ 69 ] J . Pizarro - Cerd´a , M . Bonazzi , and P . Cossart , “Clathrin - mediated endocytosis : what works for small , also works for big , ” BioEssays , vol . 32 , no . 6 , pp . 496 – 504 , 2010 . [ 70 ] F . Tebar , S . K . Bohlander , and A . Sorkin , “Clathrin assembly lymphoid myeloid leukemia ( CALM ) protein : localization in endocytic - coated pits , interactions with clathrin , and the impact of overexpression on clathrin - mediated tra ﬃ c , ” Molecular Biology of the Cell , vol . 10 , no . 8 , pp . 2687 – 2702 , 1999 . [ 71 ] C . R . Brunetti , R . L . Burke , B . Hoﬂack , T . Ludwig , K . S . Dingwell , and D . C . Johnson , “Role of mannose - 6 - phosphate receptors in herpes simplex virus entry into cells and cell - to - cell transmission , ” Journal of Virology , vol . 69 , no . 6 , pp . 3517 – 3528 , 1995 . [ 72 ] M . Molinari , C . Galli , N . Norais et al . , “Vacuoles induced by Helicobacter pylori toxin contain both late endosomal and lysosomal markers , ” Journal of Biological Chemistry , vol . 272 , no . 40 , pp . 25339 – 25344 , 1997 . [ 73 ] K . Nakayama and S . Wakatsuki , “The structure and function of GGAs , the tra ﬃ c controllers at the TGN sorting cross - roads , ” Cell Structure and Function , vol . 28 , no . 5 , pp . 431 – 442 , 2003 . [ 74 ] E . M . Rabin , K . Gordon , M . H . Knoppers et al . , “Inhibition of T cell activation and adhesion functions by soluble CD2 protein , ” Cellular Immunology , vol . 149 , no . 1 , pp . 24 – 38 , 1993 . [ 75 ] N . C . Gauthier , P . Monzo , T . Gonzalez et al . , “Early en - dosomes associated with dynamic F - actin structures are required for late tra ﬃ cking of H . pylori VacA toxin , ” Journal of Cell Biology , vol . 177 , no . 2 , pp . 343 – 354 , 2007 . [ 76 ] P . L . W . Yun , A . A . Decarlo , C . C . Chapple , C . A . Collyer , and N . Hunter , “Binding of Porphyromonas gingivalis gingipains to human CD4 + T cells preferentially down - regulates surface CD2 and CD4 with little a ﬀ ect on co - stimulatory molecule expression , ” Microbial Pathogenesis , vol . 38 , no . 2 - 3 , pp . 85 – 96 , 2005 . [ 77 ] E . Moreno - Ruiz , M . Gal´an - D´ıez , W . Zhu et al . , “Candida albicans internalization by host cells is mediated by a clathrin - dependent mechanism , ” Cellular Microbiology , vol . 11 , no . 8 , pp . 1179 – 1189 , 2009 . [ 78 ] M . Selbach and S . Backert , “Cortactin : an Achilles’ heel of the actin cytoskeleton targeted by pathogens , ” Trends in Microbiology , vol . 13 , no . 4 , pp . 181 – 189 , 2005 . [ 79 ] N . Tegtmeyer , R . Wittelsberger , R . Hartig , S . Wessler , N . Martinez - Quiles , and S . Backert , “Serine phosphorylation of cortactin controls focal adhesion kinase activity and cell scattering induced by Helicobacter pylori , ” Cell Host and Microbe , vol . 9 , no . 6 , pp . 520 – 531 , 2011 . [ 80 ] S . Cudmore , I . Reckmann , and M . Way , “Viral manipulations of the actin cytoskeleton , ” Trends in Microbiology , vol . 5 , no . 4 , pp . 142 – 148 , 1997 . [ 81 ] H . Mustonen , A . Lepist¨o , S . Lehtonen , E . Lehtonen , P . Puolakkainen , and E . Kivilaakso , “CD2AP contributes to cell migration and adhesion in cultured gastric epithelium , ” Biochemical and Biophysical Research Communications , vol . 332 , no . 2 , pp . 426 – 432 , 2005 . [ 82 ] M . Lecuit , R . Hurme , J . Pizarro - Cerda , H . Ohayon , B . Geiger , and P . Cossart , “A role for α - and β - catenins in bacterial uptake , ” Proceedings of the National Academy of Sciences , vol . 97 , no . 18 , pp . 10008 – 10013 , 2000 . [ 83 ] S . Backert , N . Tegtmeyer , and M . Selbach , “The versatility of helicobacter pylori caga e ﬀ ector protein functions : the master key hypothesis , ” Helicobacter , vol . 15 , no . 3 , pp . 163 – 176 , 2010 . [ 84 ] B . Hoy , M . L¨ower , C . Weydig et al . , “Helicobacter pylori HtrA is a new secreted virulence factor that cleaves E - cadherin to disrupt intercellular adhesion , ” EMBO Reports , vol . 11 , no . 10 , pp . 798 – 804 , 2010 . [ 85 ] A . MacIntyre , C . J . Hammond , C . S . Little , D . M . Appelt , and B . J . Balin , “Chlamydia pneumoniae infection alters the junctional complex proteins of human brain microvascular endothelial cells , ” FEMS Microbiology Letters , vol . 217 , no . 2 , pp . 167 – 172 , 2002 . [ 86 ] M . J . Taylor , D . Perrais , and C . J . Merriﬁeld , “A high precision survey of the molecular dynamics of mammalian clathrin - mediated endocytosis , ” PLoS Biology , vol . 9 , no . 3 , Article ID e1000604 , 2011 . [ 87 ] A . S . Nicot , A . Toussaint , V . Tosch et al . , “Mutations in amphiphysin 2 ( BIN1 ) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy , ” Nature Genetics , vol . 39 , no . 9 , pp . 1134 – 1139 , 2007 . [ 88 ] K . Nishi and K . Saigo , “Cellular internalization of green ﬂuo - rescent protein fused with herpes simplex virus protein VP22 via a lipid raft - mediated endocytic pathway independent of caveolae and Rho family GTPases but dependent on dynamin and Arf6 , ” Journal of Biological Chemistry , vol . 282 , no . 37 , pp . 27503 – 27517 , 2007 . [ 89 ] H . T . McMahon , P . Wigge , and C . Smith , “Clathrin interacts speciﬁcally with amphiphysin and is displaced by dynamin , ” FEBS Letters , vol . 413 , no . 2 , pp . 319 – 322 , 1997 . [ 90 ] E . S . Gold , R . M . Simmons , T . W . Petersen , L . A . Campbell , C . C . Kuo , and A . Aderem , “Amphiphysin IIm is required for survival of Chlamydia pneumoniae in macrophages , ” Journal of Experimental Medicine , vol . 200 , no . 5 , pp . 581 – 586 , 2004 . [ 91 ] V . Wixler , E . Laplantine , D . Geerts et al . , “Identiﬁcation of novel interaction partners for the conserved membrane proximal region of α - integrin cytoplasmic domains , ” FEBS Letters , vol . 445 , no . 2 - 3 , pp . 351 – 355 , 1999 . [ 92 ] M . Ulanova , S . Gravelle , and R . Barnes , “The role of epithelial integrin receptors in recognition of pulmonary pathogens , ” Journal of Innate Immunity , vol . 1 , no . 1 , pp . 4 – 17 , 2008 . [ 93 ] N . Tegtmeyer , S . Wessler , and S . Backert , “Role of the cag - pathogenicity island encoded type IV secretion system in Helicobacter pylori pathogenesis , ” FEBS Journal , vol . 278 , no . 8 , pp . 1190 – 1202 , 2011 . [ 94 ] P . R . Crocker and P . Redelinghuys , “Siglecs as positive and negative regulators of the immune system , ” Biochemical Society Transactions , vol . 36 , no . 6 , pp . 1467 – 1471 , 2008 . [ 95 ] E . C . Brinkman - Van der Linden and A . Varki , “New aspects of siglec binding speciﬁcities , including the signiﬁcance of fucosylation and of the sialyl - Tn epitope . Sialic acid - binding immunoglobulin superfamily lectins , ” Journal of Biological Chemistry , vol . 275 , no . 12 , pp . 8625 – 8632 , 2000 . [ 96 ] J . R . Teuton and C . R . Brandt , “Sialic acid on herpes simplex virus type 1 envelope glycoproteins is required for e ﬃ cient infection of cells , ” Journal of Virology , vol . 81 , no . 8 , pp . 3731 – 3739 , 2007 . [ 97 ] M . L . Rodrigues , S . Rozental , J . N . Couceiro , J . Angluster , C . S . Alviano , and L . R . Travassos , “Identiﬁcation of N - Acetylneuraminic acid and its 9 - O - acetylated derivative on the cell surface of Cryptococcus neoformans . Inﬂuence on fungal phagocytosis , ” Infection and Immunity , vol . 65 , no . 12 , pp . 4937 – 4942 , 1997 . International Journal of Alzheimer’s Disease 27 [ 98 ] D . Hul´ınsk´a , P . Volf , and L . Grubho ﬀ er , “Characterization of Borrelia burgdorferi glycoconjugates and surface carbo - hydrates , ” Zentralblatt fur Bakteriologie , vol . 276 , no . 4 , pp . 473 – 480 , 1992 . [ 99 ] M . Aspholm , F . O . Olfat , J . Nord´en et al . , “SabA is the H . pylori hemagglutinin and is polymorphic in binding to sialy - lated glycans , ” PLoS Pathogens , vol . 2 , no . 10 , Article ID e110 , 2006 . [ 100 ] H . J . Bennett and I . S . Roberts , “Identiﬁcation of a new sialic acid - binding protein in Helicobacter pylori , ” FEMS Immunology and Medical Microbiology , vol . 44 , no . 2 , pp . 163 – 169 , 2005 . [ 101 ] U . Hall´en , A . E . Bj¨orkner , and E . C . Hallberg , “Binding of the periodontitis associated bacterium Porphyromonas gingivalis to glycoproteins from human epithelial cells , ” Oral Microbiology and Immunology , vol . 23 , no . 5 , pp . 367 – 371 , 2008 . [ 102 ] A . J . Muller , J . B . DuHadaway , P . S . Donover , E . Sutanto - Ward , and G . C . Prendergast , “Inhibition of indoleamine 2 , 3 - dioxygenase , an immunoregulatory target of the cancer suppression gene Bin1 , potentiates cancer chemotherapy , ” Nature Medicine , vol . 11 , no . 3 , pp . 312 – 319 , 2005 . [ 103 ] A . M¨uller , K . Heseler , S . K . Schmidt , K . Spekker , C . R . MacKenzie , and W . D¨aubener , “The missing link between indoleamine 2 , 3 - dioxygenase mediated antibacterial and immunoregulatory e ﬀ ects , ” Journal of Cellular and Molecular Medicine , vol . 13 , no . 6 , pp . 1125 – 1135 , 2009 . [ 104 ] C . R . MacKenzie , K . Heseler , A . M¨uller , and W . D¨aubener , “Role of indoleamine 2 , 3 - dioxygenase in antimicrobial de - fence and immuno - regulation : tryptophan depletion versus production of toxic kynurenines , ” Current Drug Metabolism , vol . 8 , no . 3 , pp . 237 – 244 , 2007 . [ 105 ] L . Capuron and A . H . Miller , “Immune system to brain signaling : neuropsychopharmacological implications , ” Phar - macology and Therapeutics , vol . 130 , no . 2 , pp . 226 – 238 , 2011 . [ 106 ] E . Gulaj , K . Pawlak , B . Bien , and D . Pawlak , “Kynurenine and its metabolites in Alzheimer’s disease patients , ” Advances in Medical Sciences , vol . 55 , no . 2 , pp . 204 – 211 , 2010 . [ 107 ] B . Widner , F . Leblhuber , J . Walli , G . P . Tilz , U . Demel , and D . Fuchs , “Tryptophan degradation and immune activation in Alzheimer’s disease , ” Journal of Neural Transmission , vol . 107 , no . 3 , pp . 343 – 353 , 2000 . [ 108 ] R . G . Hamilton , D . W . MacGlashan Jr . , and S . S . Saini , “IgE antibody - speciﬁc activity in human allergic disease , ” Immunologic Research , vol . 47 , no . 1 – 3 , pp . 273 – 284 , 2010 . [ 109 ] S . Ida , R . P . Siraganian , and A . L . Notkins , “Cell - bound and circulating IgE antibody to herpes simplex virus , ” Journal of General Virology , vol . 64 , no . 3 , pp . 533 – 537 , 1983 . [ 110 ] J . Lagace - Simard , J . D . Portnoy , and M . A . Wainberg , “High levels of IgE in patients su ﬀ ering from frequent recurrent herpes simplex lesions , ” Journal of Allergy and Clinical Immunology , vol . 77 , no . 4 , pp . 582 – 585 , 1986 . [ 111 ] E . Caleno ﬀ , J . C . Zhao , E . L . Derlacki et al . , “Patients with Meniere’s disease possess IgE reacting with herpes family viruses , ” Archives of Otolaryngology : Head and Neck Surgery , vol . 121 , no . 8 , pp . 861 – 864 , 1995 . [ 112 ] A . Aceti , D . Celestino , M . Caferro et al . , “Basophil - bound and serum immunoglobulin E directed against Helicobacter pylori in patients with chronic gastritis , ” Gastroenterology , vol . 101 , no . 1 , pp . 131 – 137 , 1991 . [ 113 ] M . H . Bluth , J . Robin , M . Ruditsky et al . , “IgE anti - Borrelia burgdorferi components ( p18 , p31 , p34 , p41 , p45 , p60 ) and increased blood CD8 + CD60 + T cells in children with Lyme disease , ” Scandinavian Journal of Immunology , vol . 65 , no . 4 , pp . 376 – 382 , 2007 . [ 114 ] U . Emre , N . Sokolovskaya , P . M . Roblin , J . Schachter , and M . R . Hammerschlag , “Detection of anti - Chlamydia pneumoniae IgE in children with reactive airway disease , ” Journal of Infectious Diseases , vol . 172 , no . 1 , pp . 265 – 267 , 1995 . [ 115 ] M . Liutu , K . Kalimo , J . Uksila , and J . Savolainen , “Extrac - tion of ige - binding components of helicobacter pylori by immunoblotting analysis in chronic urticaria patients , ” Inter - national Archives of Allergy and Immunology , vol . 126 , no . 3 , pp . 213 – 217 , 2001 . [ 116 ] M . Feldmesser , A . Casadevall , Y . Kress , G . Spira , and A . Orlof - sky , “Eosinophil - Cryptococcus neoformans interactions in vivo and in vitro , ” Infection and Immunity , vol . 65 , no . 5 , pp . 1899 – 1907 , 1997 . [ 117 ] K . Ishibashi , M . Suzuki , S . Sasaki , and M . Imai , “Identiﬁca - tion of a new multigene four - transmembrane family ( MS4A ) related to CD20 , HTm4 and β subunit of the high - a ﬃ nity IgE receptor , ” Gene , vol . 264 , no . 1 , pp . 87 – 93 , 2001 . [ 118 ] H . Xu , Y . Yan , M . S . Williams et al . , “MS4a4B , a CD20 Homologue in T Cells , Inhibits T Cell Propagation by Modulation of Cell Cycle , ” PLoS ONE , vol . 5 , no . 11 , Article ID e13780 , 2010 . [ 119 ] M . Li , L . Wang , X . Ren , and C . Zheng , “Host cell targets of tegument protein VP22 of herpes simplex virus 1 , ” Archives of Virology , vol . 156 , no . 6 , pp . 1079 – 1084 , 2011 . [ 120 ] G . M . di Guglielmo , C . Le Roy , A . F . Goodfellow , and J . L . Wrana , “Distinct endocytic pathways regulate TGF - β receptor signalling and turnover , ” Nature Cell Biology , vol . 5 , no . 5 , pp . 410 – 421 , 2003 . [ 121 ] K . B . Reddy , M . C . Karode , A . K . Harmony , and P . H . Howe , “Interaction of transforming growth factor β receptors with apolipoprotein J / clusterin , ” Biochemistry , vol . 35 , no . 1 , pp . 309 – 314 , 1996 . [ 122 ] L . Yang , Y . Pang , and H . L . Moses , “TGF - β and immune cells : an important regulatory axis in the tumor microenvironment and progression , ” Trends in Immunology , vol . 31 , no . 6 , pp . 220 – 227 , 2010 . [ 123 ] C . J . Tartari , L . Scapozza , and C . Gambacorti - Passerini , “The ALK gene , an attractive target for inhibitor development , ” Current Topics in Medicinal Chemistry , vol . 11 , no . 11 , pp . 1406 – 1419 , 2011 . [ 124 ] L . Lamant , R . D . Gascoyne , M . M . Duplantier et al . , “Non - muscle myosin heavy chain ( MYH9 ) : a new partner fused to ALK in anaplastic large cell lymphoma , ” Genes Chromosomes and Cancer , vol . 37 , no . 4 , pp . 427 – 432 , 2003 . [ 125 ] N . Wang , D . Lan , M . Gerbod - Giannone et al . , “ATP - binding cassette transporter A7 ( ABCA7 ) binds apolipoprotein A - I and mediates cellular phospholipid but not cholesterol e ﬄ ux , ” Journal of Biological Chemistry , vol . 278 , no . 44 , pp . 42906 – 42912 , 2003 . [ 126 ] S . L . Chan , W . S . Kim , J . B . Kwok et al . , “ATP - binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro , ” Journal of Neurochemistry , vol . 106 , no . 2 , pp . 793 – 804 , 2008 . [ 127 ] I . L . Van Genderen , R . Brandimarti , M . R . Torrisi , G . Cam - padelli , and G . Van Meer , “The phospholipid composition of extracellular herpes simplex virions di ﬀ ers from that of host cell nuclei , ” Virology , vol . 200 , no . 2 , pp . 831 – 836 , 1994 . [ 128 ] W . L . Steinhart , C . M . Nicolet , and J . L . Howland , “Incor - poration of 32P - phosphate into membrane phospholipids during infection of cultured human ﬁbroblasts by herpes 28 International Journal of Alzheimer’s Disease simplex virus type 1 , ” Intervirology , vol . 16 , no . 2 , pp . 80 – 85 , 1981 . [ 129 ] W . L . Steinhart , J . S . Busch , J . P . Oettgen , and J . L . Howland , “Sphingolipid metabolism during infection of human ﬁbrob - lasts by herpes simplex virus type 1 , ” Intervirology , vol . 21 , no . 2 , pp . 70 – 76 , 1984 . [ 130 ] V . R . Gupta , B . A . Wilson , and S . R . Blanke , “Sphingomyelin is important for the cellular entry and intracellular localiza - tion of Helicobacter pylori VacA , ” Cellular Microbiology , vol . 12 , no . 10 , pp . 1517 – 1533 , 2010 . [ 131 ] K . Wolf and T . Hackstadt , “Sphingomyelin tra ﬃ cking in Chlamydia pneumoniae - infected cells , ” Cellular Microbiol - ogy , vol . 3 , no . 3 , pp . 145 – 152 , 2001 . [ 132 ] S . Galdiero , A . Falanga , G . Vitiello et al . , “Role of mem - branotropic sequences from herpes simplex virus type I glycoproteins B and H in the fusion process , ” Biochimica et Biophysica Acta , vol . 1798 , no . 3 , pp . 579 – 591 , 2010 . [ 133 ] C . J . Chrisman , P . Albuquerque , A . J . Guimaraes , E . Nieves , and A . Casadevall , “Phospholipids trigger Cryptococcus neoformans capsular enlargement during interactions with amoebae and macrophages , ” PLoS Pathogens , vol . 7 , no . 5 , Article ID e1002047 , 2011 . [ 134 ] D . Kielar , W . E . Kaminski , G . Liebisch et al . , “Adeno - sine triphosphate binding cassette ( ABC ) transporters are expressed and regulated during terminal keratinocyte dif - ferentiation : a potential role for ABCA7 in epidermal lipid reorganization , ” Journal of Investigative Dermatology , vol . 121 , no . 3 , pp . 465 – 474 , 2003 . [ 135 ] E . A . Hunsperger and C . L . Wilcox , “Caspase - 3 - dependent reactivation of latent herpes simplez virus type 1 in sensory neuronal cultures , ” Journal of NeuroVirology , vol . 9 , no . 3 , pp . 390 – 398 , 2003 . [ 136 ] J . Marino , I . Stoeckli , M . Walch et al . , “Chlamydophila pneumoniae derived from inclusions late in the infectious cycle induce aponecrosis in human aortic endothelial cells , ” BMC Microbiology , vol . 8 , article 32 , 2008 . [ 137 ] R . V . Srinivas , Y . V . Venkatachalapathi , Z . Rui et al . , “Inhibition of virus - induced cell fusion by apolipoprotein A - I and its amphipathic peptide analogs , ” Journal of Cellular Biochemistry , vol . 45 , no . 2 , pp . 224 – 237 , 1991 . [ 138 ] N . Tanaka , S . Abe - Dohmae , N . Iwamoto , and S . Yokoyama , “Roles of ATP - binding cassette transporter A7 in cholesterol homeostasis and host defense system , ” Journal of Atheroscle - rosis and Thrombosis , vol . 18 , pp . 274 – 281 , 2011 . [ 139 ] J . S . Burgos , C . Ramirez , I . Sastre , and F . Valdivieso , “Apo - lipoprotein E genotype inﬂuences vertical transmission of herpes simplex virus type 1 in a gender speciﬁc manner , ” Aging Cell , vol . 6 , no . 6 , pp . 841 – 842 , 2007 . [ 140 ] W . Cun , J . Jiang , and G . Luo , “The C - terminal α - helix domain of apolipoprotein E is required for interaction with nonstructural protein 5A and assembly of hepatitis C virus , ” Journal of Virology , vol . 84 , no . 21 , pp . 11532 – 11541 , 2010 . [ 141 ] T . Hishiki , Y . Shimizu , R . Tobita et al . , “Infectivity of hepatitis C virus is inﬂuenced by association with apolipoprotein E isoforms , ” Journal of Virology , vol . 84 , no . 22 , pp . 12048 – 12057 , 2010 . [ 142 ] J . Turchan - Cholewo , Y . Liu , S . Gartner et al . , “Increased vul - nerability of ApoE4 neurons to HIV proteins and opiates : protection by diosgenin and l - deprenyl , ” Neurobiology of Disease , vol . 23 , no . 1 , pp . 109 – 119 , 2006 . [ 143 ] W . R . Lin , M . A . Wozniak , M . M . Esiri , P . Klenerman , and R . F . Itzhaki , “Herpes simplex encephalitis : involvement of apolipoprotein E genotype , ” Journal of Neurology Neuro - surgery and Psychiatry , vol . 70 , no . 1 , pp . 117 – 119 , 2001 . [ 144 ] H . C . G´erard , E . Fomicheva , J . A . Whittum - Hudson , and A . P . Hudson , “Apolipoprotein E4 enhances attachment of Chlamydophila ( Chlamydia ) pneumoniae elementary bodies to host cells , ” Microbial Pathogenesis , vol . 44 , no . 4 , pp . 279 – 285 , 2008 . [ 145 ] C . M . Brown , E . Choi , Q . Xu , M . P . Vitek , and C . A . Colton , “The APOE4 genotype alters the response of microglia and macrophages to 17 β - estradiol , ” Neurobiology of Aging , vol . 29 , no . 12 , pp . 1783 – 1794 , 2008 . [ 146 ] M . P . Vitek , C . M . Brown , and C . A . Colton , “APOE geno - type - speciﬁc di ﬀ erences in the innate immune response , ” Neurobiology of Aging , vol . 30 , no . 9 , pp . 1350 – 1360 , 2009 . [ 147 ] M . N . Haan , A . E . Aiello , N . A . West , and W . J . Jagust , “C - reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype , ” Neurobiology of Aging , vol . 29 , no . 12 , pp . 1774 – 1782 , 2008 . [ 148 ] D . Thompson , M . B . Pepys , and S . P . Wood , “The physiolog - ical structure of human C - reactive protein and its complex with phosphocholine , ” Structure , vol . 7 , no . 2 , pp . 169 – 177 , 1999 . [ 149 ] N . de Bont , M . G . Netea , P . N . Demacker et al . , “Apolipopro - tein E knock - out mice are highly susceptible to endotox - emia and Klebsiella pneumoniae infection , ” Journal of Lipid Research , vol . 40 , no . 4 , pp . 680 – 685 , 1999 . [ 150 ] D . G . Alber , K . L . Powell , P . Vallance , D . A . Goodwin , and C . Grahame - Clarke , “Herpesvirus infection accelerates atherosclerosis in the apolipoprotein E - deﬁcient mouse , ” Circulation , vol . 102 , no . 7 , pp . 779 – 785 , 2000 . [ 151 ] K . Ayada , K . Yokota , K . Kobayashi , Y . Shoenfeld , E . Matsuura , and K . Oguma , “Chronic infections and atherosclerosis , ” Annals of the New York Academy of Sciences , vol . 1108 , pp . 594 – 602 , 2007 . [ 152 ] R . Ezzahiri , F . R . Stassen , H . A . Kurvers , M . M . van Pul , P . J . Kitslaar , and C . A . Bruggeman , “Chlamydia pneumo - niae infection induces an unstable atherosclerotic plaque phenotype in LDL - receptor , ApoE double knockout mice , ” European Journal of Vascular and Endovascular Surgery , vol . 26 , no . 1 , pp . 88 – 95 , 2003 . [ 153 ] E . Hsich , Y . F . Zhou , B . Paigen , T . M . Johnson , M . S . Burnett , and S . E . Epstein , “Cytomegalovirus infection increases development of atherosclerosis in Apolipoprotein - E knockout mice , ” Atherosclerosis , vol . 156 , no . 1 , pp . 23 – 28 , 2001 . [ 154 ] L . Li , E . Messas , E . L . Batista Jr . , R . A . Levine , and S . Amar , “Porphyromonas gingivalis infection accelerates the progres - sion of atherosclerosis in a heterozygous apolipoprotein E - deﬁcient murine model , ” Circulation , vol . 105 , no . 7 , pp . 861 – 867 , 2002 . [ 155 ] M . Naghavi , P . Wyde , S . Litovsky et al . , “Inﬂuenza infection exerts prominent inﬂammatory and thrombotic e ﬀ ects on the atherosclerotic plaques of apolipoprotein E - deﬁcient mice , ” Circulation , vol . 107 , no . 5 , pp . 762 – 768 , 2003 . [ 156 ] L . R . Portugal , L . R . Fernandes , G . C . Cesar et al . , “Infection with Toxoplasma gondii increases atherosclerotic lesion in ApoE - deﬁcient mice , ” Infection and Immunity , vol . 72 , no . 6 , pp . 3571 – 3576 , 2004 . [ 157 ] K . Ayada , K . Yokota , K . Hirai et al . , “Regulation of cellular immunity prevents Helicobacter pylori - induced atheroscle - rosis , ” Lupus , vol . 18 , no . 13 , pp . 1154 – 1168 , 2009 . [ 158 ] M . S . Warner , R . J . Geraghty , W . M . Martinez et al . , “A cell surface protein with herpesvirus entry activity ( Hveb ) confers susceptibility to infection by mutants of herpes simplex virus type 1 , herpes simplex virus type 2 , and International Journal of Alzheimer’s Disease 29 pseudorabies virus , ” Virology , vol . 246 , no . 1 , pp . 179 – 189 , 1998 . [ 159 ] I . Derr´e , M . Pypaert , A . Dautry - Varsat , and H . Agaisse , “RNAi screen in Drosophila cells reveals the involvement of the tom complex in Chlamydia infection , ” PLoS Pathogens , vol . 3 , no . 10 , pp . 1446 – 1458 , 2007 . [ 160 ] J . Harland , P . Dunn , E . Cameron , J . Conner , and S . M . Brown , “The herpes simplex virus ( HSV ) protein ICP34 . 5 is a virion component that forms a DNA - binding complex with proliferating cell nuclear antigen and HSV replication proteins , ” Journal of NeuroVirology , vol . 9 , no . 4 , pp . 477 – 488 , 2003 . [ 161 ] A . Lupo , E . Cesaro , G . Montano , P . Izzo , and P . Costanzo , “ZNF224 : structure and role of a multifunctional KRAB - ZFP protein , ” International Journal of Biochemistry and Cell Biology , vol . 43 , no . 4 , pp . 470 – 473 , 2011 . [ 162 ] J . Yu , B . Shin , E . S . Park et al . , “Protein arginine methyltrans - ferase 1 regulates herpes simplex virus replication through ICP27 RGG - box methylation , ” Biochemical and Biophysical Research Communications , vol . 391 , no . 1 , pp . 322 – 328 , 2010 . [ 163 ] A . Kamiya , K . Kubo , T . Tomoda et al . , “A schizophrenia - associated mutation of DISC1 perturbs cerebral cortex development , ” Nature Cell Biology , vol . 7 , no . 12 , pp . 1067 – 1078 , 2005 . [ 164 ] C . Janke , K . Rogowski , D . Wloga et al . , “Biochemistry : tubulin polyglutamylase enzymes are members of the TTL domain protein family , ” Science , vol . 308 , no . 5729 , pp . 1758 – 1762 , 2005 . [ 165 ] P . Gee , Y . Ando , H . Kitayama et al . , “APOBEC1 - mediated editing and attenuation of HSV - 1 DNA implicates an antiviral role in neurons during encephalitis , ” The Journal of Virology , vol . 85 , no . 19 , pp . 9726 – 9736 , 2011 . [ 166 ] S . K . Bose , W . Gibson , R . S . Bullard , and C . D . Donald , “PAX2 oncogene negatively regulates the expression of the host defense peptide human beta defensin - 1 in prostate cancer , ” Molecular Immunology , vol . 46 , no . 6 , pp . 1140 – 1148 , 2009 . [ 167 ] R . Tesse , N . Santoro , P . Giordano , F . Cardinale , D . D . Mattia , and L . Armenio , “Association between defb1 gene haplotype and herpes viruses seroprevalence in children with acute lymphoblastic leukemia , ” Pediatric Hematology and Oncology , vol . 26 , no . 8 , pp . 573 – 582 , 2009 . [ 168 ] A . K . Kocsis , Z . F . Kiss , L . Tiszlavicz , Z . Tiszlavicz , and Y . Mandi , “Potential role of human beta - defensin 1 in Helicobacter pylori - induced gastritis , ” Scandinavian Journal of Gastroenterology , vol . 44 , pp . 289 – 295 , 2009 . [ 169 ] B . Wiechula , K . Cholewa , A . Ekiel , M . Romanik , H . Dolezych , and G . Martirosian , “HBD - 1 and hBD - 2 are expressed in cervico - vaginal lavage in female genital tract due to microbial infections , ” Ginekologia Polska , vol . 81 , no . 4 , pp . 268 – 271 , 2010 . [ 170 ] R . Circo , B . Skerlavaj , R . Gennaro , A . Amoroso , and M . Zanetti , “Structural and functional characterization of hBD - 1 ( Ser35 ) , a peptide deduced from a DEFB1 polymorphism , ” Biochemical and Biophysical Research Communications , vol . 293 , no . 1 , pp . 586 – 592 , 2002 . [ 171 ] P . Meyer , C . Caillat , D . Topalis , J . Balzarini , and D . Deville - Bonne , “Structural basis for the speciﬁcity of thymidylate kinases from human pathogens : implications for nucleotide analogues activation , ” Nucleic Acids Symposium Series , no . 53 , p . 41 , 2009 . [ 172 ] Y . Sawayama , M . Tatsukawa , S . Maeda , H . Ohnishi , N . Furusyo , and J . Hayashi , “Association of hyperhomocys - teinemia and Chlamydia pneumoniae infection with carotid atherosclerosis and coronary artery disease in Japanese patients , ” Journal of Infection and Chemotherapy , vol . 14 , no . 3 , pp . 232 – 237 , 2008 . [ 173 ] T . Matsui , “Helicobacter pylori and Arteriosclerosis , ” Gan To Kagaku Ryoho , vol . 38 , no . 3 , pp . 365 – 369 , 2011 . [ 174 ] H . P . Huemer , H . J . Menzel , D . Potratz et al . , “Herpes simplex virus binds to human serum lipoprotein , ” Intervirology , vol . 29 , no . 2 , pp . 68 – 76 , 1988 . [ 175 ] S . I . Vieira , S . Rebelo , H . Esselmann et al . , “Retrieval of the Alzheimer’s amyloid precursor protein from the endosome to the TGN is S655 phosphorylation state - dependent and retromer - mediated , ” Molecular Neurodegeneration , vol . 5 , no . 1 , article 40 , 2010 . [ 176 ] N . R . Marquez - Sterling , A . C . Lo , S . S . Sisodia , and E . H . Koo , “Tra ﬃ cking of cell - surface β - amyloid precursor protein : evidence that a sorting intermediate participates in synaptic vesicle recycling , ” Journal of Neuroscience , vol . 17 , no . 1 , pp . 140 – 151 , 1997 . [ 177 ] M . S . Song , G . B . Baker , K . G . Todd , and S . Kar , “Inhibition of beta - amyloid1 - 42 internalization attenuates neuronal death by stabilizing the endosomal - lysosomal system in rat cortical cultured neurons , ” Neuroscience , vol . 178 , pp . 181 – 188 , 2011 . [ 178 ] S . Mandrekar , Q . Jiang , C . Y . Lee , J . Koenigsknecht - Talboo , D . M . Holtzman , and G . E . Landreth , “Microglia mediate the clearance of soluble a β through ﬂuid phase macropinocyto - sis , ” Journal of Neuroscience , vol . 29 , no . 13 , pp . 4252 – 4262 , 2009 . [ 179 ] F . Wu , Y . Matsuoka , M . P . Mattson , and P . J . Yao , “The clathrin assembly protein AP180 regulates the generation of amyloid - β peptide , ” Biochemical and Biophysical Research Communications , vol . 385 , no . 2 , pp . 247 – 250 , 2009 . [ 180 ] J . R . Cirrito , J . E . Kang , J . Lee et al . , “Endocytosis is required for synaptic activity - dependent release of amyloid - β in vivo , ” Neuron , vol . 58 , no . 1 , pp . 42 – 51 , 2008 . [ 181 ] M . M . Hussain , “Structural , biochemical and signaling prop - erties of the low - density lipoprotein receptor gene family , ” Frontiers in Bioscience , vol . 6 , pp . D417 – D428 , 2001 . [ 182 ] M . Dieckmann , M . F . Dietrich , and J . Herz , “Lipoprotein receptors - an evolutionarily ancient multifunctional receptor family , ” Biological Chemistry , vol . 391 , no . 11 , pp . 1341 – 1363 , 2010 . [ 183 ] M . Deuss , K . Reiss , and D . Hartmann , “Part - time α - secre - tases : the functional biology of ADAM 9 , 10 and 17 , ” Current Alzheimer Research , vol . 5 , no . 2 , pp . 187 – 201 , 2008 . [ 184 ] C . Sato , G . Zhao , and M . X . Ilagan , “An overview of notch signaling in adult tissue renewal and maintenance , ” Current Alzheimer Research . In press . [ 185 ] B . B . Fuchs , R . J . Tang , and E . Mylonakis , “The temperature - sensitive role of Cryptococcus neoformans ROM2 in cell morphogenesis , ” PLoS ONE , vol . 2 , no . 4 , article e368 , 2007 . [ 186 ] J . Mital and T . Hackstadt , “Diverse requirements for SRC - family tyrosine kinases distinguish chlamydial species , ” MBio , vol . 2 , no . 2 , 2011 . [ 187 ] R . Pai , T . L . Cover , and A . S . Tarnawski , “Helicobacter pylori vacuolating cytotoxin ( VacA ) disorganizes the cytoskeletal architecture of gastric epithelial cells , ” Biochemical and Biophysical Research Communications , vol . 262 , no . 1 , pp . 245 – 250 , 1999 . [ 188 ] H . Takeuchi , N . Furuta , I . Morisaki , and A . Amano , “Exit of intracellular Porphyromonas gingivalis from gingival epithelial cells is mediated by endocytic recycling pathway , ” Cellular Microbiology , vol . 13 , no . 5 , pp . 677 – 691 , 2011 . [ 189 ] M . D . Weingarten , A . H . Lockwood , S . Y . Hwo , and M . W . Kirschner , “A protein factor essential for microtubule assembly , ” Proceedings of the National Academy of Sciences of 30 International Journal of Alzheimer’s Disease the United States of America , vol . 72 , no . 5 , pp . 1858 – 1862 , 1975 . [ 190 ] P . J . Dolan and G . V . Johnson , “The role of tau kinases in Alzheimer’s disease , ” Current Opinion in Drug Discovery and Development , vol . 13 , no . 5 , pp . 595 – 603 , 2010 . [ 191 ] ´A . Zambrano , L . Solis , N . Salvadores , M . Cort´es , R . Ler - chundi , and C . Otth , “Neuronal cytoskeletal dynamic mod - iﬁcation and neurodegeneration induced by infection with herpes simplex virus type 1 , ” Journal of Alzheimer’s Disease , vol . 14 , no . 3 , pp . 259 – 269 , 2008 . [ 192 ] C . J . Carter , “Alzheimer’s disease : a pathogenetic autoim - mune disorder caused by herpes simplex in a gene - dependent manner , ” International Journal of Alzheimer’s Disease , 2010 , article 140539 . [ 193 ] S . B . Cheng , P . Ferland , P . Webster , and E . L . Bearer , “Herpes simplex virus dances with amyloid precursor protein while exiting the cell , ” PLoS ONE , vol . 6 , no . 3 , Article ID e17966 , 2011 . [ 194 ] L . Benboudjema , M . Mulvey , Y . Gao , S . W . Pimplikar , and I . Mohr , “Association of the herpes simplex virus type 1 Us11 gene product with the cellular kinesin light - chain - related protein PAT1 results in the redistribution of both polypeptides , ” Journal of Virology , vol . 77 , no . 17 , pp . 9192 – 9203 , 2003 . [ 195 ] P . Zheng , J . Eastman , P . S . Vande , and S . W . Pimplikar , “PAT1 , a microtubule - interacting protein , recognizes the basolateral sorting signal of amyloid precursor protein , ” Proceedings of the National Academy of Sciences of the United States of America , vol . 95 , no . 25 , pp . 14745 – 14750 , 1998 . [ 196 ] S . J . Soscia , J . E . Kirby , K . J . Washicosky et al . , “The Al - zheimer’s disease - associated amyloid β - protein is an antimi - crobial peptide , ” PLoS ONE , vol . 5 , no . 3 , Article ID e9505 , 2010 . [ 197 ] W . J . Lukiw , J . G . Cui , L . Y . Yuan et al . , “Acyclovir or A β 42 peptides attenuate HSV - 1 - induced miRNA - 146a levels in human primary brain cells , ” NeuroReport , vol . 21 , no . 14 , pp . 922 – 927 , 2010 . [ 198 ] A . Salminen , J . Ojala , A . Kauppinen , K . Kaarniranta , and T . Suuronen , “Inﬂammation in Alzheimer’s disease : amyloid - β oligomers trigger innate immunity defence via pattern recognition receptors , ” Progress in Neurobiology , vol . 87 , no . 3 , pp . 181 – 194 , 2009 . [ 199 ] K . Tahara , H . D . Kim , J . J . Jin , J . A . Maxwell , L . Li , and K . Fukuchi , “Role of toll - like receptor signalling in A β uptake and clearance , ” Brain , vol . 129 , no . 11 , pp . 3006 – 3019 , 2006 . [ 200 ] J . - H . Sohn , J . O . So , H . J . Hong et al . , “Identiﬁcation of autoantibody against beta - amyloid peptide in the serum of elderly , ” Frontiers in Bioscience , vol . 14 , no . 10 , pp . 3879 – 3883 , 2009 . [ 201 ] A . Lle´o and C . A . Saura , “ γ - secretase substrates and their implications for drug development in Alzheimer’s disease , ” Current Topics in Medicinal Chemistry , vol . 11 , no . 12 , pp . 1513 – 1527 , 2011 . [ 202 ] O . Takeuchi and S . Akira , “Innate immunity to virus in - fection , ” Immunological Reviews , vol . 227 , no . 1 , pp . 75 – 86 , 2009 . [ 203 ] I . Zanoni and F . Granucci , “Regulation of antigen uptake , migration , and lifespan of dendritic cell by Toll - like recep - tors , ” Journal of Molecular Medicine , vol . 88 , no . 9 , pp . 873 – 880 , 2010 . [ 204 ] D . Y . Kim , L . A . Ingano , and D . M . Kovacs , “Nectin - 1 α , an immunoglobulin - like receptor involved in the formation of synapses , is a substrate for presenilin / γ - secretase - like cleavage , ” Journal of Biological Chemistry , vol . 277 , no . 51 , pp . 49976 – 49981 , 2002 . [ 205 ] M . L . Hemming , J . E . Elias , S . P . Gygi , and D . J . Selkoe , “Pro - teomic proﬁling of gamma - secretase substrates and mapping of substrate requirements , ” PLoS Biology , vol . 6 , no . 10 , p . e257 , 2008 . [ 206 ] S . Bacsa , G . Karasneh , S . Dosa , J . Liu , T . Valyi - Nagy , and D . Shukla , “Syndecan - 1 and syndecan - 2 play key roles in herpes simplex virus type - 1 infection , ” Journal of General Virology , vol . 92 , no . 4 , pp . 733 – 743 , 2011 . [ 207 ] M . Kalia , V . Chandra , S . A . Rahman , D . Sehgal , and S . Jameel , “Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection , ” Journal of Virology , vol . 83 , no . 24 , pp . 12714 – 12724 , 2009 . [ 208 ] S . Shafti - Keramat , A . Handisurya , E . Kriehuber , G . Meneguzzi , K . Slupetzky , and R . Kirnbauer , “Di ﬀ erent hepar - an sulfate proteoglycans serve as cellular receptors for human papillomaviruses , ” Journal of Virology , vol . 77 , no . 24 , pp . 13125 – 13135 , 2003 . [ 209 ] A . J . Smith , T . W . Schacker , C . S . Reilly , and A . T . Haase , “A role for syndecan - 1 and claudin - 2 in microbial translocation during HIV - 1 infection , ” Journal of Acquired Immune Deﬁ - ciency Syndromes , vol . 55 , no . 3 , pp . 306 – 315 , 2010 . [ 210 ] L . de Witte , M . Bobardt , U . Chatterji et al . , “Syndecan - 3 is a dendritic cell - speciﬁc attachment receptor for HIV - 1 , ” Proceedings of the National Academy of Sciences of the United States of America , vol . 104 , no . 49 , pp . 19464 – 19469 , 2007 . [ 211 ] L . de Witte , Y . Zoughlami , B . Aengeneyndt et al . , “Binding of human papilloma virus L1 virus - like particles to dendritic cells is mediated through heparan sulfates and induces immune activation , ” Immunobiology , vol . 212 , no . 9 - 10 , pp . 679 – 691 , 2008 . [ 212 ] G . A . Wilke and W . J . Bubeck , “Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus α - hemo - lysin—mediated cellular injury , ” Proceedings of the National Academy of Sciences of the United States of America , vol . 107 , no . 30 , pp . 13473 – 13478 , 2010 . [ 213 ] A . Jong , C . H . Wu , G . M . Shackleford et al . , “Involvement of human CD44 during Cryptococcus neoformans infection of brain microvascular endothelial cells , ” Cellular Microbiology , vol . 10 , no . 6 , pp . 1313 – 1326 , 2008 . [ 214 ] B . D . Persson , N . B . Schmitz , C . Santiago et al . , “Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens , ” PLoS Pathogens , vol . 6 , no . 9 , Article ID e01122 , 2010 . [ 215 ] H . Mahtout , F . Chandad , J . M . Rojo , and D . Grenier , “Por - phyromonas gingivalis mediates the shedding and proteolysis of complement regulatory protein CD46 expressed by oral epithelial cells , ” Oral Microbiology and Immunology , vol . 24 , no . 5 , pp . 396 – 400 , 2009 . [ 216 ] H . Wang , Z . - Y . Li , Y . Liu et al . , “Desmoglein 2 is a receptor for adenovirus serotypes 3 , 7 , 11 and 14 , ” Nature Medicine , vol . 17 , no . 1 , pp . 96 – 104 , 2011 . [ 217 ] F . Hofer , M . Gruenberger , H . Kowalski et al . , “Members of the low density lipoprotein receptor family mediate cell entry of a minor - group common cold virus , ” Proceedings of the National Academy of Sciences of the United States of America , vol . 91 , no . 5 , pp . 1839 – 1842 , 1994 . [ 218 ] B . Ronacher , T . C . Marlovits , R . Moser , and D . Blaas , “Expres - sion and folding of human very - low - density lipoprotein receptor fragments : neutralization capacity toward human rhinovirus HRV2 , ” Virology , vol . 278 , no . 2 , pp . 541 – 550 , 2000 . International Journal of Alzheimer’s Disease 31 [ 219 ] S . Jahan , S . Khaliq , B . Samreen et al . , “E ﬀ ect of combined siRNA of HCV E2 gene and HCV receptors against HCV , ” Virology Journal , vol . 8 , article 295 , 2011 . [ 220 ] L . J . Anderson and R . Longnecker , “Epstein - Barr virus latent membrane protein 2A exploits Notch1 to alter B - cell identity in vivo , ” Blood , vol . 113 , no . 1 , pp . 108 – 116 , 2009 . [ 221 ] S . Kusano and N . Raab - Traub , “An Epstein - Barr virus protein interacts with Notch , ” Journal of Virology , vol . 75 , no . 1 , pp . 384 – 395 , 2001 . [ 222 ] E . Tzahar , J . D . Moyer , H . Waterman et al . , “Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network , ” EMBO Journal , vol . 17 , no . 20 , pp . 5948 – 5963 , 1998 . [ 223 ] C . Tu ﬀ ereau , J . B´en´ejean , D . Blondel , B . Kie ﬀ er , and A . Fla - mand , “Low - a ﬃ nity nerve - growth factor receptor ( P75NTR ) can serve as a receptor for rabies virus , ” EMBO Journal , vol . 17 , no . 24 , pp . 7250 – 7259 , 1998 . [ 224 ] T . A . Bowden , A . R . Aricescu , R . J . Gilbert , J . M . Grimes , E . Y . Jones , and D . I . Stuart , “Structural basis of Nipah and Hendra virus attachment to their cell - surface receptor ephrin - B2 , ” Nature Structural and Molecular Biology , vol . 15 , no . 6 , pp . 567 – 572 , 2008 . [ 225 ] R . J . Orentas and J . E . Hildreth , “Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV , ” AIDS Research and Human Retroviruses , vol . 9 , no . 11 , pp . 1157 – 1165 , 1993 . [ 226 ] S . W . Rothwell and D . G . Wright , “Characterization of inﬂuenza A virus binding sites on human neutrophils , ” Journal of Immunology , vol . 152 , no . 5 , pp . 2358 – 2367 , 1994 . [ 227 ] E . Pericolini , E . Gabrielli , E . Cenci et al . , “Involvement of glycoreceptors in galactoxylomannan - induced T cell death , ” Journal of Immunology , vol . 182 , no . 10 , pp . 6003 – 6010 , 2009 . [ 228 ] J . Vomaske , R . M . Melnychuk , P . P . Smith et al . , “Differen - tial ligand binding to a human cytomegalovirus chemok - ine receptor determines cell type - speciﬁc motility , ” PLoS Pathogens , vol . 5 , no . 2 , Article ID e1000304 , 2009 . [ 229 ] M . Minami , N . Kume , T . Shimaoka et al . , “Expression of SR - PSOX , a novel cell - surface scavenger receptor for phos - phatidylserine and oxidized LDL in human atherosclerotic lesions , ” Arteriosclerosis , Thrombosis , and Vascular Biology , vol . 21 , no . 11 , pp . 1796 – 1800 , 2001 . [ 230 ] O . Geiger , N . Gonz´alez - Silva , I . M . L´opez - Lara , and C . Sohlenkamp , “Amino acid - containing membrane lipids in bacteria , ” Progress in Lipid Research , vol . 49 , no . 1 , pp . 46 – 60 , 2010 . [ 231 ] W . Cao , M . D . Henry , P . Borrow et al . , “Identiﬁcation of α - dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus , ” Science , vol . 282 , no . 5396 , pp . 2079 – 2081 , 1998 . [ 232 ] N . Sevilla , S . Kunz , A . Holz et al . , “Immunosuppression and resultant viral persistence by speciﬁc viral targeting of dendritic cells , ” Journal of Experimental Medicine , vol . 192 , no . 9 , pp . 1249 – 1260 , 2000 . [ 233 ] S . Sasaki , F . Takeshita , K . Okuda , and N . Ishii , “Mycobac - terium leprae and leprosy : a compendium , ” Microbiology and Immunology , vol . 45 , no . 11 , pp . 729 – 736 , 2001 . [ 234 ] E . Boelen , F . R . Stassen , A . J . van der Ven et al . , “Detection of amyloid beta aggregates in the brain of BALB / c mice after Chlamydia pneumoniae infection , ” Acta Neuropathologica , vol . 114 , no . 3 , pp . 255 – 261 , 2007 . [ 235 ] J . Miklossy , A . Kis , A . Radenovic et al . , “ β - amyloid deposition and Alzheimer’s type changes induced by Borrelia spiro - chetes , ” Neurobiology of Aging , vol . 27 , no . 2 , pp . 228 – 236 , 2006 . [ 236 ] R . Piacentini , L . Civitelli , C . Ripoli et al . , “HSV - 1 promotes Ca2 + - mediated APP phosphorylation and A β accumulation in rat cortical neurons , ” Neurobiology of Aging , vol . 32 , no . 12 , pp . 2323 . e13 – 2323 . e26 , 2011 . [ 237 ] M . S . Elkind , “Infectious burden : a new risk factor and treatment target for atherosclerosis , ” Infectious Disorders , vol . 10 , no . 2 , pp . 84 – 90 , 2010 . [ 238 ] D . Kanduc , “Describing the hexapeptide identity platform between the inﬂuenza A H5N1 and Homo sapiens pro - teomes , ” Biologicals , vol . 4 , pp . 245 – 261 , 2010 . [ 239 ] D . Kanduc , A . Stufano , G . Lucchese , and A . Kusalik , “Massive peptide sharing between viral and human proteomes , ” Peptides , vol . 29 , no . 10 , pp . 1755 – 1766 , 2008 . [ 240 ] R . Ricco and D . Kanduc , “Hepatitis B virus and Homo sapiens proteome - wide analysis : a profusion of viral peptide overlaps in neuron - speciﬁc human proteins , ” Biologics , no . 4 , pp . 75 – 81 , 2010 . [ 241 ] B . Trost , G . Lucchese , A . Stufano , M . Bickis , A . Kusalik , and D . Kanduc , “No human protein is exempt from bacterial motifs , not even one , ” Self / Nonself , vol . 1 , no . 4 , pp . 328 – 334 , 2010 . [ 242 ] W . M . Pardridge , “Re - engineering biopharmaceuticals for delivery to brain with molecular Trojan horses , ” Bioconjugate Chemistry , vol . 19 , no . 7 , pp . 1327 – 1338 , 2008 . [ 243 ] P . Grammas , J . Martinez , and B . Miller , “Cerebral microvas - cular endothelium and the pathogenesis of neurodegenera - tive diseases , ” Expert Reviews in Molecular Medicine , vol . 13 , Article ID e19 , 2011 . [ 244 ] G . Baravalle , M . Brabec , L . Snyers , D . Blaas , and R . Fuchs , “Human Rhinovirus Type 2 - Antibody Complexes Enter and Infect Cells via Fc - γ Receptor IIB1 , ” Journal of Virology , vol . 78 , no . 6 , pp . 2729 – 2737 , 2004 . [ 245 ] D . L . Mallery , W . A . McEwan , S . R . Bidgood , G . J . Towers , C . M . Johnson , and L . C . James , “Antibodies mediate intra - cellular immunity through tripartite motif - containing 21 ( TRIM21 ) , ” Proceedings of the National Academy of Sciences of the United States of America , vol . 107 , no . 46 , pp . 19985 – 19990 , 2010 . [ 246 ] M . Jaume , M . S . Yip , C . Y . Cheung et al . , “Anti - severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH - and cysteine protease - independent Fc γ R pathway , ” The Journal of Vir - ology , vol . 85 , no . 20 , pp . 10582 – 10597 , 2011 . [ 247 ] Y . N . Li , X . J . Qin , F . Kuang et al . , “Alterations of Fc γ receptor I and Toll - like receptor 4 mediate the antiinﬂammatory actions of microglia and astrocytes after adrenaline - induced blood - brain barrier opening in rats , ” Journal of Neuroscience Research , vol . 86 , no . 16 , pp . 3556 – 3565 , 2008 . [ 248 ] C . J . Carter , “Epstein - Barr and other viral mimicry of autoantigens , myelin and vitamin D related proteins , and of EIF2B , the cause of vanishing white matter disease : massive mimicry of multiple sclerosis relevant proteins by the Syn - echococcus phage , ” Immunopharmacology and Immunotoxi - cology . In press . [ 249 ] C . J . Carter , “Pathogen and autoantigen homologous regions within the cystic ﬁbrosis transmembrane conductance reg - ulator ( CFTR ) protein suggest an autoimmune treatable component of cystic ﬁbrosis , ” FEMS Immunology & Medical Microbiology , vol . 62 , no . 2 , pp . 197 – 214 , 2011 . [ 250 ] C . J . Carter , “Schizophrenia : a pathogenetic autoimmune disease caused by viruses and pathogens and dependent on genes , ” Journal of Pathogens , vol . 2011 , Article ID 128318 , 37 pages , 2011 . 32 International Journal of Alzheimer’s Disease [ 251 ] A . J . Espay and K . K . Henderson , “Postencephalitic parkin - sonism and basal ganglia necrosis due to Epstein - Barr virus infection , ” Neurology , vol . 76 , no . 17 , pp . 1529 – 1530 , 2011 . [ 252 ] F . Roselli , I . Russo , A . Fraddosio et al . , “Reversible Parkin - sonian syndrome associated with anti - neuronal antibodies in acute EBV encephalitis : a case report , ” Parkinsonism and Related Disorders , vol . 12 , no . 4 , pp . 257 – 260 , 2006 . [ 253 ] J . Woulfe , H . Hoogendoorn , M . Tarnopolsky , and D . G . Munoz , “Monoclonal antibodies against Epstein - Barr virus cross - react with alpha - synuclein in human brain , ” Neurology , vol . 55 , no . 9 , pp . 1398 – 1401 , 2000 . [ 254 ] C . J . Carter , “Extensive viral mimicry of 22 AIDS - related autoantigens by HIV - 1 proteins and pathway analysis of 561 viral / human homologues suggest an initial treatable autoimmune component of AIDS , ” FEMS Immunology & Medical Microbiology , vol . 63 , no . 2 , pp . 254 – 268 , 2011 . [ 255 ] D . Kanduc , “The self / nonself issue a confrontation between proteomes , ” Self / Nonself , vol . 1 , no . 3 , pp . 255 – 258 , 2010 . [ 256 ] L . Jones , P . A . Holmans , M . L . Hamshere et al . , “Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer’s disease , ” PLoS ONE , vol . 5 , no . 11 , Article ID e13950 , 2010 . [ 257 ] D . Phillips , L . Prentice , M . Upadhyaya et al . , “Autosomal dominant inheritance of autoantibodies to thyroid peroxi - dase and thyroglobulin—studies in families not selected for autoimmune thyroid disease , ” Journal of Clinical Endocrinol - ogy and Metabolism , vol . 72 , no . 5 , pp . 973 – 975 , 1991 . [ 258 ] N . S . Zuckerman , H . Hazanov , M . Barak et al . , “Somatic hypermutation and antigen - driven selection of B cells are altered in autoimmune diseases , ” Journal of Autoimmunity , vol . 35 , no . 4 , pp . 325 – 335 , 2010 . [ 259 ] J . H . Rho , W . Zhang , M . Murali , M . H . Roehrl , and J . Y . Wang , “Human proteins with a ﬃ nity for dermatan sulfate have the propensity to become autoantigens , ” American Journal of Pathology , vol . 178 , no . 5 , pp . 2177 – 2190 , 2011 . [ 260 ] T . Wadstr¨om and ˚A . Ljungh , “Glycosaminoglycan - binding microbial proteins in tissue adhesion and invasion : key events in microbial pathogenicity , ” Journal of Medical Microbiology , vol . 48 , no . 3 , pp . 223 – 233 , 1999 . [ 261 ] H . Rosenmann , N . Grigoriadis , D . Karussis et al . , “Tauopa - thy - like abnormalities and neurologic deﬁcits in mice immu - nized with neuronal tau protein , ” Archives of Neurology , vol . 63 , no . 10 , pp . 1459 – 1467 , 2006 . [ 262 ] S . Capsoni , G . Ugolini , A . Comparini , F . Ruberti , N . Berardi , and A . Cattaneo , “Alzheimer - like neurodegeneration in aged antinerve growth factor transgenic mice , ” Proceedings of the National Academy of Sciences of the United States of America , vol . 97 , no . 12 , pp . 6826 – 6831 , 2000 . [ 263 ] I . Ferrer , R . M . Boada , M . L . S´anchez Guerra , M . J . Rey , and F . Costa - Juss ` a , “Neuropathology and pathogenesis of encephalitis following amyloid - β immunization in Al - zheimer’s disease , ” Brain Pathology , vol . 14 , no . 1 , pp . 11 – 20 , 2004 . [ 264 ] R . Furlan , E . Brambilla , F . Sanvito et al . , “Vaccination with amyloid - β peptide induces autoimmune encephalomyelitis in C57 / BL6 mice , ” Brain , vol . 126 , no . 2 , pp . 285 – 291 , 2003 . [ 265 ] A . J . Rozemuller , W . A . van Gool , and P . Eikelenboom , “The neuroinﬂammatory response in plaques and amyloid an - giopathy in Alzheimer’s disease : therapeutic implications , ” Current Drug Targets , vol . 4 , no . 3 , pp . 223 – 233 , 2005 . [ 266 ] D . Vacirca , C . Barbati , B . Scazzocchio et al . , “Anti - ATP synthase autoantibodies from patients with Alzheimer’s disease reduce extracellular HDL level , ” Journal of Alzheimer’s Disease , vol . 26 , no . 3 , pp . 441 – 445 , 2011 . [ 267 ] D . Vacirca , F . Delunardo , P . Matarrese et al . , “Autoantibodies to the adenosine triphosphate synthase play a pathogenetic role in Alzheimer’s disease , ” Neurobiology of Aging . In press . [ 268 ] P . Foley , H . F . Bradford , M . Docherty et al . , “Evidence for the presence of antibodies to cholinergic neurons in the serum of patients with Alzheimer’s disease , ” Journal of Neurology , vol . 235 , no . 8 , pp . 466 – 471 , 1988 . [ 269 ] R . G . Nagele , P . M . Cli ﬀ ord , G . Siu et al . , “Brain - reactive autoantibodies prevalent in human sera increase intra - neuronal amyloid - γ 1 - 42 deposition , ” Journal of Alzheimer’s Disease , vol . 25 , no . 4 , pp . 605 – 622 , 2011 . [ 270 ] L . Koval , O . Lykhmus , O . Kalashnyk et al . , “The presence and origin of autoantibodies against α 4 and α 7 nicotinic acetyl - choline receptors in the human blood : possible relevance to Alzheimer’s pathology , ” Journal of Alzheimer’s Disease , vol . 25 , no . 4 , pp . 747 – 761 , 2011 . [ 271 ] S . Mruthinti , J . J . Buccafusco , W . D . Hill et al . , “Autoim - munity in Alzheimer’s disease : increased levels of circulating IgGs binding A β and RAGE peptides , ” Neurobiology of Aging , vol . 25 , no . 8 , pp . 1023 – 1032 , 2004 . [ 272 ] M . A . Gruden , T . B . Davidova , M . Maliˇsauskas et al . , “Dif - ferential neuroimmune markers to the onset of Alzheimer’s disease neurodegeneration and dementia : autoantibodies to A β ( 25 - 35 ) oligomers , S100b and neurotransmitters , ” Journal of Neuroimmunology , vol . 186 , no . 1 - 2 , pp . 181 – 192 , 2007 . [ 273 ] H . B . D . Kettlewell , “Selection experimants on industrial melanism in the Lepidoptera , ” Heredity , vol . 9 , pp . 323 – 342 , 1955 . [ 274 ] J . S . Burgos , C . Ramirez , I . Sastre , and F . Valdivieso , “E ﬀ ect of apolipoprotein E on the cerebral load of latent herpes simplex virus type 1 DNA , ” Journal of Virology , vol . 80 , no . 11 , pp . 5383 – 5387 , 2006 . [ 275 ] S . Li , D . Carpenter , C . Hsiang , S . L . Wechsler , and C . Jones , “Herpes simplex virus type 1 latency - associated transcript inhibits apoptosis and promotes neurite sprouting in neu - roblastoma cells following serum starvation by maintaining protein kinase B ( AKT ) levels , ” Journal of General Virology , vol . 91 , no . 4 , pp . 858 – 866 , 2010 . [ 276 ] C . L . Wilcox and E . M . Johnson Jr . , “Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro , ” Journal of Virology , vol . 61 , no . 7 , pp . 2311 – 2315 , 1987 . [ 277 ] V . Camarena , M . Kobayashi , J . Y . Kim et al . , “Nature and duration of growth factor signaling through receptor tyrosine kinases regulates HSV - 1 latency in neurons , ” Cell Host and Microbe , vol . 8 , no . 4 , pp . 320 – 330 , 2010 . [ 278 ] S . E . Counts , M . Nadeem , J . Wuu , S . D . Ginsberg , H . U . Saragovi , and E . J . Mufson , “Reduction of cortical TrkA but not p75NTR protein in early - stage Alzheimer’s disease , ” Annals of Neurology , vol . 56 , no . 4 , pp . 520 – 531 , 2004 . [ 279 ] S . Kheirvari , K . Uezu , S . Yamamoto , and Y . Nakaya , “High - dose dietary supplementation of vitamin A induces brain - derived neurotrophic factor and nerve growth factor produc - tion in mice with simultaneous deﬁciency of vitamin A and zinc , ” Nutritional Neuroscience , vol . 11 , no . 5 , pp . 228 – 234 , 2008 . [ 280 ] B . Jiang , E . Y . Liao , L . M . Tan , R . C . Dai , Z . J . Xiao , and H . J . Liao , “E ﬀ ects of long - term replacement therapy of compound nylestriol tablet or low - dose 17 beta - estradiol on the expression of nerve growth factor in OVX rat hippocampal formation , ” Zhong Nan Da Xue Xue Bao . Yi Xue Ban , vol . 29 , no . 5 , pp . 529 – 533 , 2004 . [ 281 ] R . D . Vicetti Miguel , B . S . Sheridan , S . A . K . Harvey , R . S . Schreiner , R . L . Hendricks , and T . L . Cherpes , “17 - β estradiol International Journal of Alzheimer’s Disease 33 promotion of herpes simplex virus type 1 reactivation is estrogen receptor dependent , ” Journal of Virology , vol . 84 , no . 1 , pp . 565 – 572 , 2010 . [ 282 ] M . I . Geerlings , L . J . Launer , F . H . de Jong et al . , “Endogenous estradiol and risk of dementia in women and men : the Rotterdam study , ” Annals of Neurology , vol . 53 , no . 5 , pp . 607 – 615 , 2003 . [ 283 ] G . Ravaglia , P . Forti , F . Maioli et al . , “Endogenous sex hor - mones as risk factors for dementia in elderly men and women , ” Journals of Gerontology , vol . 62 , no . 9 , pp . 1035 – 1041 , 2007 . [ 284 ] C . Clement , P . S . Bhattacharjee , H . E . Kaufman , and J . M . Hill , “Heat - induced reactivation of HSV - 1 in latent mice : upregulation in the TG of CD83 and other immune response genes and their LAT - ICP0 locus , ” Investigative Ophthalmolo - gy and Visual Science , vol . 50 , no . 6 , pp . 2855 – 2861 , 2009 . [ 285 ] J . D . Kriesel , J . Ricigliano , S . L . Spruance , H . H . Garza Jr . , and J . M . Hill , “Neuronal reactivation of herpes simplex virus may involve interleukin - 6 , ” Journal of NeuroVirology , vol . 3 , no . 6 , pp . 441 – 448 , 1997 . [ 286 ] I . Walev , J . Podlech , and D . Falke , “Enhancement by TNF - alpha of reactivation and replication of latent herpes simplex virus from trigeminal ganglia of mice , ” Archives of Virology , vol . 140 , no . 6 , pp . 987 – 992 , 1995 . [ 287 ] J . K´alm´an , A . Juh´asz , G . Laird et al . , “Serum interleukin - 6 levels correlate with the severity of dementia in down syn - drome and in Alzheimer’s disease , ” Acta Neurologica Scandi - navica , vol . 96 , no . 4 , pp . 236 – 240 , 1997 . [ 288 ] F . Shalit , B . Sredni , L . Stern , E . Kott , and M . Huberman , “Elevated interleukin - 6 secretion levels by mononuclear cells of Alzheimer’s patients , ” Neuroscience Letters , vol . 174 , no . 2 , pp . 130 – 132 , 1994 . [ 289 ] Y . X . Sun , L . Minthon , A . Wallmark , S . Warkentin , K . Blennow , and S . Janciauskiene , “Inﬂammatory markers in matched plasma and cerebrospinal ﬂuid from patients with Alzheimer’s disease , ” Dementia and Geriatric Cognitive Dis - orders , vol . 16 , no . 3 , pp . 136 – 144 , 2003 . [ 290 ] P . Kragsbjerg , T . Vikerfors , and H . Holmberg , “Cytokine responses in patients with pneumonia caused by Chlamydia or Mycoplasma , ” Respiration , vol . 65 , no . 4 , pp . 299 – 303 , 1998 . [ 291 ] N . Mehmet , M . Reﬁk , M . Harputluoglu , Y . Ersoy , N . E . Aydin , and B . Yildirim , “Serum and gastric ﬂuid levels of cytokines and nitrates in gastric diseases infected with Helicobacter pylori , ” New Microbiologica , vol . 27 , no . 2 , pp . 139 – 148 , 2004 . [ 292 ] D . Delﬁno , L . Cianci , E . Lupis et al . , “Interleukin - 6 pro - duction by human monocytes stimulated with Cryptococcus neoformans components , ” Infection and Immunity , vol . 65 , no . 6 , pp . 2454 – 2456 , 1997 . [ 293 ] S . Noisakran , W . P . Halford , L . Veress , and D . J . Carr , “Role of the hypothalamic pituitary adrenal axis and IL - 6 in stress - induced reactivation of latent herpes simplex virus type 1 , ” Journal of Immunology , vol . 160 , no . 11 , pp . 5441 – 5447 , 1998 . [ 294 ] K . L . Davis , B . M . Davis , B . S . Greenwald et al . , “Cortisol and Alzheimer’s disease . I : basal studies , ” American Journal of Psychiatry , vol . 143 , no . 3 , pp . 300 – 305 , 1986 . [ 295 ] C . W . Huang , C . C . Lui , W . N . Chang , C . H . Lu , Y . L . Wang , and C . C . Chang , “Elevated basal cortisol level predicts lower hippocampal volume and cognitive decline in Alzheimer’s disease , ” Journal of Clinical Neuroscience , vol . 16 , no . 10 , pp . 1283 – 1286 , 2009 . [ 296 ] A . Rodriguez , D . L . M . Sainz , J . Missry , and C . S . Foster , “The role of cyclic nucleotide mediators in latency and reactivation of HSV - 1 infected neuroblastoma cells , ” Eye , vol . 5 , no . 5 , pp . 627 – 635 , 1991 . [ 297 ] R . L . Smith , L . I . Pizer , E . M . Johnson Jr . , and C . L . Wilcox , “Activation of second - messenger pathways reactivates latent herpes simplex virus in neuronal cultures , ” Virology , vol . 188 , no . 1 , pp . 311 – 318 , 1992 . [ 298 ] B . M . Gebhardt and H . E . Kaufman , “Propranolol suppresses reactivation of herpesvirus , ” Antiviral Research , vol . 27 , no . 3 , pp . 255 – 261 , 1995 . [ 299 ] B . Sainz , J . M . Loutsch , M . E . Marquart , and J . M . Hill , “Stress - associated immunomodulation and herpes simplex virus infections , ” Medical Hypotheses , vol . 56 , no . 3 , pp . 348 – 356 , 2001 . [ 300 ] R . E . Martin , J . M . Loutsch , H . H . Garza , D . J . Boedeker , and J . M . Hill , “Iontophoresis of lysophosphatidic acid into rabbit cornea induces HSV - 1 reactivation : evidence that neuronal signaling changes after infection , ” Molecular Vision , vol . 5 , p . 36 , 1999 . [ 301 ] M . K . Aghi , T . C . Liu , S . Rabkin , and R . L . Martuza , “Hypoxia enhances the replication of oncolytic herpes simplex virus , ” Molecular Therapy , vol . 17 , no . 1 , pp . 51 – 56 , 2009 . [ 302 ] Y . Hashimoto , H . Kawatsura , Y . Shiga , S . Furukawa , and T . Shigeno , “Signiﬁcance of nerve growth factor content levels after transient forebrain ischemia in gerbils , ” Neuroscience Letters , vol . 139 , no . 1 , pp . 45 – 46 , 1992 . [ 303 ] J . C . de la Torre , “The vascular hypothesis of Alzheimer’s disease : bench to bedside and beyond , ” Neurodegenerative Diseases , vol . 7 , no . 1 – 3 , pp . 116 – 121 , 2010 . [ 304 ] C . E . Isaacs , R . Kascsak , R . K . Pullarkat , W . Xu , and K . Schneidman , “Inhibition of herpes simplex virus replication by retinoic acid , ” Antiviral Research , vol . 33 , no . 2 , pp . 117 – 127 , 1997 . [ 305 ] E . D . To ﬀ anello , E . M . Inelmen , N . Minicuci et al . , “Ten - year trends in vitamin intake in free - living healthy elderly people : the risk of subclinical malnutrition , ” Journal of Nutrition , Health and Aging , vol . 15 , pp . 99 – 103 , 2010 . [ 306 ] F . J . Jimenez - Jimenez , J . A . Molina , F . de Bustos et al . , “Serum levels of β - carotene , α - carotene and vitamin A in patients with Alzheimer’s disease , ” European Journal of Neurology , vol . 6 , pp . 495 – 497 , 1999 . [ 307 ] D . N . Frank , W . Zhu , R . B . Sartor , and E . Li , “Investigating the biological and clinical signiﬁcance of human dysbioses , ” Trends in Microbiology , vol . 19 , no . 9 , pp . 427 – 434 , 2011 . [ 308 ] B . Wolozin , W . Kellman , P . Ruosseau , G . G . Celesia , and G . Siegel , “Decreased prevalence of Alzheimer disease associ - ated with 3 - hydroxy - 3 - methyglutaryl coenzyme A reductase inhibitors , ” Archives of Neurology , vol . 57 , no . 10 , pp . 1439 – 1443 , 2000 . [ 309 ] M . C . Morris , D . A . Evans , J . L . Bienias et al . , “Consumption of ﬁsh and n - 3 fatty acids and risk of incident Alzheimer disease , ” Archives of Neurology , vol . 60 , no . 7 , pp . 940 – 946 , 2003 . [ 310 ] L . B . Lopez , D . Kritz - Silverstein , and C . E . Barrett - Connor , “High dietary and plasma levels of the omega - 3 fatty acid docosahexaenoic acid are associated with decreased dementia risk : the Rancho Bernardo study , ” Journal of Nutrition , Health and Aging , vol . 15 , pp . 25 – 31 , 2010 . [ 311 ] V . Solfrizzi , F . Panza , and A . Capurso , “The role of diet in cognitive decline , ” Journal of Neural Transmission , vol . 110 , no . 1 , pp . 95 – 110 , 2003 . [ 312 ] P . L . McGeer , M . Schulzer , and E . G . McGeer , “Arthritis and anti - inﬂammatory agents as possible protective factors for Alzheimer’s disease : a review of 17 epidemiologic studies , ” Neurology , vol . 47 , no . 2 , pp . 425 – 432 , 1996 . 34 International Journal of Alzheimer’s Disease [ 313 ] D . A . Snowdon , “Healthy aging and dementia : ﬁndings from the nun study , ” Annals of Internal Medicine , vol . 139 , no . 5 , pp . 450 – 454 , 2003 . [ 314 ] A . D . Smith , S . M . Smith , C . A . de Jager et al . , “Homo - cysteine - lowering by b vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment : a randomized controlled trial , ” PLoS ONE , vol . 5 , no . 9 , Article ID e12244 , pp . 1 – 10 , 2010 . [ 315 ] M . L . Daviglus , B . L . Plassman , A . Pirzada et al . , “Risk factors and preventive interventions for Alzheimer disease : state of the science , ” Archives of Neurology , vol . 68 , no . 9 , pp . 1185 – 1190 , 2011 . [ 316 ] X . Song , A . Mitnitski , and K . Rockwood , “Nontraditional risk factors combine to predict Alzheimer disease and dementia , ” Neurology , vol . 77 , no . 3 , pp . 227 – 234 , 2011 . [ 317 ] D . E . Barnes and K . Ya ﬀ e , “The projected e ﬀ ect of risk factor reduction on Alzheimer’s disease prevalence , ” The Lancet Neurology , vol . 10 , no . 9 , pp . 819 – 828 , 2011 . [ 318 ] H . B . Larman , Z . Zhao , U . Laserson et al . , “Autoantigen dis - covery with a synthetic human peptidome , ” Nature Biotech - nology , vol . 29 , no . 6 , pp . 535 – 541 , 2011 . [ 319 ] J . Miklossy , “Alzheimer’s disease—a neurospirochetosis . Analysis of the evidence following Koch’s and Hill’s criteria , ” Journal of Neuroinﬂammation , vol . 8 , pp . 90 – 96 , 2011 . [ 320 ] E . Nagele , M . Han , C . Demarshall , B . Belinka , and R . Nagele , “Diagnosis of Alzheimer’s disease based on disease - speciﬁc autoantibody proﬁles in human sera , ” PLoS ONE , vol . 6 , no . 8 , Article ID e23112 , 2011 . [ 321 ] L . Restrepo , P . Sta ﬀ ord , D . M . Magee , and S . A . Johnston , “Application of immunosignatures to the assessment of Alzheimer’s disease , ” Annals of Neurology , vol . 70 , no . 2 , pp . 286 – 295 , 2011 . Submit your manuscripts at http : / / www . hindawi . com Stem Cells International Hindawi Publishing Corporation http : / / www . hindawi . com Volume 2014 Hindawi Publishing Corporation http : / / www . hindawi . com Volume 2014 MEDIATORS INFLAMMATION of Hindawi Publishing Corporation http : / / www . hindawi . com Volume 2014 Behavioural Neurology Endocrinology International Journal of Hindawi Publishing Corporation http : / / www . hindawi . com Volume 2014 Hindawi Publishing Corporation http : / / www . hindawi . com Volume 2014 Disease Markers Hindawi Publishing Corporation http : / / www . hindawi . com Volume 2014 BioMed Research International Oncology Journal of Hindawi Publishing Corporation http : / / www . hindawi . com Volume 2014 Hindawi Publishing Corporation http : / / www . hindawi . com Volume 2014 Oxidative Medicine and Cellular Longevity Hindawi Publishing Corporation http : / / www . hindawi . com Volume 2014 PPAR Research The Scientific World Journal Hindawi Publishing Corporation http : / / www . hindawi . com Volume 2014 Immunology Research Hindawi Publishing Corporation http : / / www . hindawi . com Volume 2014 Journal of Obesity Journal of Hindawi Publishing Corporation http : / / www . hindawi . com Volume 2014 Hindawi Publishing Corporation http : / / www . hindawi . com Volume 2014 Computational and Mathematical Methods in Medicine Ophthalmology Journal of Hindawi Publishing Corporation http : / / www . hindawi . com Volume 2014 Diabetes Research Journal of Hindawi Publishing Corporation http : / / www . hindawi . com Volume 2014 Hindawi Publishing Corporation http : / / www . hindawi . com Volume 2014 Research and Treatment AIDS Hindawi Publishing Corporation http : / / www . hindawi . com Volume 2014 Gastroenterology Research and Practice Hindawi Publishing Corporation http : / / www . hindawi . com Volume 2014 Parkinson’s Disease Evidence - Based Complementary and Alternative Medicine Volume 2014 Hindawi Publishing Corporation http : / / www . hindawi . com